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1 ABSTRACT 
This PhD thesis is focused on the study of the evolution of the proteolytic phenomenon in dry-cured hams as 
a function of the technological process (with particular emphasis on the possible technological solution 
aimed at reducing salt content) and on the evaluation of the functional properties linked to the occurrence 
and possible formation of bioactive peptides (in particular, antioxidant and antihypertensive activity). The 
characterization of the peptide profile and the study of its evolution is carried out by advanced methods of 
mass spectrometry hyphenated with chromatographic and electrophoretic separations. The evaluation of the 
functional properties is performed by in vitro tests, taking into account also the effect of the gastrointestinal 
digestion on the possible release of active peptides sequences encrypted in meat proteins. For this aspect, the 
project is also aimed at obtaining structure-activity relationships for the identified peptides and to perform 
the synthesis of the most significant structures in order to better characterize their properties. 
 
Riassunto 
Lo scopo di questo progetto di dottorato è quello di studiare l’evoluzione del fenomeno proteolitico in 
prosciutti crudi stagionati in funzione delle caratteristiche tecnologiche di produzione (con particolare 
riferimento alle soluzioni tecnologiche che permettano di ridurre il contenuto di sale) e di valutare le 
proprietà funzionali legate alla presenza e/o alla formazione di peptidi bioattivi (in particolare, attività 
antiossidante e antiipertensiva). La caratterizzazione del profilo peptidico e lo studio della sua evoluzione 
con la stagionatura viene effettuata mediante l’utilizzo di tecniche avanzate di spettrometria di massa 
accoppiate a metodi di separazione cromatografici e/o elettroforetici. La valutazione delle proprietà 
funzionali sarà condotta mediante test in vitro, considerando anche l’effetto della digestione 
gastrointestinale sul possibile rilascio di sequenze peptidiche bioattive incluse nelle proteine della carne. Per 
questo aspetto, il progetto ha anche l’obiettivo di studiare le correlazioni struttura-attività dei peptidi 
identificati e di realizzare la sintesi delle sequenze più significative per studiarne meglio le proprietà. 
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2 INTRODUCTION 
2.1 DRY-CURED HAMS 
There are many types of dry-cured hams whose main characteristics depend on the pig crossbreed, age, 
composition of the feed and type of production process. Some of the most important dry-cured hams are: 
Spanish Iberian and Serrano hams, Italian Parma and San Daniele hams and French Bayonne ham (Toldrà,  
2006). 
Traditional dry-cured ham is a high-quality product with a typical and characteristic texture and flavour. 
These parameters require a long process of production involving salting, post-salting, and ripening steps, 
which could last up to 24 months or even more.  
2.1.1 PRODUCTION PROCESS  
Dry-cured hams are manufactured with posterior thighs of domestic heavy pigs.  
The production process of dry-cured hams may be divided in two main phases as a function of applied 
temperatures: the so called “cold phase”, generally a 4°C, which is divided in salting and post-salting steps 
and a second phase, the “hot phase”, generally between 14°C-20°C (the maturation step). The typical 
workflow of a dry-cured ham production process is summarized in Figure 1:  
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Figure 1. Typical workflow of dry-cured ham processing (Mora, 2013). 
1. Salting. Hams are bledded on a steel belt with pressing rollers and receive the adequate amount of 
cure salt on the outer surface. During salting, that is kept under refrigeration (temperatures 
between 2 and 4°C), hams are placed on shelves and they are left to stand for 10–14 days to allow 
salt penetration into the ham (Toldrà, 2006). 
2. Post-salting. In the next stage, named post-salting, the temperature is kept below 4°C for a period 
of time not less than 20 days but not exceeding 2 months. This step allows salt diffusion into the 
full piece.  
3. Ripening. During this step several variable conditions such as time, temperature, relative humidity 
and air velocity could change as a function of the final characteristics of the product. In general, 
hams are placed in natural or air-conditioned chambers and subjected to different time-
temperature-relative humidity cycles. Temperature is usually held between 14 and 20°C with a 
relative humidity decreasing from 90 to 70%. Hams ripening (or ageing or maturation time) might 
take from 6 to 18 months. The external part of the ham, which mainly corresponds to the muscle 
Semimembranosus (SM), as shown in Figure 2, dries up during the process due to the dehydration. 
On the other hand, internal muscles such as Biceps femoris (BF) present higher residual moisture 
content that allows a better enzyme activity for longer periods of time, thus inducing larger 
biochemical changes (Toldrà, 1997).   
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Figure 2. Muscles in dry cured hams: biceps femoris and semimembranosus muscle. 
 
Many biochemical reactions take place during this process and are responsible for the final characteristic 
texture and flavour properties of the product (Toldrà, 2002). In order to properly understand them, it is 
essential to deeply know muscle structure and composition. 
2.2 PROTEINS AND PROTEOLYSIS 
2.2.1 Muscle composition. 
Meat derives from the biochemical processes that take place in the skeletal muscles of slaughtered animals 
upon resolution of rigor mortis. 
Skeletal muscle is composed of long, thin cells arranged in mutually parallel fibers. Each fiber is 
surrounded by connective tissue called endomysium. The fibers are then arranged in bundles surrounded by 
large sheets of thin connective tissue known as perimisium. Finally, more units of muscle bundles are held 
together by a large and thick layer of connective tissue called epimysium. The membrane that surrounds 
each individual fiber is called sarcolemma. Each fiber is comprised of many smaller myofibrils that are the 
constitutive contractile elements. The myofibrils are composed of actin and myosin filaments repeated in 
units called sarcomeres, the basic functional units of the muscle fiber. The sarcomere is responsible for 
skeletal muscle's striated appearance and forms the basic machinery necessary for muscle contraction. A 
sarcomere has two distinct bands – an 'I' band and an 'A' band. The 'I' band corresponds to an area where 
the actin proteins are located. The 'A' band corresponds to the area in which actin and myosin overlap. An 
'H' zone marks the location of myosin proteins only. The boundary of each sarcomere is marked by 'Z' 
lines. 
The myofibrils are constituted in turn by bundles of protein filaments: the thin filaments, consisting of the 
actin protein, together with minor amounts of tropomyosin and troponine, and the thick filaments, that are 
very large and elongated aggregates of myosin. 
The bands “I” have only thin filaments while in the “H” bands only thick filaments occur; both types of 
filaments are present in other parts of the band “A” (Toldrà, 2010). 
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Meat is basically composed of water, protein, lipid, minerals and trace amounts of carbohydrate. Lean 
muscle tissue contains approximately 74% water, 21% protein, 4% fat and 1% ash. This proportion may 
change depending on the amount of fattening, especially if adipose tissue is included. The percentages of 
protein and water decrease when fat increases.  
2.2.2 Muscle proteins 
Proteins are the major constituent of skeletal muscle and make up approximately 15-22% of its weight. 
Muscle proteins may be classified in three main groups: myofibrillar, sarcoplasmic and stromal proteins. 
 Myofibrillar proteins. These proteins are soluble in high ionic strength buffers. They are the main 
constituents of the structure of the myofibrils, and, in fact, myosin and actin provide the structural 
backbone of the myofibril. Tropomyosin and troponin are regulatory proteins associated with muscle 
contraction. The proteins in Z line serve as bridges between the thin filaments of adjacent sarcomeres. 
Titin and nebulin are two very large proteins, running in parallel to the long axis of myofibril, that 
contribute to the longitudinal continuity and integrity of muscle cells. Desmin connects adjacent 
myofibrils at the level of Z line. 
 Sarcoplasmic proteins. These proteins are water-soluble proteins, composing about 30-35% of total 
muscle proteins. Sarcoplasmic proteins comprise a high number of different proteins, mainly metabolic 
enzymes (mitochondrial, lysosomal, microsomal, nuclear or cytosolic) and myoglobin. Some 
hemoglobin may also remain in the muscle, although most blood is drained from muscle during 
bleeding. Myoglobin is the protein pigment responsible for the red meat color. 
 Stromal proteins. Collagen is the basic protein-forming part of the connective tissue that surrounds the 
fibers and muscles (epimysium, perimysium and endomysium). Collagen provides strength and support 
to the muscle structure (Toldrà, 2002). 
 
Several muscle proteases (cathepsins, calpains, peptidases and aminopeptidases) and lipases 
(lysosomal acid lipase, acid phospholipase and adipose tissue lipase) are involved in important 
biochemical mechanisms taking place during the processing of dry-cured meat products which are 
directly related to the final quality. These enzymes are affected by the conditions typically found in the 
processing of dry-cured meat products, being dehydration one of the most important factors (Toldrà,  
2006). 
2.2.3 Proteolysis  
One of the most important biochemical changes that occurs during dry-curing is the intense proteolysis that 
takes place as a result of the action of endogenous muscle peptidases. It is assumed that the main enzymes 
responsible for the degradation of muscle proteins during this period are endopeptidases, mainly calpains 
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and cathepsins, and certain groups of exopeptidases (Toldrá, 1998b;Toldrà,  2002). The proteolysis process 
is summarized in the following Figure 3: 
 
Figure 3. Flow chart showing the major steps in post-mortem proteolysis (Toldrà, 1998a). 
 
 Endopeptidases. The action of muscle endopeptidases such as cathepsins and calpains is of great 
importance during processing because they are directly responsible for changes in postmortem muscle 
texture: in fact they degrade the muscle protein structure by cleaving intact proteins, giving rise to large 
polypeptides which are further degraded by exopeptidases (Lametsch, 2003). Between these 
endopeptidases, cathepsins B, H , and L have been reported to be stable during dry-cured ham processing, 
showing activity even after 15 months of processing (Toldrá, 1993), whereas cathepsin D activity 
disappears after 6–10 months of processing (Rico, 1991). An excess of activity of cathepsins can damage 
the texture of the product, inducing a clear effect also on sensory quality (Virgili, 1995). Calpains can 
participate in the post-mortem muscle proteolysis only during the first stages of the curing processes since 
its stability is rather poor and the activity disappears in near 2 weeks (Toldrá, 1998b).  
Exopeptidases. These proteolytic enzymes degrade the large polypeptides generated by endopeptidases, 
giving rise to small peptides and free amino acids. In this sense, dipeptidyl peptidases (DPP I, II, III, and 
IV) are a group of enzymes able to release different dipeptides from the N-terminal site of peptides. The 
DPP II activity is relevant only from the end of the post-salting period (50 days) up to 240 days. The 
contribution of DPP IV activity during dry-curing is also expected although in a lower degree, as it 
expresses a low percentage of activity at pH around 6.0 and it is partially inhibited by NaCl (Sentandreu, 
2001). Its activity decreases to very low values at 240 days, although it remains active until the end of the 
process. 
 Aminopeptidases. These enzymes are responsible for the release of amino acids from the N-terminus of 
peptides and proteins. Their activities are relevant for the development of the characteristic dry-cured 
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flavour of dry-cured ham that is attributed to the accumulation of free amino acids. Aminopeptidase activity 
is involved in the later stages of protein degradation:  in meat products it has been detected even after more 
than 12 months of processing. Curing agent, the presence of other peptides or many other factors can 
modulate the activity of these enzymes (Toldrá, 2000).  
Exopeptidases. Carboxypeptidases and peptidyl dipeptidases are responsible for the hydrolysis of amino 
acids and dipeptides, respectively, from the C-terminal side of the protein fragments. Their stability during 
curing period remains unknown: these groups of enzymes have not been so well studied in dry-cured ham 
(Mora, 2013). 
 
2.3 THE ROLE OF SODIUM CHLORIDE AS CURING AGENT 
 
Salt is one of the most widely used additives in food industries because of its low cost and varied 
properties. The first capacity of sodium chloride is to reduce water activity values and so it’s used for his 
preservative and antimicrobial effect but an excess of intake of this salt could have negative effects on 
human health. 
2.3.1 Sodium and health implications  
The trends in food industries point to salt replacement or reduction due to the negative effects of excess 
dietary intake of sodium, which has been linked to hypertension and, consequently, to an increased risk of 
cardiovascular disease (Morgan, 2011). The main source of sodium in the diet is sodium chloride and great 
contributions are given by meat products. The average total daily sodium intake per capita in developed 
countries is 4–5 g of Na (10–12 g of NaCl), which is up to 25 times greater than the minimum adult 
requirement (0.5 g of NaCl) (Katsiari, 2000). Therefore, the need to reduce salt intake for the serious public 
health implications. 
 
2.3.2 Salt reduction in dry-cured ham 
 
Salt reduction is not an easy task to achieve in dry-cured ham. In fact salt has a great number of advantages, 
inducing: 
 a good microbial stability through the reduction of water activity; 
 a pleasant salty taste; 
 a partial solubilization and cohesiveness of myofibrillar proteins;  
 an important inhibition of most muscle proteases (Armenteros, 2008); 
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  the development of the typical color: the pigment responsible for the stable pink-red color is the 
Zinc-protoporphyrin IX (Wakamatsu, 2004),  generated through a substitution process of the heme 
iron atom by a zinc atom, a metal of which pork meat is rich. The zinc-chelatase enzyme seems to 
be involved in this reaction, catalyzing the substitution of iron with zinc in presence of salt and of 
mild temperature (Benedini, 2008); 
  formation of flavor volatiles in dry-cured hams catalyzing oxidation as a pro-oxidant agent 
(Coutron-Gambotti, 1999).  
The reduction in the total amount of salt has been found to cause excessive proteolysis and considerable 
softening due to the intense action of muscle endopeptidase enzymes (Virgili, 1995). Furthermore, hams 
cured with 6% salt have been found to be significantly drier, harder and more fibrous than hams cured with 
3% salt, which (3% salt) moreover have a better salty taste (Andrés, 2004). The reduction could have a 
negative impact on the control of microorganisms such as Pseudomonas, Acinetobacter, Enterobacteriacee, 
Clostridium and Bacillus. 
 
2.3.3 Salt reduction in dry-cured ham: strategies 
In dry-cured hams, salt uptake can be managed by means of the selection of raw matter, by varying the 
length of the salting phase, by reducing the salt amount added to fresh ham or with the replacement of 
sodium with others salts (Schivazappa, 2013). 
 
Replacement of NaCl by other salt. The replacement with alternative salts like KCl, CaCl2 and MgCl2 can 
affect the sensory quality as for instance: an excess of KCl imparts a noticeable bitterness and astringency 
to the ham. In a recent study, however, differences in perceived quality between dry-cured loins with 50% 
substitution of NaCl by KCl and controls with 100% NaCl were found to be non-significant (Armenteros,  
2009).  
 
Replacement of NaCl by flavour enhancers. To correct the salty taste it is possible to use flavor enhancers 
like monosodium glutamate, sodium lactate or yeast extracts. Taste enhancers work by activating receptors 
in the mouth and throat, which helps to compensate for the salt reduction. Potassium lactate has also been 
used recently as an alternative salt for restructured hams (Fulladosa, 2008). Also phosphates may be used as 
salt substitutes. 
 
16 
 
Optimization of the physical form of salt. Another option is based on the use of a different physical form of 
salt, i.e. changing from granular to flaked: the flaked salt showed greater functionality, in fact it has a faster 
solubility, which allows to use it in smaller amounts (Sacks, 2001). 
 
Alternative processing techniques.  
 Reduction of salt added in % of the weight of the ham: this approach implies consequent changes 
in the process parameters (i.e., longer period of post-salting phase or maturation time). The longer 
resting phase is necessary for microbiological safety reason (Simoncini, 2009). 
 Pre-rigor meat. Meat removed from the carcass early postmortem, when it is still physiologically 
active (it responds to electrical stimulation; it has a high pH and available energy) and it has not 
entered the onset of rigor (stiffening process), is referred to as pre-rigor meat. Pre-rigor meat has 
higher emulsifying capacity and it shows greater extractability of salt soluble proteins (myosin, 
actin, tropomyosin) than post-rigor meat (Claus, 2006). The use of this approach allows to 
improve the extractability of myofibrillar proteins, water-binding and water-holding capacity. 
 High pressure technologies. The texture of the products may be improved by high pressure 
application: this allows to obtain an improvement of protein functionality. 
 
The combinations of any of the above mentioned approaches represent other ways to obtain a reduction in 
salt content in meat product. 
2.4 PEPTIDES RELEASED BY PROTEOLYSIS 
In literature, a great number of papers focus their attention on the evolution of peptides throughout the 
complete processing of high-quality dry-cured ham in order to better understand the path of proteolysis 
mechanisms, flavour development and texture on the final products. Proteomic techniques have been 
successfully applied to the identification of the generated peptides and their sequencing in order also to 
reveal key biomarker peptides controlling the process and establish strategies to drive and optimise enzyme 
reactions for the production of optimal quality products (Mora, 2013). 
For example, a proteomic approach has been carried out to investigate the extensive proteolysis occurring in 
the processing of Serrano ham: a total of 14 peptide fragments derived from myosin light chain I and titin 
have been identified (Mora, 2009). Peptides like TKQEYDEAGPSIVHR, ITKQEYDEAGPSIVHRK 
DSGDGVTHNVPIYE and DSGDGVTHNVPIYEG originated instead from muscle actin (Sentandreu, 
2007). Other 27 peptides generated during the dry-cured processing originated from Troponin T, a 
myofibrillar protein with important structural and regulatory functions have been founded by Mora et al. 
(Mora, 2010). Eleven fragments of myoglobin detected at the end of the processing of dry-cured have been 
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confirmed by (Mora,2012). The increase of small peptides (MW <3000Da) generated during the long 
process of italian-style dry-cured ham have been analyzed by Hansen-Møller et al., (Hansen-Møller, 1997) 
and by Sforza et al. (Sforza, 2006). In this last paper were also detected the presence of γ-glutamyl 
dipeptides. The characteristics of these compounds are their remarkable increase during ham aging and their 
function as taste-active compounds. 
 
2.4.1 NPADs  
Proteolysis is the most important phenomenon occurring during ageing of dry-cured ham, giving rise to an 
accumulation of free amino acids and small peptides having a fundamental high nutritional value and 
playing a fundamental role in flavour development.  
Among the low-molecular weight nitrogen fraction of several cheeses and non-dairy products, a particular 
group of unusual amino acyl derivatives of non-proteolytic origin, namely γ-glutamyl-amino acids, lactoyl-
amino acids and pyroglutamyl-amino acids, collectively known as Non-Proteolytic Aminoacyl Derivatives 
(NPADs), were found in consistent amount (Figure 4).  
 
 
Figure 4. Chemical structures of NPADs (Sforza, 2009). 
 
In particular, γ-glutamyl-phenylalanine (γ -Glu-Phe, brothy, salty, slighty sour), γ-glutamyl-tyrosine (γ -
Glu-Tyr, sour and salty) and γ -glutamyl-leucine (γ -Glu-Leu) have been reported in Comte´ cheese 
(Roudot-Algaron, 1994). In addition to these three compunds, also γ -glutamyl-methionine (γ -Glu-Met), γ -
glutamyl-valine (γ -Glu-Val) and γ -glutamyl-methionine (γ -Glu-Ile) were reported in Grana Padano, 
Parmigiano Reggiano and Asiago cheese (Sforza, 2009). γ -Glutamyl-amino acids has also been reported in 
18 
 
Gouda cheeses (Toelstede, 2009), thus confirming their widespread distribution in dairy products. Their 
total amounts vary between few mg and more than 50 mg per 100 g of cheese. 
Properties of these compounds are still largely unknown, apart from their peculiar characteristic taste, 
which for most of them have been described as kokumi taste (Toelstede, 2009).  
Indeed, γ-Glutamyl-leucine, γ-glutamyl-valine and γ-glutamyl-cysteinyl-alanine having this characteristics 
have been isolated by edible beans (Dunkel, 2007) as well as γ-glutamyl–valyl–glycine discovered in 
Vietnamese fish sauce (Kuroda, 2012). A patent to prepare these interesting flavour compounds have been 
registered (Dunkel, 2007). 
In a recent paper (Bottesini, 2014), the conditions that favour the bioproduction and biodegradation of these 
compounds were investigated using pure enzymes and biological media both on NPAD and their amino 
acidic precursors. The data suggested that their production in cheese, and also their partial degradation, 
might be due to the action of peptidases and γ -glutamyl transpeptidase.  
As well as the other NPADs, pyroglutamyl peptides have been reported in wheat (Higaki-Sato, 2003) and 
mushrooms (Altamura, 1970) and for the first time also in Parmigiano-Reggiano cheese (Sforza, 2009). 
The occurrence in cheese is probably related also to the widespread occurrence of the precursor 
pyroglutamic acid which has been reported to be present in Parmigiano-Reggiano and other hard cheeses, 
derived from an enzymatic reaction that catalyses the internal cyclization of glutamic acid (Mucchetti, 
2002). Derivatives of pyroglutamyl peptides have been patented by Nestle´ SA as umami taste enhancers to 
foodstuffs (Schlichtherle-Cerny, 2003). 
Lactoyl-amino acids were recently reported for the first time in cheeses which have been proved to be 
formed by enzymatic actions of Lactic acid bacteria in Parmigiano-Reggiano cheese starting from lactic 
acid and amino acids. The same activities are responsible for the formation of g-glutamyl-amino acids in 
cheeses.  
Lastly, in a recent paper, all these compounds have been also found in fermented soy sauce: in particular, γ 
-glutamyl, γ -glutamyl, and pyroglutamyl dipeptides, as well as lactoyl amino acids, were identified in the 
acidic fraction of soy sauce (Frerot, 2013). 
Again, the most studied characteristics of all these compounds is their taste enhancing properties both for 
kokumi and umami taste, as proved by several recent activities and patents (Winkel, 2008).  
The presence of small dipeptides with the composition Glu-Phe, Glu-Ile, Glu-Leu and Glu-Tyr has already 
been reported in Parma ham, although at that time not recognized as γ-glutamyl derivatives: their content 
was found to increase during the ripening time and to be possibly linked to the pleasant aged flavour of the 
product (Sforza, 2006). 
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2.5 BIOACTIVE PEPTIDES 
Food proteins have long been recognized for their nutritional and functional properties associated with their 
amino acid content and their physiological utilization of specific amino acids upon digestion and absorption 
but also for their contribution to the physico-chemical and sensory properties of foods. In the last years,  a 
considerable amount of research are also focused on the release of bioactive peptides encrypted in food 
proteins.  Bioactive peptides have been defined as “food derived components (genuine or generated) that, in 
addition to their nutritional value exert a physiological effect in the body”. Bioactive peptides are usually 
composed of 2–20 amino acid residues in length, but some bioactive peptides have been found also with 
>20 amino acid residues. To exert their different physiological effects, bioactive peptides may be absorbed 
through the intestine and subsequently enter the circulatory system, but they also may induce local effects 
in the digestive tract. Food derived bioactive peptides have been shown to display a wide range of 
physiological functions including antihypertensive, antioxidant, opioid agonistic, immunomodulatory, 
antimicrobial, prebiotic, mineral binding, antithrombotic and hypocholesterolemic effects.  
Meat proteins offer huge potential as novel sources of bioactive peptides displaying antihypertensive, 
antioxidant, antimicrobial and antiproliferative effects (Ryan, 2011). 
2.5.1 Antihypertensive peptides 
Hypertension affects one third of the Western worlds’ population and is a known risk factor for stroke and 
cardiovascular disease. ACE inhibitory peptides were first discovered in snake venom and since then 
numerous synthetic ACE inhibitors have been produced, with Captopril being the most common. Captopril 
and other synthetic ACE inhibitors are known to exert various side-effects such as coughing, taste 
disturbances and skin rashes (Atlas, 2007): for these reasons, research efforts have been oriented towards the 
discovery of antihypertensive peptides derived from food, as an alternative and/or complementary way to 
control blood pressure.  
 
2.5.1.1  Mechanism of ACE inhibition  
ACE, or kininase ІІ, is a dipeptidyl carboxy peptidase (a zinc metallopeptidase) found in various tissues in 
the body and it is integral to the moderation of blood pressure and normal heart function (Shalaby, 2006). 
In the rennin-angiotensin system, ACE catalyzes the conversion of the inactive form of angiotensin I (Ang 
І) to the potent vasoconstrictor angiotensin II (Ang ІІ) and at the same time it deactivates the hypotensive 
peptide, bradykinin, by cleaving the C-terminal dipeptide from both Ang І (His-Leu) and bradykinin 
(Figure 5). Ang ІІ is a documented potent vasoconstrictor and it is also responsible for the expansion of 
vascular volume via sodium retention and fluid retention (Brown, 1998).  
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 While synthetic ACE inhibitors, such as Captopril function by directly blocking the action of ACE, ACE 
inhibitory peptides function by reacting with ACE, thus ACE is unavailable to cleave Ang І and  prevent the 
production of the vasoconstrictor Ang ІІ (Iwaniak, 2014) .  
 
Figure 5. Action of Angiotensin-Converting-Enzyme (Iwaniak, 2014). 
 
2.5.1.2 ACE inhibitor type peptides 
 
The ACE inhibitory peptides can be divided into three categories: 
1. “true inhibitor type” peptides: peptides that bind to the enzyme, blocking the activity of ACE 
without being modified, thus preventing the binding of  the natural substrate (Ang І) to the active 
site; 
2.  “substrate type” peptides: they are hydrolyzed by ACE resulting in weak inhibitory activity; 
3.  “pro-drug type” inhibitors: the peptides in this category are converted to “true inhibitor type” 
peptides by ACE or proteases of the digestive tract. 
In vivo studies have demonstrated that only peptides belonging to the groups of true inhibitor type or pro-
drug type reduce the systolic blood pressure of spontaneously hypertensive rats (SHR). 
To date, the majority of ACE inhibitory peptides found in meat can be classified as true inhibitor type 
peptides (Ahhmed, 2010).  
2.5.1.3 Structure correlation of ACE inhibitory peptides 
The mode of action of the majority of ACE inhibitory peptides is thought to be as competitive substrates for 
ACE. Several structure activity relationships have been hypothesized for ACE inhibitory peptides, thus 
characteristics positively influencing the ACE inhibitory activity are the followings:   
 for tripeptides, the presence of hydrophobic amino acid residues at the C-terminal end with, at the 
penultimate positions, aliphatic (V, I, and A), basic (R) and aromatic (Y and F) residues; the 
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presence of aromatic (W, Y, and F), proline (P) and aliphatic (I, A, L and M) residues at the 
ultimate position of the C-terminal end of the peptide, probably on account of the interaction of 
these residues with the three hydrophobic sub-sites located on the active site of ACE. The positive 
charge associated with arginine or lysine at the C-terminus has also been associated with the ACE 
inhibitory activity of some peptides; the presence of hydrophobic amino acids also at the N-
terminal end of the peptide (Ahhmed, 2010); 
 for tetrapeptides, the most favorable amino acids (starting from C-terminus) are Tyr and Cys. 
Residues such as His, Trp, and Met are usually found in the 2nd position of a tetrapeptide. In the 
3rd position, Ile, Leu, Val, and Met are favorable with Trp placed as the 4th residue (Iwaniak, 
2014). 
 
Hydrophilic peptides possess weak or no ACE inhibitory activity, since hydrophilic peptides are 
incompatible with the active sites of ACE. Indeed, inhibition of ACE is achieved by hydrophobic peptides 
which display high affinity to the active sub-sites of ACE (Matsui, 2006). 
 
2.5.1.4 Ace-inhibitory peptides from meat protein 
Antihypertensive peptides have been identified in meat from various sources (Jang, 2005; (Escudero, 
2013a): as far as pork meat, it has been demonstrated that biopeptides may be released by meat proteins by 
the action of endogenous or exogenous peptidases during processing (Lafarga, 2014a). Antihypertensive 
peptides have also been identified and their activity has been proven both in vitro as well as on 
spontaneously hypertensive rats (Escudero, 2013a). Antihypertensive peptides were found after gastro-
intestinal digestion of pork meat by the action of pepsin and pancreatin at simulated gut conditions: ER, 
KLP, and RPR with IC50 values of 667 μM, 500 μM, and 382 μM, respectively. The strongest ACE 
inhibition was observed for peptide KAPVA (IC50 = 46.56 μM) followed by the sequence PTPVP (IC50 = 
256.41 μM), peptides that derive from muscle titin (Escudero, 2010). 
In Spanish dry-cured hams, the peptide AAATP was found with an IC50 value of 100 μM which also 
showed a good in vivo activity: indeed, it decreased systolic blood pressure by −25.62±4.5 mm Hg (p<0.05) 
in spontaneous hypertensive rats after 8 h administration (Escudero, 2013a). Another paper reported that the 
water soluble fractions of a Spanish dry-cured ham extract, corresponding to a peptide fraction with 
molecular weight up to 1700 Da, determine changes in systolic blood pressure of spontaneously 
hypertensive rats after oral administration (decrease of 38.38 mm Hg) (Escudero, 2012). 
The identification of bioactive peptides may be also supported by in-silico techniques as recently 
demomstrated by using software able to predict and to identify bioactive peptides (Lafarga, 2014a).  
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2.5.2 Antioxidant peptides 
Antioxidants play a vital role in both food systems as well as in the human body to reduce oxidative 
processes. In foods antioxidants are useful to maintain flavor, texture, and, in some cases, the color during 
storage.  In the human body, endogenous antioxidants help to protect tissues and organs from oxidative 
damage caused by reactive oxygen and reactive nitrogen species. However, in certain circumstances the 
endogenous defense system fails to protect the body against reactive radicals: thus, a great interest has 
aroused for the potential health benefits with no or little side effects of natural antioxidants from food 
resources (Sarmadi, 2010). 
Use of dietary antioxidants has been recognized as potentially effective to promote human health by 
increasing the body’s antioxidant load: in vitro studies using various chemical assays have indicated the 
potential of food-derived peptides to act as antioxidant agents to control various oxidative processes in the 
human body as well as in food. Antioxidant peptides can be released from different proteins of plant or 
animal origin during preparation of protein hydrolysates using exogenous or endogenous enzymes, food 
processing or during microbial fermentation, as well as during gastro-intestinal (GI) digestion of food 
proteins.  
2.5.2.1 Mechanisms of action of antioxidant peptides 
The antioxidant potential is strongly influenced by the amino acid composition, sequence, and size of 
peptides. The different amino acid residues and peptide sequences are responsible for the inhibition of 
oxidative reactions that are initiated by different types of free radicals or pro-oxidants such as metal ions, as 
well as in different molecular environments i.e., aqueous, lipid, or emulsion systems, or different pH 
conditions, or the presence of other compounds in the food matrices or biological systems, etc. (Elias, 
2008). The majority of the antioxidant peptides derived from food sources have molecular weights ranging 
from 500 to 1800 Da (Ranathunga, 2006). In general, all 20 amino acids found in proteins can interact with 
free radicals: the most reactive ones include the nucleophilic sulfur-containing amino acids Cys and Met, the 
aromatic amino acids Trp, Tyr, and Phe, and the imidazole-containing amino acid His; others include 
hydrophobic amino acid residues such as Val or Leu at the N-terminus of the peptides, and Pro, His, Tyr, 
Trp, Met, and Cys in their sequences (Elias, 2008).  
2.5.2.2 Antioxidant assay 
Specific assays have not yet been developed or standardized to measure the antioxidant capacity of peptides 
or peptide mixtures. Therefore, assays that are commonly used for measuring antioxidant capacity of non-
peptidic antioxidants have been used in the literature to measure the antioxidant capacity of peptides as well.  
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On the basis of the chemical reactions, the assays for measuring antioxidant capacity are classified into two 
groups: methods based on hydrogen atom transfer (HAT) and methods based on electron transfer (ET) : 
 HAT assays: oxygen radical absorbance capacity (ORAC), total radical trapping antioxidant 
parameter (TRAP).   The HAT-based assays usually involve the use of a synthetic free radical 
generator, an oxidizable molecular probe, and an antioxidant. Quantification is obtained from 
kinetic curves derived from competitive reaction kinetics (Sarmadi, 2010); 
 ET assays: Trolox equivalent antioxidant capacity (TEAC), the ferric ion reducing antioxidant 
power (FRAP) and 2,2-diphenyl-1-picrylhydrazyl radical-scavenging capacity (DPPH)  or 2,2-
Azino-bis-3-ethylbenzothyazoline-6-sulfonic acid (ABTS). These methods measure the capacity 
of an antioxidant to reduce a chromophoric oxidant, which changes colour when reduced: the 
degree of color change is correlated with the sample’s antioxidant activity. These assays measure 
the radical-scavenging activity of an antioxidant (Di Bernardini, 2011). 
More commonly used assays include measuring the inhibition of lipid peroxidation in a linoleic acid model 
system and the capacity to scavenge the DPPH radical in studying radical-antioxidant interactions. The 
DPPH, however, is a test that is more affected by the composition of the peptides, the abundance in free 
amino acids, the size and the molecular weight of the peptides, the effect of the solvent / solubility of the 
peptide due to steric hindrance that is created between the radical and the same amino acid residues. It is 
also a test which does not allow to evaluate the hydrophilic antioxidants because it is conducted in ethanol. 
The ABTS assay instead allows to study both hydrophilic and lipophilic antioxidants and it is not affected 
by steric hindrance (Samaranayaka, 2011). 
Lipid oxidation occurs when oxygen reacts with lipids in a series of free radical chain reactions that lead to 
complex chemical changes. Oxidation of lipids in foods causes quality losses. In vivo, lipid oxidation may 
play a role in coronary heart disease, atherosclerosis, cancer, and the ageing process (Joshipura, 1996). The 
susceptibility of low density lipoproteins (LDL) to radical peroxidation is believed to be an important factor 
in the process responsible for foam-cell formation and atherosclerosis. 
Many factors affect oxidation, including temperature, oxygen pressure, metal catalysts, fat composition and 
form, that may vary depending on the oxidation conditions used (Frankel, 1993). Antioxidants, when 
present in the medium, can delay or inhibit lipid oxidation. The use of iron or copper enhance the rate of 
oxidation, principally by homolytic cleavage of the weak O-O bond in hydroperoxides and subsequent 
formation of radicals (Bondet, 2000). Through reaction with acidic Fe(II)-thiocyanate, these peroxides can 
be colorimetrically determined by formation of the red Fe(III)-thiocyanate complex. Peroxide production as 
a function of time in a LA system was used to determine both antioxidant and prooxidant activities initiated 
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by a metal catalyst (Cu(II)) (Fukumoto, 2000). The antioxidant activity of protector compounds added to the 
medium is inversely proportional to the amount of Fe(III)–thiocyanate complex formed per unit time. 
Lipid peroxidation induced by transition metal ions (e.g., copper(II)) requires the occurrence of a redox 
cycle with Cu(II) (initiation), where AH symbolizes an antioxidant (such as ascorbic acid) and LOOH a 
lipid hydroperoxide: 
Cu
2+
 +AH → A• + H+ +Cu+ (1a) 
Cu
2+
 +LOOH → LOO• + H+ +Cu+ (1b) 
Propagation proceeds via molecular oxygen or Fenton-type reactions: 
Cu
+
 +O2→ Cu
2+
 +O2 
−• (slow) (2) 
Cu
+
 +LOOH → Cu2+ +LO• + OH− (fast) (3) 
The lipid oxidation chain reaction propagates as these lipid radicals (LO• and LOO•) react with other lipids 
in their immediate vicinity or with other radicals (McClements, 2000). 
 
2.5.2.3 Antioxidant peptides in meat products 
The total antioxidant capacities of different types of raw meat (beef, chicken, pork) has been investigated as 
ABTS scavenging activity and they ranged between 25.9±1.0 and 51.7±1.2 mmol Trolox Eq./k: the highest 
value has been measured for raw chicken, followed from pork and beef (Serpen, 2012). 
The antioxidant activity of peptides in a water soluble extract of Spanish dry-cured ham have been studied 
using the DPPH radical-scavenging assay and the reducing power assay. The strongest radical-scavenging 
activity was observed for the peptide SAGNPN whit an inhibition of 50% at a concentration of 1.5 mg/ml. 
On the other hand, the peptide GLAGA showed the higher reducing power with 0.5 units of absorbance at 
700 nm at a concentration of 1 mg/ml (Escudero, 2013b). In another paper, the peptide SNAAC was 
identified with an IC50 of 75.2 μM for DPPH radical-scavenging assay and 205 μM for ferric-reducing 
antioxidant (Mora, 2014).  
Well known antioxidant peptides are also, for example, carnosine (-alanyl-L-histidine) and anserine (-
alanyl-L-3-methyl-L-histidine). Carnosine can act both as a free radical scavenger as well as a metal ion 
chelator, and it has demonstrated both in vivo and in vitro antioxidative activity in rat skeletal muscle lipid 
and protein components under the conditions of oxidative stress (Nagasawa, 2001). 
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2.5.3 Models of gastrointestinal digestions 
Simulated gastro-intestinal digestion is widely employed in many fields of food and nutritional sciences: 
this method typically include the oral, gastric and small intestinal phases, and occasionally large intestinal 
fermentation. In addition, it tries to mimic in vivo physiological conditions, taking into account the presence 
of digestive enzymes and their concentrations, pH, digestion time, and salt concentrations, among other 
factors. However, the results of in vitro digestion model are often different if compared to those found using 
in vivo models because of the difficulties in accurately simulating the highly complex physicochemical and 
physiological events occurring in animal and human digestive tracts. In vivo feeding methods, using animals 
or humans, usually provide the most accurate results (Boisen, 1991), but they are time consuming and 
costly, which explains why so much effort has been devoted to the development of in vitro procedures 
(Coles, 2005). 
The ideal in vitro digestion method would provide accurate results in a short time (Hur, 2011).  
In the literature many in vitro digestion models are reported that differ for: 
 the number and type of steps included in the digestion sequence (mouth, stomach, small 
intestine, large intestine); 
 the composition of the digestive fluids used in each step (enzymes, salts, buffers, biological 
polymers, and surface-active components); 
 the mechanical stresses and fluid flows utilized in each step in the digestion sequence 
(magnitude and direction of applied stresses, flow geometries, and flow profiles). However, 
the majority of models reported in literature are static ones, that are useful to study the 
digestion of single substrates or simple meals under specific conditions (Hur, 2011).  
The most frequently utilized enzymes and other biological molecules used within in vitro digestion models 
were pepsin, pancreatin, trypsin, chymotrypsin, peptidase, -amylase, lipase, bile salt, and mucin. Several 
studies have utilized enzymes collected from human subjects, whereas others have used enzymes extracted 
from animal or plant sources. The types of enzyme included within an in vitro digestion model tend to 
reflect the major food components being investigated, e.g., lipases for lipid digestion, proteases for protein 
digestion, and amylases for starch digestion. It should be noted that different enzymes are usually added 
sequentially, rather than all together, so as to simulate the different steps of the digestive process. The 
enzyme composition of a particular digestive fluid can often be simulated by mixing together appropriate 
amounts of pure enzymes (Boisen, 1991). It should also be noted that enzymes often require additional 
components within the digestive fluids to operate efficiently.  
For all in vitro digestion models the digestion temperature was 37 °C.  
The length of the incubation times of samples in the various simulated digestive fluids should mimic the 
reported digestion times in humans. Important factors influencing the digestion time depends upon 
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individual characteristics (age, sex, health status, mental state, time of the day) and food properties (total 
amount, composition, particle size) (Hur, 2009). 
Many paper reported the use of a single purified enzyme, also for complex biological mixture, because it 
facilitates the standardization of in vitro digestion models, which enables more consistent laboratory-to-
laboratory comparisons (Coles, 2005). However, the digestion of one nutrient is often influenced by the 
digestion of other nutrients, and so it is often more realistic to use a complex mixture of enzymes rather 
than a single purified one (Boisen, 1991).  
In order to allow in the future the comparison between different in vitro static gastrointestinal digestions 
models, a recent paper, within the COST Infogest network (which is an international network joined by 
more than 200 scientists from 32 countries working in the field of digestion), proposed a general 
standardized and practical static digestion method based on physiologically relevant conditions that can be 
applied for various endpoints, which may be amended to accommodate further specific requirements. 
(Minekus, 2014). 
Another fundamental part of the study of peptide bioactivity is related to their ability to cross the intestinal 
barrier thus reaching blood circulation and allowing to exert a systemic action. Also the eventual 
modification taking place on account of epithelial cell enzymatic activities should be considered. 
 
2.5.4 Peptides transport across the intestinal barrier 
Cell culture models have been utilized as part of in vitro digestion models, in order to assess the 
bioavailability of nutrients. In particular, the Caco-2 cell culture model has been widely used as a predictive 
tool for the absorption of bioactive components from foods and pharmaceutical preparations. 
As far as peptides are concerned, small di- and tri-peptides may be absorbed intact across the brush border 
membrane using H
+
-coupled PepT1 transporter system (Vermeirssen, 2002). Larger water-soluble peptides 
can cross the intestinal barrier paracellularly via the tight junction between cells, while highly lipid-soluble 
peptides may diffuse via the transcellular route. Peptides may also enter the enterocytes via endocytosis, 
which entails membrane binding and vesiculisation of the material (Ziv, 2000). The intestinal basolateral 
membrane also possesses a peptide transporter, which facilitates the exit of hydrolysis-resistant small 
peptides from the enterocyte into the portal circulation. Further, the contribution of each route and the 
ability of individual peptides to cross the membrane depends upon the molecular size and other structural 
characteristics such as hydrophobicity, as well as their resistance to brush-border peptidases (Satake, 2002). 
The major pathways for intestinal absorption of peptides are display in Figure 6. 
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Figure 6. Major pathways for intestinal absorption of bioactive peptides. Mechanisms for absorption of bioactive 
peptides in the intestine are largely categorized into carrier-mediated transport, transcytosis and paracellular 
passive diffusion (Wadaa, 2014) .  
 
2.5.4.1 Caco-2 cells line  
Peptides may exert their actions locally at the level of the gastrointestinal tract or after intestinal absorption 
that allows their distribution to peripheral tissues and organs. Peptides that are resistant to proteolytic 
degradation and are taken up to a significant extent are good candidates to exert beneficial effects in vivo. 
The in vivo determination of intestinal uptake of nutrients in the intestine is technically difficult, so 
transport studies across human colon adenocarcinoma (Caco-2) cell monolayers have been routinely utilized 
as an in vitro model to mimic absorption by human intestinal epithelium. The parental cell line undergoes in 
culture a process of spontaneous differentiation that leads to the formation of a monolayer of cells, 
expressing several morphological and functional characteristics of the mature enterocyte such as cell 
polarization, microvillous structure, carrier-mediated transport systems, functional tight junctions between 
adjacent cells and expression of brush border membrane associated proteases and peptidases. The intestinal 
absorption predicted by using Caco-2 cell monolayers is well correlated with intestinal uptake in vivo, at 
least from a qualitative viewpoint (Picariello, 2013). To better reproduce the steric conditions existing in the 
intestine in vivo, Caco-2 cells were cultured on permeable filter supports that allow free access of ions and 
nutrients to the two sides of the cell monolayer. Trans-epithelial electrical resistance after confluence and 
permeability of marker molecules have been used to monitor the integrity of the cell layer, and ultrastructure 
morphology, by transmission electron microscopy, has been utilized to check for morphological 
differentiation. The mosaic expression of brush border enzymes in confluent Caco-2 cell is present.  
Culture-related conditions were shown to influence the expression of these characteristics, in part due to the 
intrinsic heterogeneity of the parental cell line, leading to selection of sub-populations of cells becoming 
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prominent in the culture. Culture-related conditions, as well as different Caco-2 cell lines utilized in 
different laboratories, often make it extremely difficult to compare results in the literature (Sambuy, 2005).  
2.5.4.2 Ussing chamber 
The Ussing chamber provides a physiological system to measure the transport of ions, nutrients, and drugs 
across various epithelial tissues. One of the most studied epithelia is the intestine. The method was 
developed over 50 years ago by the Danish biologist Hans H. Ussing as a means to understand the 
phenomenon of active NaCl transport (Clarke, 2009). The intestinal segment is mounted in an Ussing 
chamber where one side will be exposed to buffer with the compound of interest (mucosa  side) and the 
other side to buffer without the compound of interest (serum side). This method is defined as an ex-vivo 
technique due to use of an intestinal tissue. 
 
2.6  METHODS FOR THE STUDY AND THE CHARACTERIZATION OF    
PEPTIDES 
2.6.1 High-performance liquid chromatography (HPLC) 
High-performance liquid chromatography (HPLC) is now firmly established as the premier technique for 
the analysis, characterization and purification of peptides and proteins. Reversed-phase high-performance 
liquid chromatography (RP-HPLC) involves the separation of molecules on the basis of hydrophobicity: the 
separation depends on the hydrophobic binding of the solute molecule from the mobile phase to the 
immobilized hydrophobic ligands attached to the stationary phase. The solute mixture is initially applied to 
the stationary phase in the presence of aqueous buffers, and the solutes are eluted by the addition of organic 
solvent to the mobile phase: elution can proceed either by isocratic conditions (concentration of organic 
solvent is constant) or by gradient elution (the amount of organic solvent is increased over a period of 
time). The solutes are, therefore, eluted in order of increasing molecular hydrophobicity.  
RP-HPLC is a very powerful technique for the analysis of peptides and proteins for the following factors:  
1. excellent resolution that can be achieved under a wide range of chromatographic conditions 
for very closely related molecules as well as structurally quite distinct molecules; 
2. experimental easiness: the chromatographic selectivity can be manipulated through changes in 
mobile phase characteristics; 
3. generally high recoveries and, hence, high productivity;  
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4. excellent reproducibility of repetitive separations carried out over a long period of time, which 
is due partly to the stability of the stationary phase materials, resistant to a wide range of 
mobile phase conditions; 
5. extreme versatility for the isolation of peptides and proteins from a wide variety of synthetic 
or biological sources;  
6. applicability to both analytical and preparative experiments. Analytical applications range 
from the assessment of purity of peptides following solid phase peptide synthesis, to the 
analysis of tryptic maps of proteins. In the case of synthetic peptides, RP-HPLC is generally 
employed both for the initial analysis and the final large-scale purification. The purification of 
synthetic peptides usually involves an initial separation on an analytical scale to assess the 
complexity of the mixture followed by large-scale purification and collection of the target 
product. A sample of the purified material can then be subjected to RP-HPLC analysis under 
the same or different elution conditions to check for purity (Aguilar, 2004).  
2.6.2 Mass spectrometry 
Mass spectrometry is a central analytical technique for protein research and for the study of biomolecules in 
general. A wide range of new mass spectrometry–based analytical platforms and experimental strategies 
have emerged driven by the need to identify, characterize, and quantify proteins and peptides at ever 
increasing sensitivity and in ever more complex samples. Mass spectrometers are used both to: to measure 
simply the molecular mass of a polypeptide as well to determine additional structural features including the 
amino acid sequence or the site of attachment and type of post-translational modifications. In the former 
case, single-stage mass spectrometers are used, acting essentially as balances to weigh molecules. In the 
latter case, after the initial mass determination, specific ions are selected and subjected to fragmentation 
through collision.  
A triple quadrupole, able to perform MS/MS experiments, is achieved by combining three quadrupole units 
in series. A quadrupole consists of four cylindrical rods, set parallel to each other: it’s the component of the 
instrument responsible for filtering sample ions, based on their mass-to-charge ratio (m/z). Ions are 
separated in a quadrupole based on the stability of their trajectories in the oscillating electric fields that are 
applied to the rods. In a triple quadrupole, as shown in Figure 7, the first and third quadrupoles act as mass 
filters and the middle quadrupole is employed as a collision cell.  
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Figure 7. The Triple Quadrupole Mass Spectrometer (Scott). 
. 
In such experiments, referred to as tandem mass spectrometry (MS/MS), detailed structural features of the 
peptides can be inferred from the analysis of the masses of the resulting fragments. Schematic 
representation of various types of tandem mass spectrometry experiments is reported in Figure 8. 
 
Figure 8. Schematic representation of various types of tandem mass spectrometry experiments: a) product ion 
scanning; precursor ion scanning; c) neutral loss scanning; d) multiple ion monitoring (Domon, 2006). 
 (A) Product ion scanning is the most common MS/MS experiment in proteomics: generation of fragment 
ion spectra for the  identification of the amino acid sequence of specific peptides. In this experiment, the 
first analyzer (MS1) is set to a value that selects one specific precursor ion at a time. The selected ion 
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undergoes CID in the collision cell, and the resulting fragments are analyzed by the second analyzer (MS2). 
This process is repeated for different precursors.  
(B) Precursor ion scanning sets the second analyzer (MS2) to transmit only one specific fragment ion to the 
detector. MS1 is scanned to detect all the precursor ions that generate this fragment. Typically, this method 
is used to detect a subset of peptides in a sample that contain a specific functional group, for instance a 
phosphate ester or a carbohydrate modification.  
(C) Neutral loss scanning scans both analyzers in a synchronized manner, so that the mass difference of 
ions passing through MS1 and MS2 remains constant. The mass difference corresponds to a neutral 
fragment that is lost from a peptide ion in the collision cell. The neutral loss scan is therefore used to detect 
those peptides in a sample that contain a specific functional group, as the detection of peptides 
phosphorylated at serine or threonine residues via a loss of phosphoric acid.  
(D) Multiple ion monitoring (MRM) consists of a series of short experiments in which one precursor ion 
and one specific fragment characteristic for that precursor are selected by MS1 and MS2, respectively. 
Typically, the instrument cycles through a series of transitions (precursor fragment pair) and records the 
signal as a function of time (chromatographic elution). MRM is used for the detection of a specific analyte 
with known fragmentation properties in complex samples. (Domon, 2006) 
 
A typical peptide fragmentation is reported in Figure 9. 
 
Figure 9. A typical peptide fragmentation: x, y, z, a, b, c fragments. 
The fragments, obtained from MS/MS experiments, are conventionally denoted by the letters “a, b or c” if 
the charge is retained in the N-terminal fragment and the letters “x, y or z” if the charge is instead retained 
in the C-terminal fragment. The site of fragmentation more likely is the peptide bond, generating the 
fragments to “b and/or y”. 
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3 TRADITIONAL AND REDUCED SALT DRY-CURED 
HAM: STUDY OF THE PEPTIDE FRACTION  
3.1 INTRODUCTION 
Recent innovations in the meat industry are addressed towards the production of healthier meats and 
processed meats. The strategies are based on either reducing the content of unhealthy substances (like less 
added sodium chloride, less nitrate and nitrite) or improving the content of substances with healthy benefits 
(i.e. natural antioxidants, omega-3 fatty acids, probiotics and bioactive peptides). These trends are due to the 
increased attention of consumers to well-being.  
One of the unhealthy substances present in dry-cured ham is the sodium. In Western societies the intake of 
salt is very high, thus leading to a higher risk of hypertension, cardiovascular diseases, diabetes, and kidney 
disease. The reduction of salt in hams is not an easy task, as salt content affects the microbiological growth, 
the proteolysis, the texture of the product, the development of the aroma and flavor, the color. 
In particular, proteolysis, which is the main process taking place during ham maturation and ageing, is 
strongly influenced by salt content, as salt affects aw and enzyme activity. 
To establish strategies for optimizing the enzyme reactions towards optimal quality of the products, and so 
benefit the production and economy related to this important sector, the optimization of the proteomic 
strategy is crucial in the identification of key peptides acting as biomarkers to control and direct the 
industrial processes for dry-cured ham. 
The aim of this work is to study the peptide fraction of traditional hams, obtained by the normal procedure 
applied in the production of Parma ham, and compare it with the peptide fraction characterizing salt-reduced 
dry-cured hams, the latter being obtained by a modified processing aimed at reducing by 25% the sodium 
chloride content. In particular, the salt reduction techniques tested are the conventional technique where salt 
is reduced of 25% as a function of ham weight and another technique that is similar to conventional one but 
it considers also the amount of fat/lean tissue present in legs. 
The aim of the project is to obtain healthier products that nevertheless still maintain the peculiar 
organoleptic properties of the traditional ones. 
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3.2 MATERIALS AND METHODS 
3.2.1 Reagents and solvents 
Bidistilled water was produced in our laboratory by a Millipore Alpha Q purification system (Waters, 
Billerica, MA, USA). Acetonitrile, methanol, L-phenylalanyl-L-phenylalanine (Phe-Phe), acetic acid, 
hydrochloric acid (0,1N),  sodium hydroxide, sodium phosphate dibasic dodecahydrate, sodium phosphate 
monobasic, potassium phosphate monobasic, diethyl ether,  trypsin, dithiothreitol,  iodoacetamide, 
tris(hydroxymethyl)aminomethane (TIS),  trifluoroacetic acid, dimethylformamide, n-butanol, methylene 
chloride, N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU), N,N-
diisopropylethylamine (DIPEA), ethyl acetate, potassium bisulfate, sodium bicarbonate, sodium sulfate 
anhydrous, tetrahydrofuran (THF), barium hydroxide octahydrate, m-cresol and  thioanisol  were all 
purchased from Sigma-Aldrich (St. Louis, MO, USA). Hydrochloric acid (37% v/v), potassium chloride, 
phosphoric acid were purchased from Carlo Erba (Milan, Italy). Formic acid was purchased from Acros 
Organics (Geel, Belgium). Thionyl chloride and ammonium bicarbonate was purchased from Fluka (St. 
Louis, MO, USA). Sodium chloride was purchased from VWR (Milan, Italy).  SDS-PAGE standards Broad 
Range, XT Reducing Agent, XT Sample Buffer 4x, XT MES Running Buffer 20x, Comassie Brillant Blu R-
250 were purchased from BIO-RAD (Hercules, CA, USA).  
 
3.2.2 Samples 
Dry-cured ham samples (n=95) were purchased from the market and from the Experimental Station for the 
Food Preserving Industry (Parma). Samples of Biceps Femoris muscles were analyzed at different ageing 
time: salting (n=19), post salting (n=30), 18 (n=35) and 24 (n=11) ripening months with low salt content 
(<5.4%) and “traditional” content (> 5.4%). Samples are taken from the Biceps femoris muscle, regarded as 
the reference muscle for evaluating most technological and nutritional parameters of dry-cured ham, such as 
salt content, texture, colour, etc. The muscles were triturated by a common mill (Moulinex, Milano, Italia) 
and stored at freezing temperature (-22 °C) until analysis.  
3.2.3  Extraction of the peptide fraction (MW<10 kDa)  
To 5 g of minced dry-cured ham 45 ml of a HCl 0.1N solution and 250 l of a 1mM Phe-Phe aqueous 
solution were added and the mixture homogenized for 1 minute with Ultra Turrax T50 Basic (IKA Werke, 
Staufen, Germany) at 322g. After centrifugation at 4°C (3200g for 1 h), the supernatant is purified by a 
series of filtration steps using different filters (paper, 5μm type SMWP, 0.45μm type HPLV: for sample at 
salting and post-salting steps, it’s also necessary another centrifugation at 4°C, 3200g for 15 minutes 
between filtration at 5μm and at 0.45μm). 4 ml of the obtained extract is evaporated to dryness under 
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vacuum by rotary evaporator and the residue was dissolved with 2 ml of a 0.1% formic acid aqueous 
solution. This solution was then filtered on a Vivaspin 2 (Sartorius) filtration system with 10 kDa cut off 
filters, at room temperature and 5423g for 45 minutes. The filter is washed for 3 times with 2 ml of a 0.1% 
formic acid aqueous solution. All filtered samples is evaporated by rotavapor and the residue dissolved in 
150 µl of a 0.1% formic acid aqueous solution and  is centrifuged at 4°C, at 16060 g, for 10 minutes before 
the UPLC-ESI-MS analysis. 
 
3.2.4 SDS-PAGE analysis on extracted samples 
Extracted samples: 5 μl of extracted samples filtered at 0,45 μm  was evaporated under nitrogen flux and 
dissolved in 25 μl of reducing sample buffer (1x, BIO-RAD).  
Reducing sample buffer is composed by 5% of XT Reduce Agent (BIO-RAD) in Sample buffer 1x (BIO-
RAD). The running buffer (1x) is prepared by dilution of XT MES Running Buffer 20x (BIO-RAD) with 
bidistilled water. Comassie staining solution: for 1 liter of solution, 1g of Comassie Brillant Blu R-250 
(BIO-RAD) was dissolved with 100 ml of acetic acid, 400 ml of methanol and 500 ml of bidistilled water. 
Comassie destaining solution: for 1 liter of solution, 100 ml di 100 ml of acetic acid, 400 ml of  methanol 
and 500 ml of bidistilled water were mixed.  Marker: the molecular marker SDS-PAGE standards (BIO-
RAD), is in ratio of 1:20 with the reducing sample buffer. GEL: CriterionTM XT Precast gel, 12% Bis-Tris 
(BIO-RAD). Run time: around 50 minutes at 150 V. Volume of marker used: 5μl. Data analysis with 
scanner GS-800 Calibrated Densitometer controlled by software “Quantity one” (BIO-RAD).  
3.2.5 In-gel digestion 
The gel was destained and the reduction, alkylation and digestion of the bands of interest were carried out as 
described by the in-gel digestion protocol of the Biological Mass Spectrometry Laboratory (Ontario Wide 
Protein Identification Facility, http://www.uwo.ca/biochem/bmsl/in-gel_digestion.html#coom). 
3.2.5.1 UPLC-ESI-MS analysis 
UPLC/ESI-MS analyses were performed with an UPLC/ESI-MS system (UPLC Acquity Waters equipped 
with a single quadrupole mass spectrometer Waters Acquity Ultraperformance). Conditions were as follows: 
column, RP ACQUITY UPLC BEH 300 C18 (1.7 μm, 2.1 x 150 mm, Waters); gradient elution: eluent A, 
water with 0.1% formic acid and 0.2% acetonitrile, eluent B, acetonitrile with 0.1% formic acid; gradient: 0-
7 min 100% A, 7-50 min linear from 100% A to 50%  A, 50-52.6 min isocratic 50% A, 52.6-53 min linear 
from 50% A to 0% A, 53-58.2 min isocratic 0% A, 58.2-59 min linear from 0% A to 100% A, 59-72 min 
isocratic 100% A. LC parameters: flow rate, 0.2 ml/min; analysis time, 72 min; column temperature, 35°C; 
sample temperature, 18°C; injection volume, 4 μl for extract samples (no solvent delay). MS parameters: 
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Full Scan mode, acquisition time 7-58.2 min; ionization type, ESI + (positive ions); scan range, 100-2000 
m/z; capillary voltage, 3.2 kV; cone voltage, 30 V; source block temperature, 150°C; desolvation 
temperature, 300°C; cone gas flow, 100 l/h; desolvation gas flow, 650 l/h. Data were acquired and analyzed 
by MassLynx 4.0 software (Waters Co., Milford, MA, USA).  
3.2.6 HPLC/ESI-MS/MS analyses 
HPLC/ESI-MS/MS analyses were performed using a HPLC (Mod. Alliance 2695, Waters) equipped with a 
triple quadrupole mass spectrometer (Mod. 4 Micro, Waters) and a RP column JUPITER 5 μm C18, 300 Å 
250 x 2 mm I.D. (Phenomenex, Bologna, Italy). Gradient elution was as follows: eluent A, water with 0.1% 
formic acid and 0.2% acetonitrile; eluent B, acetonitrile with 0.1% formic acid; gradient: 0-12 min 100% A, 
12-77 min linear from 100% A to 50% A, 77-81 min 50% A, 81-82 min linear from 50% A to 0% A, 82-90 
min 0% A, 90-91 min linear from 0% A to 100% A, 91-110 min 100% A. Samples (extracts samples) were 
first analyzed in Full Scan mode, to identify the characteristic ions and the retention time of  the unknown 
compounds, then in Daughters Scan modality, using a variable collision energy from 10 to 30 eV. 
HPLC/ESI-MS/MS parameters were as follows: flow rate, 0.2 ml/min; analysis time, 110 min; column 
temperature, 35°C; sample temperature, 23°C; injection volume, 10 μl for Full Scan mode and 30 μl for 
Daughter Scan mode; acquisition time, 90 min; ionization type, ESI + (positive ions); scan range, 100-2000 
m/z; capillary voltage, 3.2 kV; cone voltage, 35 V; source block temperature, 100°C; desolvation  
temperature, 200°C; cone gas flow, 100 l/h; desolvation gas flow, 650 l/h. The peptide sequences were 
assigned on the basis of the obtained mass spectra and using the Bioinfomatics resource portal ExPasy with 
the tools FindPept (Swiss Institute of Bioinformatics, Switzerland) and with the web application 
“Proteomics Toolkit” (Institute for Systems Biology, Seattle, WA, USA). 
3.2.7  LTQ-Orbitrap analysis 
Analyses were performed by a LTQ-Orbitrap (Thermo Fischer Scientific, Milano, Italy) equipped with a 
column Jupiter Proteo 4 µm (90 Å, 150 x 0.30 mm, Phenomenex). Gradient elution was as follows: eluent 
A, H2O + 0.2% HCOOH; eluent B, CH3CN + 0.2% HCOOH. Gradient: 0-4 min, 95%A, 4-60 min, linear 
from 95% to 50% A, 62-72 min, isocratic 95%B, 70-72 min linear from 5% A to 95% A, plus 
reconditioning (3 min in 95% A). Samples (extracts) were analysed using a column Acclaim PepMap 300Å 
5 μm (300 Å, 150 × 0.30mm, LC Packings, Dionex Company). Gradient elution was as follows: eluent A, 
H2O + 0.2% HCOOH; eluent B, CH3CN + 0.2% HCOOH. Gradient: 0–4 min, 90%A, 4–60 min, linear 
from 90% to 50% A, 62–72 min, isocratic 95%B, 72–74 min linear from 5% A to 90% A, plus 
reconditioning (16 min in 95% A). Samples were desalted by ZipTip (Millipore) before the analyses. Other 
parameters: flow rate, 5 μl/min; injection volume, 5 μl; MS run time: 65 min; scan event details: (1) FTMS 
+ res = 30000; (2) ITMS + Dep MS/MS most intense ion (1); (3) ITMS + Dep MS/MS second most intense 
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ion from (1); (4) ITMS + Dep MS/MS third most intense ion from (1); (5) ITMS + Dep MS/MS fourth most 
intense ion from (1); collision energy, 35. Data-dependent setting: charge state rejection enabled; 
Unassigned charge states: rejected, charge state 1 rejected, charge states 2, 3 and 4 not rejected. Dynamic 
exclusion enabled. Repeat count: 3. Repeat duration 30.00 s. Exclusion list size: 50. Exclusion duration: 
180.00 s. Exclusion mass width by mass. Exclusion mass width low and high: 1.5000. 
3.2.8 Synthesis of NPADs 
3.2.8.1 Synthesis of L-Phenylalanine methyl ester hydrochloride (deuterated) 
1g of deuterated L-phenylalanine (d5-L-Phe) were dissolved in 50 ml of dry-methanol and kept under 
continuous stirring in an ice bath; SOCl2 was added to a final concentration of 1 M (3,62 ml of SOCl2  plus 
46,38 ml dry-methanol). The reaction closed with a valve of calcium chloride, was left to react overnight 
and was monitored by TLC (n-butanol: acetic acid:water 4:1:1 as eluent, UV and ninidrine detection). The 
reaction mixture was dried at rotavapor. Residual HCl was eliminated by adding methanol (50 ml) and 
redrying by rotavapor (4 times). Characterization MH
+
 (ESI–MS): 185.2 L-Phenylalanine methyl ester 
hydrochloride (deuterated). 
3.2.8.2 Synthesis of L-Lactoyl-L-Phenylalanine (d5) 
 (S)-(-)-2-Acetoxypropionic acid (1.56 mmol) was diluted in CH2Cl2 (3 ml) together with 1.48 mmol of 
HBTU and the mixture was kept under continuous stirring at room temperature for 30 min, in order to 
activate the carboxylic function. L-Phenylalanine-methyl ester d5 (1.56 mmol) was dissolved in 2 ml of 
CH2Cl2, together with DIPEA (4.68 mmol) and then added to the activated acetoxypropionic acid. The 
reaction was left to react under magnetic stirring overnight at room temperature. The reaction was 
monitored by TLC (ethyl acetate as eluent, UV absorbance detector). The organic solution was washed with 
10 ml of saturated solutions of KHSO4 (3 times) and NaHCO3 (3 times) in order to remove the unreacted 
reagents, dried with Na2SO4 and filtered. The product was dried under nitrogen flux and vacuum. The 
methyl and acetyl protecting groups were removed by reaction in 5 ml of THF (without inhibitor) and 5 ml 
of water with 0.78 mmol of Ba(OH)2 (which corresponded to 2 equivalents of the protected molecules, ratio 
between THF and H2O is 1:1) for 20 min, on ice bath. THF was then eliminated under vacuum by rotavapor 
and the aqueous solution was acidified to pH 3 with HCl. Characterization MH
+
 (ESI–MS): 243.2 L-
Lactoyl-L-Phenylalanine (d5). 
3.2.8.3 Synthesis of L-Pyroglutamyl-L-Phenylalanine (d5) 
1.5 mmol of L-pyroglutamic acid were diluted in CH2Cl2 (5 ml) together with 1.42 mmol of HBTU and the 
mixture was kept under continuous stirring at room temperature for 30 min, in order to activate the 
carboxylic function. L-Phenylalanine-methyl ester d5 (1.5 mmol) was dissolved in 2 ml of CH2Cl2, together 
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with DIPEA (4.5 mmol) and then added to the activated pyroglutamic acid. The reaction was left to react 
under magnetic stirring overnight at room temperature. The reaction was monitored by TLC (ethyl acetate 
as eluent, UV absorbance detector). In order to make the reaction complete, 0.75 mmol of L-pyroglutamic 
acid and 0.71 mmol of HBTU in 2 ml of CH2Cl2:dry DMF (1:1) plus 2.25 mmol of DIPEA were added. The 
organic solution was evaporated under vacuum, at 40°C, in order to eliminate the DMF and redissolved in 5 
ml of CH2Cl2.  The organic solution was washed with 10 ml of saturated solutions of KHSO4 (3 times) and 
NaHCO3 (3 times) in order to remove the unreacted reagents, dried with Na2SO4 and filtered. The product 
was dried under nitrogen flux and vacuum. The methyl protecting group was removed by dissolving the 
ester in 12 ml of THF (without inhibitor) and 12 ml of water with 0.9 mmol of Ba(OH)2 (which 
corresponded to 2 equivalents of the protected molecules, ratio between THF and H2O is 1:1) for 1h and 30 
min, on ice bath.  The reaction was monitored by TLC (ethyl acetate as eluent, UV detector).   THF was 
then eliminated under vacuum by rotavapor and the aqueous solution was acidified to pH 3 with HCl. 
Characterization MH
+
 (ESI–MS): 282.2 L-Pyroglutamyl-L-Phenylalanine (d5). 
3.2.8.4 Synthesis of γ-glutamil-L-Phenylalanine (d5) 
N
α
-Boc-L-Glutamic acid α-tbutyl ester (2.055 mmol) was dissolved in DMF (2.5ml) together with 1.955 
mmol of HBTU and the mixture was stirred at room temperature for 30 minutes. L-Phenylalanine-methyl 
ester d5 (2.055 mmol) was dissolved in DMF (1 ml) together with 6.125 mmol of DIPEA and added to the 
reaction. The mixture was left to react under magnetic stirring overnight and the reaction was monitored by 
TLC (ethyl acetate as eluent, UV detector). In order to react the residual phenylalanine, 1.027 mmol of N
α
-
Boc-L-Glutamic acid α-tbutyl ester and 0.511 mmol of HBTU in 1.5 ml of DMF and 3.06 mmol of DIPEA 
were added. The organic solution was evaporated under vacuum, at 40°C, in order to eliminate the DMF and 
redissolved in 5 ml of CH2Cl2.  The organic solution was washed with 10 ml of saturated solutions of 
KHSO4 (3 times) and NaHCO3 (3 times) in order to remove the unreacted reagents, dried with Na2SO4 and 
filtered. The product was dried under nitrogen flux and vacuum. The residue was dissolved in 15 ml of a 
trifluoroacetic/methylene chloride 1:1 solution, containing also 4% of m-cresol and 4% of thioanisol as 
scavengers. The mixture was stirred at room temperature for 1 h and then the solvent was evaporated under 
vacuum by nitrogen flux. Cold ethyl ether was added to the residue in order to precipitate the free dipeptide. 
The precipitate was washed several times with cold ethyl ether and the product dried by nitrogen flux and 
under vacuum. The methyl protecting groups was removed by dissolving the ester in 5 ml of THF (without 
inhibitor) and 5 ml of water with 0.5 mmol of Ba(OH)2 (which corresponded to 2 equivalents of the 
protected molecules, ratio between THF and H2O is 1:1) for 20 min, on ice bath.  The reaction was 
monitored by TLC (ethyl acetate as eluent, UV detector).   THF was thne eliminated under vacuum by 
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rotavapor and the aqueous solution was acidified to pH 3 with HCl. Characterization MH
+
 (ESI–MS): 300.2 
γ-glutamil-L-Phenylalanine (d5).  
 
For product characterization, 5 µl of all obtained NPADs were dissolved in 1 ml of H2O+0.1% HCOOH and 
the solution (1 µl) was injected in UPLC-ESI-MS (the analysis conditions are the same described in 
paragraph number 3.2.5.1). 
3.2.8.4.1 Purification of Npads: semipreprative HPLC-UV 
The purification of compounds has been made with semipreparative HPLC-UV (1525 Binary HPLC Pump, 
Waters) using a RP column (JUPITER 5 μm C18 300 Å 250 x 10 mm, Phenomenex).  Injection volume 500 
µl, flow 5 ml/min. Gradient elution was as follows: eluent A, water with 0.1% formic acid; eluent B, 
acetonitrile with 0.1% formic acid; gradient: 0-5 min 100%  A, 5-10 min linear from 100% A to 81% A (this 
% change in function of compound to purified), 10-20 min 81% A, 20-25 min linear to 0% A, 25-30 min 
linear to 100% A, 35-50 min 100%A. 
3.2.8.4.2 Quantification of Npads 
The concentration of purified compounds has been made with spectrophotometer UV (Jasco V-530, UV-
Vis, Easton, USA) monitoring the absorbance of the amino acid phenylalanine (ε=200M-1cm-1) at 257 nm in 
water.  The calibration curve was set up plotting the ratio between areas NPADs:FF (internal standard) vs 
different concentration of NPADs (γ-glutamil-L-Phenylalanine (d5) and L-Lactoyl-L-Phenylalanine (d5) 
from 25 μM to 500 μM; L-Pyroglutamyl-L-Phenylalanine (d5) from 10 μM to 500 μM). 
3.2.9 Data statistical analysis. 
The peptide profiles of the extracts, obtained by the analysis of spectra from UPLC-ESI-MS, were examined 
by principal component analysis (PCA), T-student test and ANOVA with the software SPSS Statistics 17.0.   
 
3.3 RESULTS AND DISCUSSION 
3.3.1 Extraction method 
To perform the extraction of the peptide fraction of interest a preliminary necessary step is the elimination 
of  the protein components by denaturation with hydrochloric acid (0.1 N), centrifugation and molecular cut-
off filtration (10 kDa). Moreover, although the samples from Biceps femoris muscle had been previously 
separated from the fatty tissue, a lipid fraction removal have been generally applied to the isolation of 
peptide fraction from food as this work up could be necessary in order to obtain a proper chromatographic 
separation. In order to test this aspect, we analyzed the results obtained with and without a diethyl ether 
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extraction step, comparing the obtained chromatograms and the semi-quantification values (ratio of "area of 
the peptide" and "area of internal standard", Phe-Phe) of some major peptides identified in the mixture 
(Sforza, 2001). These latter results are reported in Figure 10, in which the molecular weights of the 
considered peptides are reported on the x-axis and the semiquantification values are reported on the y-axis.  
 
Figure 10. Semi-quantification values of some peptides: MWs of the considered peptides are reported on the x-
axis and the semiquantification values (ratio of "area of the peptide" and "area of internal standard", Phe-Phe) 
are reported on the y-axis. T-student test, p<0.05. 
No significant differences were found in the chromatographic separation (efficiency, resolution, etc.) and, 
moreover, the extraction without diethyl ether (in grey) allows a greater recovery of the main peptide 
fraction with lower losses of analytes. Therefore, it has been decided to proceed with the extraction of the 
peptide fraction without the use of diethyl ether, as reported in other papers (Mora, 2009; Sentandreu, 2007). 
 
3.3.2 Characterization of the peptide fractions extracted from “traditional” dry-cured hams 
3.3.2.1 SDS-page analysis of extracted samples as a function of the ageing time 
Biochemical reactions underlying the dry-cured processing are of key relevance to understand the 
mechanisms of protein degradation and peptide generation. In this sense, the use of proteomic techniques 
contributes to an improved comprehension of the action of muscle proteolytic enzymes through the 
identification and sequencing of the peptides generated during the processing. The SDS-PAGE has been the 
method of choice for the separation of the proteins in meat and its extracts. In this sense, the structural 
alteration and progressive disappearance of muscular proteins during maturation and dry-cured processing 
have also been extensively studied. In Figure 11 a typical SDS-PAGE gel obtained from the analysis of 
water soluble extracts of traditional dry-cured hams at different ageing period is reported. 
49 
 
 
Figure 11. SDS-page of aqueous extracts of ham samples at different ageing period: salting (line 1-2), post-salting 
(line 3), 18 months (line 4), 24 months (line 5). M is the molecular weight marker. 
 
Comparing an aqueous acidic extract (filtered at 0,45 µm) of an ham sampled at the salting step (line 1 and 
2) with the profile of the extract at post-salting (line 3) and at different ageing times (18-24 months, line 4 
and 5), large differences were observed: several bands corresponding to different muscle proteins disappear 
upon the maturation time. As already reported (Larrea, 2006), the most significant change in the profile of 
water-soluble proteins of the Biceps femoris occurs during ripening, from post-salted ham to dry-cured ham. 
Indeed, during this period, most proteins undergo extensive proteolysis by the muscle enzymes: there are 
important decreases in enolase (46.4 kDa), phosphate creatin kinase (44.3 kDa), aldolase (41.6 kDa), b-
tropomyosin (35.2 kDa), myosin LC1 (24.75 kDa), troponin C (20.7 kDa), myosin heavy chain, actin. This 
decrease is attributable to the intense proteolysis taking place, particularly in the final stage of ripening: the 
long processing of dry-cured ham allows for a more intense action of muscle proteases, and results in 
extensive protein breakdown. Proteins still detectable in the aqueous acidic extract and, thus, more resistant 
to the proteolysis process were identified by LTQ-Orbitrap analysis after in gel digestion: the bands 
corresponding to molecular weight of 116.250 Da and 97,4 kDa are a mixture of isoforms of myosin 
(myosin 4, myosin 1, 2 and 7).  The bands corresponding to 45 kDa MW are the myofibrillar proteins 
tropomyosin α-1 and tropomyosin α-3 chain and the sarcoplasmic protein L-lactate dehydrogenase. 
Analysing by SDS-PAGE the peptide fraction isolated by ultrafiltration with MW cut-off filters of 10 kDa, 
some interesting observation can be made. 
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Figure 12. SDS-page of aqueous extracts (MW<10 kDa) at different ageing period: salting (line 3), post-salting 
(line 2), 18 months (line 1). M is the molecular weight marker. 
As shown in Figure 12, if we compare sample with 18 months (a similar result was obtained for 24 months, 
not shown) of ripening (line 1), samples at post-salting (line 2) and salting step (line 3) we can observe a far 
higher intensities of the bands corresponding to low MWs (around and lower than 6500 Da): a very huge 
amounts of low MW peptides are produced by protein breakdown during the long maturation time. 
 
3.3.2.2 Mass spectrometry analysis: characterization of the peptide profile in sample 
extracts of traditional hams. 
Mass spectrometry is a powerful analytical technique for both protein and peptide analysis because it can 
rapidly and reliably identify the components of complex matrices. The most popular analyzers in proteomics 
are ion traps, triple quadrupoles, time of-flight tubes, orbitrap, and Fourier transform ion cyclotron 
resonance, with their specific advantages: high sensitivity and multiple-stage fragmentation for ion traps, 
high selectivity for triple-quadrupoles, high sensitivity and speed for time-of-flight.  A complete sequence of 
the peptides of interest is often achieved by using tandem MS (MS/MS), by fragmentation of a selected 
precursor peptide ion to generate specific fragment ions for sequence elucidation (data-dependent 
acquisition): to identify these peptides, spectra are scanned against protein-sequence databases using search 
algorithms. 
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The water extracts of traditional dry-cured hams, already described in the paragraph 42, have been analyzed 
first in UPLC-ESI-MS. LC-MS analysis of the peptide pattern up to 10 kDa reveals different 
chromatograms profile, following the maturation process of dry-cured hams, as reported in Figure 13.   
 
Figure 13. Total Ion Chromatograms obtained in UPLC-ESI-MS of aqueous extracts (MW<10Da) of ham 
samples at different ageing period: salting step (a), post salting step (b),  18 months (c) and 24 months (d). 
 
At the salting step a very poor peptide profile was obtained, with low intensity signals (Figure 13, a); at 
post-salting step a sharp increase was observed, particularly in the first 25 minutes of run time (Figure 13, 
b), a elution window which corresponds to low molecular weight and polar peptides; the chromatograms of 
samples at 18 and 24 months of ripening time (Figure 13, c and d) are very similar and richer in comparison 
with the other two steps: the peaks of peptides are present all along the chromatograms, with a particular 
signal intensification also after 25 minutes of run time, corresponding to high molecular weight and more 
apolar peptides.  
The evolution of the peptide profile is strictly determined by the action of muscle proteases and by the fact 
that peptides, once generated, may then undergo to further proteolytic actions. Indeed, the molecular weight 
range in samples at salting is approximately spans between 200 to 8500 Da, in post-salting samples 
approximately from 200 to 10300 Da and in samples at18-24 months approximately from 200 to 9200 Da. 
Short peptides ever increase during the aging time, while, in contrast, the high molecular mass peptides 
show a tendency to accumulate in the first part of the ageing period and to decrease in the last part, on 
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account of their double role of products and substrates of the proteolytic activity. Raw meat (genotype, age, 
sex, ante- and post-mortem treatment) and process technology have a decisive influence on the activity of 
muscle enzymes responsible for these transformations.  
The Orbitrap analysis reveals that the main peptides present in all samples originated as expected from 
sarcoplasmatic and miofibrillar proteins: in particular, peptides originated myofibrillar proteins like actin, 
myosin, troponin T, enzymes like glygeraldehyde-3-phosphate dehydrogenase, beta-enolase, but also 
myoglobin and hemoglobin. All these proteins constitute relevant substrates for proteolysis that occurs 
during the processing of dry-cured ham: muscle endopeptidases like catepsins and calpains can degrade the 
myofibrillar structure giving rise to large polypeptides. These polypeptides are then degraded, in further 
stages, to smaller peptides and free amino acids by the action of exopeptidases such as dipeptidyl peptidases 
and aminopeptidases. The main enzymes responsible for proteolysis of sarcoplasmic proteins are muscle 
endopeptidases and certain groups of exopeptidases. The action of these enzymes during the dry-curing 
process has great importance because they are directly responsible for the changes in the post-mortem 
muscle texture and for the flavour development that occurred during the ripening of dry-cured products. 
The presence of fragments of myoglobin, the most important protein of sarcoplasm, is very important 
because it is responsible for meat color, which is associated with the product quality. Myoglobin protein has 
been found to be degraded during the post-mortem storage of pig meat as well as during the processing of 
dry-cured ham. Fragments of myoglobin detected at the end of the processing of dry-cured ham and the 
intense proteolysis of myoglobin during dry curing has been confirmed (Mora,  2012).  
The main peptides present in hams at step of salting and post-salting are reported below in Table 1. 
 
Table 1. List of main peptides (Molecular Weight, MW), retention time and observed ions in ham extracted 
samples at the salting and post-salting step with UPLC-ESI-MS analysis. 
Retention time (min) Ions MW 
6.2 136.9+268.9 268 
7.59 217 216 
10.21 246.9+229.8 246a 
11.86 246.9 246b 
12.44 179.0+357.1 356 
 401 400 
12.72 219.9 218 
 136.9+296.9 296 
13.25 232 231 
 216.9 217 
 222.9+119.9 222 
13.56 229 228a 
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Retention time (min) Ions MW 
13.77 136.8+340.9 340 
14.85 115.9+229.0 228b 
15.28 261 260a 
15.53 178.0+261.0 260b 
15.63 231.2+132.0 230 
15.69 115.9+229.0 228c 
16.03 388.4+776.0 775 
16.23 263.2+401.3 400 
16.87 305.1 304 
 336.6+672.1 671 
17.32 344.3 343 
17.35 383.7+511.4+766.3 1531 
17.68 320.1 319a 
17.75 369.9+554.2 1106 
17.88 415.8+554.3+831.1 1660 
 319.9 319b 
18.04 408.8+510.8+680.8+1020.6 2039 
18.35 513.3+769.5 1537 
18.61 322.5+386.8+483.2+644.0 1929 
18.79 444.2+592.0+887.5 1773a 
 535.8+803.2 1604 
18.9 245 244 
19.22 355.7+444.2+592.0+887.5 1773b 
19.39 381.3+476.3+634.9+951.8 1902 
 262.1 261 
19.69 444.1+517.8+621.2+776.4+1034.5 3101 
19.82 355.7+426.7+533.1+710.3 2128 
 622.1+1243.1 1242 
 304 303 
20.08 416.3+520.0+693.0+1039.2 2076 
20.11 509.4+407.4 2033 
20.41 499.7+624.3+832.2 2493 
20.48 391.8+469.9+587.1+782.5+1173.4 2345 
 525.5+656.6+875.2 2622.5 
20.68 589.4+687.5+824.5+1030.5 4118 
21.14 438.6+548.1+730.4+1095.1 2188 
21.49 410.7+547.3 1639 
21.66 487.3+973.3 972 
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Retention time (min) Ions MW 
21.68 585.1 584 
21.76 703.4+844.0+1055.0+1405.7 4215 
21.87 516.8+645.9+860.9 2579 
21.9 530.1+618.1 3703 
22 441.6+529.9 2644 
22.11 469.4+563.1+703.7+938.0 2811 
22.29 519.8+606.2+727.4+908.9 3631.5 
 469.4+586.4+781.6 2342 
22.54 494.6+593.3+741.4+988.6 2962 
22.67 457.8+548.9+686.2+914.2 2740 
22.78 455.2+546.1+682.4 2752 
22.83 275.9 275 
23.36 431.6+517.8+646.9 2584 
 204 203 
23.51 851.0+1701.3 1700 
23.77 119.9+165.9+313.0 312 (Phe-Phe) 
23.99 524.6+699.0 2094 
24.39 915.6+1830.4 1829 
24.51 610.0+762.3+1016.0 3045 
25.08 854.5+1139.3 3414 
25.59 676.1+1013.6 2025 
 738.4+1107.0 2212 
25.9 589.0+785.0+1177.2 2352 
26.14 528.6+634.3 3166 
27.43 434.1 433 
28.23 547.3+656.5+820.4+1093.7 3278 
28.56 687.2+763.4+858.7+981.3+1144.6+1373.6 6862 
28.7 789.3+902.0+1051.9+1262.3 6306 
29.37 514.9+600.5+720.5 3597 
29.57 643.9+715.5+804.8+919.6+1072.9+1287.3 6430.5 
29.88 847.5+1271.2 2540 
30.36 558.2+669.4+836.6+1114.9 3342 
 730.1+875.8+1094.5 4374 
 628.7+785.6 3138 
31.29 643.6+771.9+964.9 3855 
 574.1+860.7 1719 
31.98 650.8+704.9+769.0+845.8+939.7+1057.1+1207.8+1409.3 8448 
32.56 572.2+715.3+953.3 2857 
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About 89 peptides were identified in terms of MW in the mixture. The only compound that has been asily 
identified is inosine and its degradation product hypoxanthine (MW 268 Da), generated by enzymatic 
reactions in the post mortem metabolism of muscle that still occur at the beginning of dry-cured processing. 
This is the case for the ATP (adenosine triphosphate) degradation with the generation of nucleotide 
breakdown products and glycolysis resulting in the generation of lactic acid. The pathway of ATP 
catabolism, as a degradative sequence, has been widely studied and used in freshness and quality assessment 
in different fish species, beef, poultry and pork meat. Thus, after slaughter, ATP degradation to ADP 
(adenosine diphosphate) and AMP (adenosine monophosphate) takes place rapidly, with the subsequent 
accumulation of IMP (inosine 5′-monophosphate). The IMP is hydrolysed by autolytic enzymes (5′-
nucleotidase, N) to inosine (Ino), which, in turn, is degraded to hypoxanthine (Hx) by autolytic and/or 
microbial action (nucleoside phosphorylase, NP). Further, the Hx will be oxidized to xanthine (X) and then 
to uric acid (UA) through a much slower reaction due to xanthine oxidase (XO) in case of spoilage by 
microorganisms. Some of the ATP degradative compounds or ratios of these (Ko, K value, K′ value, Hx 
ratio or H value) have been proposed as freshness indexes. The simplest is the determination of the Hx 
concentration that, due to its accumulation during storage, has been considered an excellent index of meat 
aging and quality. On the other hand, some of these compounds affect meat flavor: indeed, IMP is a flavour 
enhancer, which contributes to the umami taste, whereas hypoxanthine together with some amino acids and 
peptides may contribute to a bitter taste in meat (Hernández-Cázares, 2011). 
 
Dry-cured hams are generally commercialized at 18-24 months, so we focused our characterization on the 
ham sample with these ageing times. 
Peptide sequences present in 18 and 24 months were identified and characterized by UPLC-ESI-MS and 
HPLC-ESI-MS/MS, confirming the identification by exact mass determination with LTQ-Orbitrap, as 
reported in Table 2. 
 
 
Table 2. Peptide sequences in 18 and 24 months samples, identified and characterized by UPLC-ESI-MS. 
Retention 
time (min) 
Ions MW Sequences Proteins 
11.63 189.4 188 n.i.  
11.95 247.3 246a ID  
12.67 358.5 357 PIE actin 
 247.4 246b LD  
13.00 220.3 219 SN  
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Retention 
time (min) 
Ions MW Sequences Proteins 
 227.3 226 piroglutamil-Pro  
13.67 229.4 228a PI  
14.41 229.4 228b PL  
 281.4 280 n.i.  
15.06 261.4 260a γ-EI  
15.62 261.4 260b γ -EL  
16.14 222.3 221 n.i.  
16.50 263.4 262 PF  
16.96 295.4+166.3 294 γ -EF  
17.17 190.4+144.1 189 lactoil-val  
17.6 231.4+ 214.4 230 n.i.  
 320.5 319a DW   
18.51 243.4+197.3 242a pir-ile  
18.8 229.4 228c n.i.  
18.91 320.5 319b n.i.  
18.93 128.3+156.4+174.3 173 n.i.  
18.95 245.4 244a II/LL/IL/LI  
19.11 477.3+636.1+953.7 1905 PAPAPAPAPAPAPAPPKEEK A1XQT6 
19.15 341.2+511.2+1020.9 1020 ALPHAIMRL P68137 
 538.6 537 YNEL  
 552.6 551 n.i.  
19.49 243.4+197.3+132.3 242b pir-leu  
19.61 245.5 244b II/LL/IL/LI  
19.88 174.3+128.3+156.3+ 
196.3+304.4 
303 n.i.  
20.38 214.4+232.4 231b VN  
 387.0+772.7+275.3 771 n.i.  
20.65 324.0+646.5+515.4 645 FHETL F1RZV8 
 275.3+202.3+159.3 274 n.i.  
21.31 158.4+204.4 203a lacto-ile  
21.49 158.4+204.4 203b lacto-leu  
21.74 301.4+451.4+901.7 901 n.i.  
22.23 498.9+598.5+747.8+99
6.7 
2987 n.i.  
22.41 530.1+706.3+1059.0 2116 n.i.  
 279.5 278 n.i.  
 471.6+942.0 941 n.i.  
22.98 344.6+213.5 343a IVL   
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Retention 
time (min) 
Ions MW Sequences Proteins 
23.19 238.4+192.3+120.3 237 lacto-phe  
23.85 120.3+166.4+313.4 312 Phe-Phe Internal 
standard 
24.11 484.2+553.3+645.2+77
4.2+967.2 
3865 n.i.  
 422.2 +527.6+703.0 2106 n.i.  
24.61 445.7 444 VITI actin 
24.81 213.4+344.5 343b IVL   
25.37 528.6+634.0+792.5 3166 GIITNWDDMEKIWHHTFYNELRVAP (y phos) actin 
25.67 553.6+622.7+711.4+82
9.9+995.8 
4973 n.i.  
 608.5+695.1+810.9+97
2.7 
4859 n.i.  
 559.6 558 IGGSIL  Actin 
26.35 530.0+618.2+741.8 3703 n.i.  
 381.0+476.2+634.4 1900 VTTAEREIVRDIKEKL Actin 
26.67 507.6+634.2+845.3 2533a DTYKSEIAHRFKDLGEQYFKG PO8835 
serum 
albumin 
 660.1  + 754.3  + 879.8  
+ 1055.6 
5273 n.i.  
 705.2+822.7+987.1 4930 n.i.  
 568.0+681.4+851.3+11
34.9 
3402 n.i.  
 816.8 815 n.i.  
27.06 441.5+514.9+617.6+ 
771.7+1028.6 
3083 n.i.  
27.19 507.7+634.3+845.3 2533b DTYKSEIAHRFKDLGEQYFKG PO8835 
serum 
albumin 
27.98 614.5+691.1+789.6+ 
921.2+1105.2 
5521 n.i.  
 698.1+1046.7 2091 n.i.  
28.17 646.6+738.7+861.6+10
33.8 
5164 n.i.  
28.27 569.1 
1136 
LAGRDLTDYL P68137 
actin 
 462.7  + 693.2 
1385 
YQKSSVKTLAFL Q9TV61 
myosin 1 
28.37 565.9+753.8+1130.5 2259 n.i.  
28.52 659.1+753.1+878.4+10
53.7 
5264 n.i.  
28.78 563.2  + 643.5  + 750.4 
+ 900.5 +1125.3 
4497 n.i.  
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Retention 
time (min) 
Ions MW Sequences Proteins 
29.1 672.2+895.9+1343.5 2684 PKPHSDAGTAFIQTQQLHAAMADTF swine 
pyruvate 
kinase 
29.11 549.5+659.2+823.6 3291 n.i.  
29.17 486.6+972.0 971 VLIREDNI F1RP07 
29.49 502.0+602.2+752.3 3006 n.i.  
 717.3+956.0 2865 n.i.  
29.88 473.9+552.7+662.9+82
8.2 
3310 n.i.  
29.98 626.3+730.5+876.4+10
95.2 
4378 n.i.  
30.37 480.3+600.1+799.7 2396 IDHLSEDKLRDKAKELWDAL Q75NG6 
troponin T 
30.87 491.5 490 VL(I)L(I)F  
31.55 580.0+632.6+695.7+77
2.8 
+869.5+993.4+1158.8 
6947 n.i.  
31.88 683.0+745.0+819.4+91
0.4+ 
1024.0+1170.1 
8184 n.i.  
32.08 645.7+699.4+762.8+83
9.1+932.2 
+1048.5+1198.1 
8381 n.i.  
32.26 589.3+643.0+707.0+78
5.4+883.5+ 
1009.6+1177.5 
7060 n.i.  
32.53 689.4+751.9+827.0+91
8.8+1033.5 
+1181.0+1377.8 
8260 n.i.  
32.54 573.0+715.9+954.2 2860 n.i.  
32.96 692.5+755.2+830.7+92
2.9+1038.1+ 
1186.3+1383.6 
8297 n.i.  
33.8 665.9+887.4+760.8 5318 n.i.  
 528.1+659.8 2635 n.i.  
 681.8+1021.1 2041 n.i.  
 507.6+608.9+760.8 3039 n.i.  
 670.7+726.6+792.5+96
8.2+871.6 
+1098.2+1245.0 
8706 n.i.  
34.03 706.1+764.9+834.3+91
7.6+1019.4 
+1146.7+1310.3+1528.
5 
9166 n.i.  
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Retention 
time (min) 
Ions MW Sequences Proteins 
 661.4+716.4+781.5+85
9.6+ 
955.0+1074.2+1227.3 
8586 n.i.  
34.35 591.2+709.1+886.2 3541 n.i.  
35.11 727.1+ 581.6+968.8 2904 n.i.  
35.12 604.6+755.4 3018 n.i.  
 567.7+662.4+794.5 3968 n.i.  
35.44 568.6(14)+612.4+663.4
+723.6 
+795.8+884.1+994.6+1
136.2 
7948 n.i.  
35.85 667.2+833.5+1111.3 3331 n.i.  
n.i.: not identified 
 
The identification has been performed by online bioinformatics resource portal such as “Expasy” with  the 
tool “FindPept” and by the “Proteomics Toolkit”(MS/MS Fragment Ion calculator): the identification 
process is based on the comparison of the theoretical fragmentation (Proteomics Toolkit) of the possible 
peptide sequences obtained by in silico experiments from unspecific cleavage of proteins (FindPept) with 
the sequence fragmentation obtained by MS/MS experiments. An example is reported Figure 14. 
 
 
Figure 14. Identification of sequence VITI by HPLC-ESI-MS/MS analysis. 
 
60 
 
Proteolysis during the ageing time determines changes in the peptide profile in term of type of sequences 
and/or relative amounts. The main peptides found in samples at different ripening periods have been 
semiquantified using the internal standard Phe-Phe (ratio between the areas) in order to verify the possibility 
to discriminate the samples on the base of their maturation time. A PCA analysis was performed and the 
results are reported below, in Figure 15.  The total explained cumulated variance is 65%, 49 % from 
component 1 and 15% from component 2. 
 
 
Figure 15. Principal Component Analysis of extracted samples at 18 (in black) and 24 months (in grey). 
The results of statistical analysis allow to conclude that it’s possible to distinguish dry-cured hams on the 
basis of their ageing period on the base of a different peptide profile, on account of the prolonged enzymatic 
proteolytic activities. Principal Component Analysis of extracted samples at 18 (in black) and 24 months (in 
grey). In order to verify which peptides are responsible for the observed difference, the semiquantification 
values of all the peptides were compared by T-student test (p<0.05): all the identified peptides are found in 
higher amounts in 24 months aged ham than in 18 months aged ones the peptides with molecular weight of 
173 Da and 303 Da.  
The knowledge of the protein fragments naturally generated during dry-curing would be very important for 
a better understanding of the texture changes and flavor development mechanisms occurring in this process. 
Due to the complexity of this study, in the literature a lot of papers focused on peptides generated from 
breakdowns of one muscle protein for time.  Peptide profile of aged Parma ham has been already partially 
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characterized (Sforza, et al., 2001).We confirmed these previous findings and identified some other 
sequences among the most abundant peptides in the extract, i.e. the sequence 
PAPAPAPAPAPAPAPPKEEK (MLC1f), a fragment of the myosin light chain already identified in Serrano 
dry cured ham (Mora, 2009), and PKPHSDAGTAFIQTQQLHAAMADTF, a sequence originating from 
swine pyruvate kinase, already previously identified by Sforza et al. (Sforza, 2003). Moreover, fragments 
from actin were found such as GIITNWDDMEKIWHHTFYNELRVAP (Y phos), VITI, PIE confirming the 
extensive proteolysis of this protein during curing.  
Some specific compounds have been identified in these dry-cured ham extracts, namely non-proteolytic 
amino acyl derivatives, NPADs.  These compounds of non-proteolytic origin have been already identified in 
cheeses and some other food matrices (soy sauce, etc.). They are de novo synthesized by non-proteolytic 
enzymatic activity and are generally characterized by an “umami” taste.  
3.3.2.2.1 NAPADs: non-proteolytic amino acyl derivatives 
The amino acyl derivatives are peptides of non-proteolytic origin but synthesized de novo by enzymatic 
activities in food. In particular, gamma-glutamyl amino acids, pyroglutamyl-amino acids and lactoyl-amino 
acids have been already observed in dairy products and are known to contribute to the taste of the products. 
Gamma-glutamyl amino acids have been already found in dry cured hams (Sforza, 2006): they are formed 
during ageing and tend to accumulate in the product.  
So, we investigated the occurrence of non-proteolytic amino acyl derivatives (NPADs) in dry cured ham. 
 We have been able to identify a lot of compounds, namely: γ-glutamyl-tyrosine, pyroglutamyl-proline,  γ-
glutamyl-isoleucine, γ-glutamyl-leucine, lactoyl-metionine, lactoyl-tyrosine, γ-glutamyl-phenilalanine, 
lactoyl-valine, pyroglutamyl-isoleucine, pyroglutamyl-leucine, lactoyl-isoleucine, lactoyl-leucine and 
lactoyl-phenialalnine. 
A typical fragmentation obtained by HPLC-ESI-MS/MS analysis is reported below in Figure 16 for 
pyroGlu-Ile/Leu. 
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Figure 16. Spectra of piroGlu-Ile (Leu) obtained by HPLC-ESI-MS/MS analysis. 
In order to quantify the identified compounds and evaluate their amount variation during ageing, we 
synthesized some derivatives to be used as standards for confirming the identification and performing the 
quantification. In particular, one NPAD for type has been synthesized: thus, γ-glutamyl-Phe, lactoyl-Phe, 
pyroglutamyl-Phe were prepared by chemical synthesis and used to quantify all the compounds occurring in 
the samples.  The calibration curves were set up plotting different concentration of  Npads  with the ratio 
area NPADs/area FF (internal standard).  
The results are reported in Figure 17.  
 
 
Figure 17.  NPADs present in aged dry-cured hams: 18 and 24 months (T-student test: p<0.05). 
Several compounds are present in the extracts and they tend to slightly increase from 18 to 24 months: this 
change with ageing has been already observed in literature in particular for cheeses. This is due to the fact 
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that these compounds, once formed, are not furtherly degraded by the proteolysis process. The two most 
abundant compounds found in aqueous acidic extracts of dry-cured ham are γ-glutamyl-leucine and lactoyl-
leucine: they have been found in maximum amount at 24 months with 46 µg and 52 µg per gram of ham. 
Only two compounds have been found in detectable amounts in the post-salting process, i.e. lactoyl-
Methionine and lactoyl-Leucine, neveretheless in far lower amounts then in 18 and 24 months samples 
(Figure 18). 
 
Figure 18.  Variation of lactoyl-Met and lactoyl-Leu during ageing of dry-cured hams: from post-salting to 24 
months of ageing time. 
  
These compounds, already detectable in the first months of processing (post-salting period), strongly 
increased during the ripening time: in particular, lactoyl-leucine a 10 times increase was recorded, from 5.4 
µg to 52 µg per g of product. 
 
3.3.2.3 Characterization of the peptide profile of traditional dry-cured hams vs dry-cured 
hams with reduced amount of salt: similarity and differences. 
 
Health authorities are associating high levels of sodium chloride (NaCl) intake with raised blood pressure, 
also known as hypertension: these data have pushed the current research and strategies to reduce sodium 
intake (He, 2003). In the case of low-salt meat products, the claim “with reduced salt”, stating that the 
content in sodium or the equivalent value for salt has been reduced, may only be reported on the label if the 
reduction is at least 25% if compared to the sodium or salt content of similar products (Nutrition claims and 
conditions applying to them as listed in the annex of regulation (EC) n°1924/2006).  
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Biceps femoris is the muscle generally taken for the reference values of different product parameters such as 
salt content. Salt content in the Biceps femoris of traditional hams is about 5.3%: to have a reduction of 25% 
it’s necessary to have 4.8% of salt in Biceps femoris at 12 months of ripening. Nevertheless, hams are 
normally commercialized at 18-24 months of ripening: thus, taking into account the weight loss of about 5% 
during the ageing period from 12 to 19 months, at the end of ripening hams with a salt content (in Biceps 
femoris) <5.4% are considered “at reduced salt”, whereas for salt content >5.4% samples are considered 
“traditional” hams. The new salt-reduced products have been prepared by SSICA (Experimental Station for 
the Food Preserving Industry of Parma).  
The extraction of peptide fraction was performed as described for the traditional hams (paragraph n° 3.2.3). 
The peptide database created with the main peptides present in traditional dry-cured hams has been used to 
compare the hams at low salt content with those at the post-salting step first and at 18-20 months of ripening 
time after. The peptides were semiquantified using the internal standard (Phe-Phe). 
The first Principal Component Analysis (PCA) on “cold” steps (post-salting periods) is reported in Figure 
19. The total cumulative variance explained is 49.5% (in which the variance of the component 1 is 31.2% 
while that of component 2 is 18.3%). 
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Figure 19. Principal Component Analysis of traditional (green) and reduced salt (blue) hams at the end of the 
"cold" step (post-salting). 
The peptide profile (<10 kDa) of low salt and traditional hams at the end of resting are slightly different and 
it allows a partial grouping of the two types of products. A little difference can be also observed in the 
intensity of the different peaks in the chromatographic profile of the peptide fractions obtained in UPLC-
ESI-MS, as shown in Figure 20 . 
 
Figure 20. Chromatograms of the peptide fraction of a traditional ham (red) and of a salt reduced ham (green). 
 
The resting phase is a critical stage in the production of cured ham. The salt, absorbed during the salting and 
concentrated in the superficial muscles (eg. semimembranosus muscles), during the resting phase diffuses 
into the internal muscles such as Biceps Femoris, due to the concentration gradient of the salt in the tissue 
fluids, and the moisture migrates from the inside to the outside of the ham then evaporating into the 
environment.  During the resting phase, the diffusion of the salt and the loss of moisture lead to a reduction 
of water activity (aw) in the inner parts of the ham, a necessary condition to achieve the microbiological 
safety before the subsequent stages at higher temperatures (14-16 °C), but these events also have an 
influence on and the activity of the endogenous proteolytic enzymes. Hams with low salt content show a 
decrease of aw in BF as far as resting time increases: a longer resting time is necessary to reach the same 
values of the traditional products, which have been demonstrated to assure the microbiological safety: in this 
case, resting time up to 145-160 days, almost 2 months longer than the traditional production, is necessary.  
This phenomenon can be explained by the fact that the salt content in the ham with reduced salt is lower 
than for the traditional hams and that diffusion occurs more slowly but still allows the salt to reach the 
inside of the ham and to concentrate. 
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The effect of the duration of the resting phase on the proteolysis is, really, determined by the complex 
combination of different events that occur simultaneously: 1) the time available for the expression of the 
proteolytic activity; 2) the variation of the concentration of the salt with inhibitory activity against 
proteolytic enzyme activity; 3) the variation of the concentration of the salt which affects protein solubility. 
In Biceps femoris, a higher proteolysis index was measured for the hams characterized by longer resting 
times (145 and 160 days): this may be the result of the lower salt content and the increased times available 
for enzymatic degradation of proteins. Indeed, when the concentration of  NaCl in the BF is low, it exerts a 
lower inhibition of the enzyme activity. In particular, cathepsins, that are likely to be inhibited by the salt 
concentration in traditional ham, could have an higher activity on low salt ham. 
In order to verify if these differences occurring at the resting step between the two type of products will be 
confirmed at the end of ageing time, the peptide profile of the samples at 18-20 months of ripening have 
been also characterized. The Principal Component Analysis (PCA) on the “hot” step is reported in Figure 
21: the total cumulative variance explained is 59%, being the variance of the first component 41% and the 
variance of the second component 18%. 
 
Figure 21. PCA of reduced salt (green) and tradiotional hams (blue) at 18-20 months of ageing time. 
The graph of the scores show as the reduced salt samples (in green) sharply differ from the traditional ones 
(in blue). These differences are also particularly evident comparing the peptide profile obtained in UPLC-
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ESI-MS for the two sets of samples: the comparison between the sample chromatogram of a low-salt (in 
green) and a traditional sample (in red) is reported Figure 22. 
 
 
 
Figure 22. Comparison between the chromatograms of the peptide fraction of a sample of low-salt ham (green) 
and a sample of traditional ham (red). 
 
Clear differences may be appreciated both in the first part of the chromatogram, where amino acids and 
small peptides generally are eluted (retention time up to 20 minutes), as well as in the second part of the 
chromatogram between 25 and 40 minutes, where generally medium-high MW peptides are eluted. 
Regarding the amino acids, they seem to be most abundant in the low salt ham samples while the medium-
high MW peptides are considerably more abundant in traditional hams. The relative amounts 
(semiquantification data) of each peptide in low salt sample or in conventional sample were compared and 
T-student test was assessed in order to evaluate significant differences (at p <0.05). In Table 3, the amount 
of each significant peptide is reported.  
 
Table 3. T Amount of peptides (MW, molecular weight) in traditional and reduced salt hams.  
MW Average amount ± std. dev. MW Average amount ± std. dev. 
 Reduced salt Traditional 
 
 Reduced salt Traditional 
 
188 0.41±0.16 0.20±0.07 3703 0.01±0.01 0.05±0.02 
219 0.26±0.04 0.22±0.06 5273 0.00±0.00 0.03±0.03 
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MW Average amount ± std. dev. MW Average amount ± std. dev. 
 Reduced salt Traditional 
 
 Reduced salt Traditional 
 
226 0.20±0.04 0.14±0.04 4930 0.01±0.01 0.04±0.03 
228b 1.30±0.08 0.05±0.02 3402 0.01±0.01 0.09±0.09 
189 1.15±0.14 0.93±0.20 3083 0.20±0.07 0.39±0.18 
230 0.14±0.06 0.04±0.03 5521 0.00±0.00 0.02±0.03 
228c 0.08±0.04 0.02±0.03 5164 0.01±0.01 0.07±0.02 
173 0.21±0.09 0.15 ±0.05 5264 0.01±0.02 0.16±0.12 
1020 0.11±0.05 0.04±0.04 4497 0.05±0.02 0.15±0.06 
551 0.03±0.01 0.02±0.02 3291 0.00±0.00 0.06±0.09 
303 0.60±0.20 0.47±0.15 3006 0.04±0.03 0.12±0.09 
231b 0.16±0.03 0.13±0.03 3310 0.04±0.02 0.08±0.08 
274 0.40±0.26 0.20±0.11 4378 0.12±0.05 0.28±0.16 
203b 2.04±0.22 1.63±0.33 8184 0.50±0.17 1.56±0.50 
343a 0.25±0.15 0.10±0.14 8381 0.09±0.06 0.15±0.1 
237 0.61±0.11 0.49±0.10 7060 0.04±0.04 0.15±0.17 
343b 0.26±0.11 0.15±0.15 8260 0.03±0.04 0.44±0.44 
246b 0.08±0.01 0.08±0.01 2860 0.17±0.13 0.01±0.07 
357 0.03±0.03 0.06±0.06 8297 0.16±0.057 0.73±0.48 
228a 1.30±0.56 1.72±0.57 5318 0.00±0.00 0.06±0.06 
280 0.11±0.06 0.19±0.0 2635 0.00±0.00 0.02±0.1 
319a 0.10±0.04 0.15±0.05 3039 0.01±0.01 0.07±0.06 
244a 0.10±0.03 0.16±0.06 8706 0.01±0.01 0.04±0.03 
1905 0.01±0.01 003±0.03 9166 0.01±0.01 0.30±0.16 
244b 0.08±0.02 0.12±0.04 8586 0.00±0.01 0.14±0.11 
2987 0.03±0.04 0.10±0.14 3541 0.01±0.01 0.06±0.05 
2116 0.08±0.03 0.17±0.14 2904 0.01±0.01 0.04±0.05 
278 0.03±0.01 0.05±0.01 3018 0.00±0.01 0.03±0.04 
4973 0.01±0.01 0.21±0.13 3968 0.00±0.00 0.05±0.03 
4859 0.01±0.01 0.44±0.18 3331 0.01±0.01± 0.04±0.06 
 
As already inferred by the analysis of the chromatograms, peptides with high molecular weight (from 3000 
to 8000 Da) were found to be in higher amount in the traditional ham samples. On the contrary, peptides 
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with a MW ranging from 200 to 300 Da were found in higher amount in ham samples with low salt content. 
These results can be explained by the fact that proteolytic activity is favoured in low salt ham, thus inducing 
the accumulation of peptides with low MW and amino acids. On the contrary, in traditional products 
proteolysis is less favoured on account of the higher amount of salt, thus inducing the accumulation of a 
greater number of high MW peptides. A lower salt content could also induce a lower extraction of 
myofibrillar proteins (known to be soluble in concentrated salt solutions), which are therefore less accessible 
to the action of proteolytic enzymes. Indeed, proteolysis index of the two type of products are significantly 
different: 31% in the case of traditional products and 34% for low salt hams. Also, sensorial analysis 
underlines the greater smell of fresh meat perceived for the low salt products. Finally, also the texture is 
different: the products with low salt show lower hardness values (TPA analysis, Texture Profile Analysis) 
than those of the traditional products while the values of adhesiveness are higher. All these results 
confirmed the difference between the two type of products clearly revealed by the peptide profile analysis. 
  
To obtain a good quality dry-cured ham both the parameters controlling salt diffusion and weight loss 
(preserving factors) and those affecting the final flavour, such as proteolysis must be taken into account 
(Schivazappa, 2002). In traditional hams there is an intense dehydration process during the ripening/drying 
stage, reaching moisture contents around 60% in the inner part of the ham (region of the muscle Biceps 
femoris) and around 50% in the outer part (region of the muscle Semimembranosus). Accordingly, water 
activity decreases during drying and its values can be reduced to near 0.90 in the inner part and around 0.85 
in the outer part of the ham. Water activity inside the dry-cured meats is important in controlling the enzyme 
actvity, especially when the ripening/drying progresses and aw approaches 0.90 or even lower values. Most 
of the muscle enzymes (cathepsins, aminopeptidases) are strongly affected by the decrease in aw along the 
processing of dry-cured meats with few exceptions. So, calpain appears to be slightly affected by aw 
reduction. The length of the process is also important for the activity of the enzymes, as a more pronounced 
action of the enzymes can be observed, especially if the drying conditions are mild. Thus, a more intense 
proteolysis can be expected when the ripening/drying time is longer and the conditions are milder. Most of 
the muscle enzymes are very stable and exhibit activity during all the process period and even some residual 
activity may be found by to 2 years. This allows a prolonged enzyme action even though its activity is 
reduced as drying progresses due to lower water activity values. Calpain and pyroglutamylaminopeptidase 
constitute an exception since they exhibit reduced stability and their activities are detectable only in the 
initial weeks of the process. Finally, other factors like salt and other curing agents must be taken into 
account because they exert inhibitory or activation effects on the muscle enzymes (Toldrà, 2006). During 
ripening and drying a large number of variable conditions as time, temperature, relative humidity and air 
velocity could determine difference in the final product. In other cases, the excess of proteolysis may be due 
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to variations in cathepsin B: low pH favours its activity, while an increase in salt concentration and a 
decrease of aw inhibits it. The inhibitory effects of sodium chloride on cathepsin B is well known. An 
impairment of texture, increase in bitter flavour, white surface film formation and tyrosine chalks (Virgili, 
1995) are observed with an excess of proteolysis. So, salt can help in controlling some defects such as the 
reported soft defective Parma hams, where the activity of cathepsin B is too high. 
 
The reduction of sodium in processed dry-cured hams requires innovations in the whole production process, 
since the use of conventional complementary treatments (syringing, use of substitutes of sodium chloride, 
and vacuum) is not allowed by PDO dry-cured ham production rules. The main technique used to reduce 
salt content in traditional ham has been generally the reduction of 25% of sodium chloride obtained with 
conventional technique (salt as a function of ham weight). Some other techniques taken into account have 
been the reduction of 25% of salt on the weight of legs but considering also the amount of fat tissue present 
in legs: to determine if the legs “fat” or “lean” the system MIS Lenz Prototype (Magnetic Induction 
Spectroscopy) have been used.  The system equipment’s operate in a non-invasive way: the former is based 
on carcass response to ultrasound, the latter on the different response of lean and fat tissues to a frequency 
dependent electromagnetic field (Simoncini, 2012). Two classes of fleshiness: hams with a content of fat or 
less than 65%, defined as "fat", and hams with a lean content equal to or higher than 67%, defined as "lean". 
This last technique has not particular advantages in comparison to the first one.  
The last techniques experimented has been the “satured” salt addition (where an excess salt cover all the leg 
and the absorbed salt depends on the duration of the salting step), but with this approach a very high 
influence of the raw material is observed on salt adsorption: the high variability between different legs 
(especially in terms of lean and fat tissue percentage) determine a great variability in salt content that it’s 
difficult to control. For this reason, this technique has been discarded. 
Some process parameters should be further improved (temperature, humidity and time duration of different 
phases) as well as a strict control of the characteristics of the raw material should be implemented in order to 
obtain products with characteristics similar to those of the traditional ones (Benedini, 2012). 
 
3.3.3 Conclusions 
The study of peptide fraction of traditional dry-cured hams is fundamental to realize innovative hams. The 
database of peptides created to compare reduced salt hams with the traditional ones has allowed to 
evidentiate large difference between the products, mainly based on the different extent of the proteolysis 
process that takes place in hams with low amount of salt: the lower value of salt increases the activity of 
proteolytic enzymes, decreases the extraction of myofibrillar proteins, determines a necessary increase of 
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period of resting in order to obtain the microbiological safety. The obtained products are characterized by an 
higher proteolysis index, a more “gummy” texture (due to the higher humidity), with a peptide profile richer 
in low MW peptides. As previously stated, to obtain a ham with the characteristics more similar to the 
traditional products, it will be necessary to change the process parameters (as temperature, water activity, 
humidity, etc) in addition to a strict control of the characteristics of the raw material. 
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4 BIOACTIVE PEPTIDES RELEASED BY THE 
GASTROINTESTINAL-DIGESTION OF DRY-CURED HAMS 
 
4.1 INTRODUCTION 
 
Dry-cured hams are meat products mostly appreciated by consumers for their organoleptic properties; they 
also represent an important example of traditional methods to preserve, and eventually improve, the 
nutritional properties of meat. In fact, while the excessive consumption of meat products is indicated as a 
risk factor for certain diseases, it is equally true that proteolysis is able not only to positively influence the 
digestibility of the products, but also to generate a pool of peptides that might be characterized by 
interesting biological activities, which may potentially counteract these negative effects. The bioactive 
peptides can be naturally present in the product or may be released during the gastro-intestinal digestion 
step.  Several studies have reported health related activities of biopeptides derived from food protein sources 
of animal origin, in particular from dairy proteins (Phelan, 2009). These bioactive peptides have been 
defined as "food components that may influence biological processes and thus have an impact on body 
functions or conditions and finally on health” (Roberts, 1994). Their activity depends on the composition of 
the amino acid sequence and on its length, and many peptides have shown multifunctional properties (on the 
cardiovascular, digestive, immune and nervous system). In this contest, a number of research investigations 
are currently focusing on the identification of functional biopeptides from meat proteins as meat is widely 
used as a nutritional source of high quality proteins (Ryan, 2011). 
Potentially antioxidant (Samaranayaka, 2011) and antihypertensive peptides have been identified in meat 
from various sources (Lafarga, 2014a): as far as pork meat, it has been demonstrated that biopeptides may 
be released by meat proteins by the action of endogenous or exogenous peptidases during processing. 
Peptides exhibiting in vitro antioxidant activities have been characterized in water soluble fraction from dry 
cured Spanish hams (Mora, 2014). Antihypertensive peptides have also been identified and their activity has 
been proven both in vitro as well as on spontaneously hypertensive rats (Escudero, 2010).  
It is worth noting that biopeptides may exert their physiological actions both in the intestinal lumen as well 
as upon crossing intestinal epithelia and reaching blood circulation: thus, their modifications by the 
gastrointestinal digestion process, the transport mechanism across the intestinal epithelium and the 
enzymatic modifications taking place there, all have to be considered. 
Thus, the application of in vitro digestion models are a necessary step to study the release of potentially 
bioactive and functional peptides from food proteins and to identify the most interesting sequences 
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(Ferranti, 2014), taking also in consideration the eventual effect of processing or maturation time of food 
products on the general digestibility and the release of these compounds. 
 
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Samples 
Dry-cured ham samples (n=10) with 18 and 24 ripening months, were provided by the Experimental Station 
for Food Preserving Industry (Parma). Samples of Biceps femoris muscle were minced by a common mill 
(Moulinex, Milano, Italia) and stored at freezing temperature (-22 °C) until analysis.  
 
4.2.2  Reagents and solvents   
Bidistilled water was produced in our laboratory by a Millipore Alpha Q purification system (Waters, 
Billerica, MA, USA). Pepsin from porcine gastric mucosa, trypsin from porcine pancreas, α-chymotrypsin 
from bovine pancreas, α-amylase from barley malt (type VIIIa), uric acid, mucin from porcine stomach 
(type III), glucose, glucuronic acid, glucosamine hydrochloride, bovine serum albumin, pancreatin from 
porcine pancreas, lipase from porcine pancreas (type II), bovine and ovine bile, sodium dihydrogen 
phosphate, potassium chloride, sodium phosphate dibasic dodecahydrate, monobasic potassium phosphate, 
acetonitrile, methanol, urea, L-phenylalanyl-L-phenylalanine (Phe-Phe), acetic acid, hydrochloric acid (0.1 
N), potassium persulfate, sodium hydroxide, trypsin, dithiothreitol, iodoacetamide, 
tris(hydroxymethyl)aminomethane (TIS),  trifluoroacetic acid, sodium phosphate dibasic dodecahydrate, 
potassium phosphate monobasic, dimethylformamide (DMF), n-butanol, methylene chloride, N,N,N′,N′-
tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU), N,N-diisopropylethylamine 
(DIPEA), ethyl acetate, potassium bisulfate, sodium bicarbonate, sodium sulfate anhydrous, tetrahydrofuran 
(THF), barium hydroxide octahydrate, m-cresol, thioanisol, sodium phosphate monobasic, methanol, 
ammonium thyocynate, ferrous chloride,  sodium phosphate monobasic, cupric nitrate trihydrate, Krebs-
ringer  bicarbonate buffer, glycerol, Angiotensin-Converting-Enzyme (ACE) 0.1U and 0.5U, captopril, 2-
(Cyclohexylamino)ethanesulfonic acid (CHES),  Ethylenedinitrilotetraacetic acid (EDTA), N-Hippuryl-His-
Leu hydrate (HHL), L-piroglutamic acid and (S)-(-)-2-Acetoxypropionic acid were all purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Hydrochloric acid (37% v/v), sodium hydroxide, sodium hydrogen 
carbonate, calcium chloride, ammonium chloride, potassium thiocyanate, potassium hydroxide, potassium 
chloride, phosphoric acid were purchased from Carlo Erba (Milan, Italy). Formic acid was purchased from 
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Acros Organics (Geel, Belgium). Sodium chloride was purchased from AnalaR Normapur (Milan, Italy). 
Sodium sulfate was purchased from Riedel de Haen (Seelze, Germany). Thionyl chloride, ammonium 
bicarbonate, 2,2-Azino-bis-3-ethylbenzothyazoline-6-sulfonic acid (ABTS), boric acid and magnesium 
chloride hexahydrate was purchased from Fluka (Sigma-Aldrich, St. Louis, MO, USA). SDS-PAGE 
standards Broad Range, XT Reducing Agent, XT Sample Buffer 4x, XT MES Running Buffer 20x, 
Comassie Brillant Blu R-250 were purchased from BIO-RAD (Hercules, CA, USA). Sodium chloride was 
purchased from VWR (Milan, Italy).   
Wang-resin, L- phenylalanine deuterated and N
α
-Boc-L-Glutamic acid α-tbutyl ester were purchased from 
Novabiochem (Billerica, MA, USA). Dulbecco's modified Eagle's minimal essential medium (DMEM with 
glucose 4500 mg/L), inactivated fetal calf serum (FCS), non-essential amino acids (NEAA), Hank's 
balanced salt solutions (HBSS), and penicillin/streptomycin (PS) were purchased from Gibco (Fisher 
Scientific). Cell culture inserts with polycarbonate membranes (pore sizes, 0.4 μm; effective area, 4.2 cm2) 
were obtained from Millipore (Saint-Quentin-en-Yvelines, France). Plastic dishes were purchased from 
Dutscher (Brumath, France). 
4.2.3 Extraction of the peptide fraction (MW<10 kDa) 
To 5 g of minced dry-cured ham 45 ml of a HCl 0.1N solution and 250 µl of a 1mM Phe-Phe aqueous 
solution were added and the mixture homogenized for 1 minute with Ultra Turrax T50 Basic (IKAWerke, 
Staufen, Germany) at 322 g. After centrifugation at 4°C (3200 g for 1 h), the supernatant was purified by a 
series of filtration steps using different filters (paper, 5 μm type SMWP, 0.45 μm type HPLV). 4 ml of the 
obtained extract were evaporated to dryness under vacuum by rotary evaporator and the residue was 
dissolved with 2 ml of a 0.1% formic acid aqueous solution. This solution was then filtered on a Vivaspin 2 
(Sartorius) filtration system equipped with 10 kDa cut off filters, at room temperature and 5423 g for 45 
minutes. The filter was washed for 3 times with 2 ml of a 0.1% formic acid aqueous solution. The filtered 
sample was evaporated to dryness under vacuum by rotary evaporator and the residue dissolved in 150 µl of 
a 0.1% formic acid aqueous solution and centrifuged at 4°C, at 16060 g, for 10 minutes before the UPLC-
ESI-MS analysis. 
 
 
4.2.4 Simulated in vitro gastro-intestinal digestion 
The simulated gastro-intestinal digestion and the preparation of the relative artificial digestive juices 
(simulated salivary juice, simulated gastric juice, simulated duodenal juice, and bile) were performed 
according to the protocol of Versantvoort (Versantvoort, 2005).  
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Briefly, the digestion procedure was as follows: minced Biceps femoris muscle (2 g) was dispersed in 3 ml 
of simulated salivary juice (pH = 6.8±0.2) and incubated at 37°C under agitation with Vortex and a 
horizontal shaker (230 rpm) for 5 min. After this first step, 6 ml of the simulated gastric juice (pH = 
1.3±0.2) was added and the mixture was left to react for 2 h under the same conditions. The last step was the 
addition of bicarbonate (1 ml, 1 M), simulated duodenal juice (6 ml, pH = 8.1±0.2 ) and bile (3 ml, pH = 
8.2±0.2) and the mixture was left to react at 37°C for other 2 h under agitation on a horizontal shaker. The 
enzyme reaction was stopped heating at 95°C for 15 min and the mixture was centrifuged at 3200 g for 20 
min to separate the supernatant (chyme) and the pellet (residual matrix). The supernatant was subjected to a 
final clean-up step by a Sep-Pak C18 cartridge (Waters Co., Milford, MA, USA): after conditioning the 
cartridge with methanol (2 ml) and bidistilled water (3 ml), chyme was applied (2 ml) and after discarding 
the first eluate, peptides were eluted with 2 ml of a solution of H2O:CH3OH (50:50, v/v). The eluate (1 ml) 
was evaporated to dryness under nitrogen flow in an Eppendorf tube and the residue was resuspended with 
1 ml of aqueous formic acid (0.1%), centrifugated and, then, analyzed in UPLC-ESI-MS (conditions 
reported below). Peptides were semiquantified comparing their peak area with that of the internal standard 
Phe-Phe: in particular, 4 µl of internal standard (1 mM aqueous solution) were added to 196 µl of digested 
sample (after clean-up) prior to the analysis by UPLC-ESI-MS.  
4.2.4.1 SemiprepLC-UV fractionation of digested samples 
10 ml of digested samples were fractionated by semipreparative HPLC- collecting a fraction 
per minute. The digested samples were separated by a RP column (JUPITER 5 μm C18 300 Å 250 x 10 
mm, Phenomenex) using a semipreparative HPLC-UV (1525 Binary HPLC Pump, Waters). The following 
gradient conditions were applied: eluent A, water with 0.1% formic acid and 0.2% acetonitrile, eluent B, 
acetonitrile with 0.1% formic acid; gradient: 0-12 min 100% A, 12-77 min linear from 100% A to 50% A, 
77-81 min 50% A, 81-82 min linear from 50% A to 0% A, 82-90 min 0% A, 90-91 min from 0% A to 100% 
A, 91-110 min 100% A. Other parameters were as follows: flow rate, 5 ml/min, analysis time, 110 min; 
column temperature, r.t.; sample temperature, r.t.;  injection volume, 2 ml; fractions collected every minute 
for a total of 52 fractions. UV detector (2998 Photodiode Array, Waters) set at λ = 214 nm. 
4.2.5 SDS-PAGE analyses 
Extracted samples: 5 μl of extracted filtered at 0,45 μm  were evaporated to dryness under nitrogen flux and 
dissolved in 25 μl of reducing sample buffer (1x, BIO-RAD). Digested samples (after clean-up) : 500 μl  of 
digested sample was evaporated under nitrogen flux and dissolved in 25 μl of reducing sample buffer (1x, 
BIO-RAD). 
Reducing sample buffer was composed by 5% of XT Reduce Agent (BIO-RAD) in Sample buffer 1x (BIO-
RAD). The running buffer (1x) is prepared by dilution of XT MES Running Buffer 20x (BIO-RAD) with 
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bidistilled water. Comassie staining solution: for 1 liter of solution, 1g of Comassie Brillant Blue R-250 
(BIO-RAD) was dissolved with with 100 ml of acetic acid, 400 ml of methanol and 500 ml of bidistilled 
water. Comassie destaining solution: for 1 liter of solution, 100 ml of acetic acid, 400 ml of methanol and 
500 ml of bidistilled water were mixed. Marker: the molecular marker (SDS-PAGE standards, BIO-RAD) is 
in the ratio of 1:20 with the reducing sample buffer. Gel: CriterionTM XT Precast gel, 12% Bis-Tris (BIO-
RAD). Run time: 50 minutes ca. at 150 V. Volume of marker used: 5μl. Data analysis with scanner GS-800 
Calibrated Densitometer controlled by the software “Quantity one” (BIO-RAD). 
4.2.5.1 In-gel digestion 
The gel was destained and the reduction, alkylation and digestion of the bands of interest were carried out as 
described by the in-gel digestion protocol of the Biological Mass Spectrometry Laboratory (Ontario Wide 
Protein Identification Facility, http://www.uwo.ca/biochem/bmsl/in-gel_digestion.html#coom). 
 
4.2.6 Peptide transport studies 
4.2.6.1 Co-culture Caco2-HT29-MTX 
The Caco-2 TC7 cells obtained by the laboratory of Thécla Lesuffleur (INSERM) were cultured in DMEM 
supplemented with 20% heat-inactivated FCS, 1% PS, and 1% NEAA. They were incubated at 37°C in a 
humidified atmosphere with 10% CO2. The mucus cells HT29-MTX were cultured in DMEM supplemented 
with 10% heat-inactivated FCS, 1% PS. They were incubated at 37°C in a humidified atmosphere with 10% 
CO2. The co-culture has been prepared and were seeded in cell culture inserts with polycarbonate 
membranes at a cell density of 250000 cell/ml for inserts of  4.1cm
2
, in ratio 90:10 Caco2 TC7 / HT29-
MTX.  The cells used in the studies had a number of passage of 44. Measurements of digesta transport with 
co-culture Caco-2/ HT29-MTX cell monolayer were performed in triplicate by transepithelial electrical 
resistance (TEER). The cells were incubated at 37°C, in a humidified atmosphere containing 10% CO2, and 
the medium was changed daily. The confluent monolayer was used between 21 and 23 days after seeding. 
The Caco-2 cells monolayer was rinsed three times with 1 mL of HBSS. The cells were incubated with 
HBSS for 30 min in the apical compartment and in the basolateral compartment. After incubation, the 
solutions in both compartments were removed, and the digesta solution was added as follows: 2 mL with 
samples (digesta at 18, 24 months and blank (matrix without ham)) prepared in HBSS (dilution 1:23 to have 
2mg/2ml of proteins and 0.5mM bile salts) and 2 mL of HBSS in the basolateral compartment. Aliquots 
were taken from the apical and basolateral compartments after 30, 60, and 120 min of incubation time (two 
inserts for each samples tested were incubated for one time determined). The aliquots were boiled at 95°C 
for 15 minutes to stop any enzymatic reaction.  At the end of the experiments, the cells were washed three 
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times with 1 mL of HBSS, and fresh culture medium was added to the apical and basolateral compartments 
in order to measure the TEER and the aliquots were boiled at 95°C for 15 minutes. 
The Measurement of Transepithelial Electrical Resistance (TEER) was then measured to determine the 
integrity of the Caco-2 cell monolayer: the measure of TEER with a Millicell-ERS Ohm Mete (Millipore, 
Billerica, MA) just before, immediately after, and 2, 4, and 20 h after the peptide transport studies. An 
increase to 350 Ω cm2 of the TEER indicated a confluent cell monolayer with tight junctions. 
4.2.6.2 Ussing Chamber 
The experiment must be performed in one hour after the animal death. Take the intestine, the proximal 
jejunum, 20-25 cm after the stomach (after the duodenum and the angle of Treitz). Wash the intestine in a 
Krebs –ringer bicarbonate buffer. The intestine undergoes stripping in order to facilitate assembly and 
oxygenation (elimination of the muscular outer side of the intestine). Put the intestine in the chamber in the 
right direction to properly identify mucosal compartments (donor) and serous (receiver). Place a sheet of 
parafilm on top of the room to separate the two compartments (with bubbling, the Krebs ringer foams and 
can pass into the serosa compartment). Screw the two half-chambers flat on the bench and put them on the 
carrier thermostat. The choice of the temperature is a function of the animal: for the pork, 40 °C. Put 
simultaneously on both sides of the tissue 4 ml of Krebs ringer with bubbling of 95% O2 5% CO2. Allow to 
equilibrate for 20 min. Then, fill 2 half-empty compartments at the same time with digested solutions 
(dilution 1:11 in Krebs-ringer in order to have 8mg/4ml of protein): 2 chambers was charged with Krebs-
ringer as system blank, 2 with sample at 18 months, 2 with samples at 24 months and 2 with the digestion 
blank. Aliquots of 1 ml (and substituted by 1 ml of Krebs ringer buffer) have been taking after 30, 60 and 
120 minutes of incubation times. The aliquots were boiled at 95°C for 15 minutes to stop any enzymatic 
reaction. 
 
4.2.7 UPLC-ESI-MS analysis 
UPLC/ESI-MS analyses were performed with an UPLC/ESI-MS system (UPLC Acquity Waters equipped 
with a single quadrupole mass spectrometer Waters Acquity Ultraperformance). Conditions were as follows: 
column, RP ACQUITY UPLC BEH 300 C18 (1.7 μm, 2.1 x 150 mm, Waters); gradient elution: eluent A, 
water with 0.1% formic acid and 0.2% acetonitrile, eluent B, acetonitrile with 0.1% formic acid; gradient: 0-
7 min 100% A, 7-50 min linear from 100% A to 50%  A, 50-52.6 min isocratic 50% A, 52.6-53 min linear 
from 50% A to 0% A, 53-58.2 min isocratic 0% A, 58.2-59 min linear from 0% A to 100% A, 59-72 min 
isocratic 100% A. LC parameters: flow rate, 0.2 ml/min; analysis time, 72 min; column temperature, 35°C; 
sample temperature, 18°C; injection volume, 2 μl for digested samples (with 7 minutes of solvent delay), 4 
μl for extracted samples (with no solvent delay), 10 μl for samples of Caco-2/HT29-MTX and Ussing 
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chamber. MS parameters: Full Scan mode, acquisition time 7-58.2 min; ionization type, ESI + (positive 
ions); scan range, 100-2000 m/z; capillary voltage, 3.2 kV; cone voltage, 30 V; source block temperature, 
150°C; desolvation temperature, 300°C; cone gas flow, 100 l/h; desolvation gas flow, 650 l/h. Data were 
acquired and analyzed by MassLynx 4.0 software (Waters Co., Milford, MA, USA).  
4.2.7.1 Data statistical analysis 
Peptide profiles of the digesta (as a function of the ageing time), obtained by the analysis of spectra from 
UPLC-ESI-MS, were examined by Principal Component Analysis (PCA) and T-student test with the 
software SPSS Statistics 17.0.   
 
4.2.8 HPLC/ESI-MS/MS analyses 
HPLC/ESI-MS/MS analyses were performed using a HPLC (Mod. Alliance 2695, Waters) equipped with a 
triple quadrupole mass spectrometer (Mod. 4 Micro, Waters) and a RP column JUPITER 5 μm C18, 300 Å 
250 x 2 mm I.D. (Phenomenex, Bologna, Italy). Gradient elution was as follows: eluent A, water with 0.1% 
formic acid and 0.2% acetonitrile; eluent B, acetonitrile with 0.1% formic acid; gradient: 0-12 min 100% A, 
12-77 min linear from 100% A to 50% A, 77-81 min 50% A, 81-82 min linear from 50% A to 0% A, 82-90 
min 0% A, 90-91 min linear from 0% A to 100% A, 91-110 min 100% A. Samples (extracted and digested 
samples) were first analyzed in Full Scan mode, to identify the characteristic ions and the retention time of  
the unknown compounds, then in Daughters Scan modality, using a variable collision energy from 10 to 30 
eV. HPLC/ESI-MS/MS parameters were as follows: flow rate, 0.2 ml/min; analysis time, 110 min; column 
temperature, 35°C; sample temperature, 23°C; injection volume, 10 μl for Full Scan mode and 30 μl for 
Daughter Scan mode; acquisition time, 90 min; ionization type, ESI + (positive ions); scan range, 100-2000 
m/z; capillary voltage, 3.2 kV; cone voltage, 35 V; source block temperature, 100°C; desolvation  
temperature, 200°C; cone gas flow, 100 l/h; desolvation gas flow, 650 l/h. The peptide sequences were 
assigned on the basis of the obtained mass spectra and using the Bioinfomatics resource portal ExPasy with 
the tools FindPept (Swiss Institute of Bioinformatics, Switzerland) and with the web application 
“Proteomics Toolkit” (Institute for Systems Biology, Seattle, WA, USA). 
 
4.2.9 LTQ-Orbitrap analyses 
Analyses were performed by a LTQ-Orbitrap (Thermo Fischer Scientific, Milano, Italy) equipped with a 
column Jupiter Proteo 4 µm (90 Å, 150 x 0.30 mm, Phenomenex). Gradient elution was as follows: eluent 
A, H2O + 0.2% HCOOH; eluent B, CH3CN + 0.2% HCOOH. Gradient: 0-4 min, 95%A, 4-60 min, linear 
from 95% to 50% A, 62-72 min, isocratic 95%B, 70-72 min linear from 5% A to 95% A, plus 
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reconditioning (3 min in 95% A). Samples (digesta) were desalted by ZipTip (Millipore) before the 
details: (1) FTMS + res = 30000; (2) ITMS + Dep MS/MS most intense ion (1); (3) ITMS + Dep MS/MS 
second most intense ion from (1); (4) ITMS + Dep MS/MS third most intense ion from (1); (5) ITMS + Dep 
MS/MS third most intense ion from (1); collision energy, 35. Data-dependent setting: charge state rejection 
enabled; Unassigned charge states: rejected, charge state 1 rejected, charge states 2, 3 and 4 not rejected. 
Dynamic exclusion enabled. Repeat count: 3. Repeat duration 30.00s. Exclusion list size: 50. Exclusion 
duration: 180.00s. Exclusion mass width by mass. Exclusion mass width low and high: 1.5000. 
4.2.10 Solid phase peptide synthesis 
The peptides NSIM, GVVPL, LGL, SFVTT, ALM were synthesized on solid phase according to Fmoc/t-
butyl strategy using a Syro I Fully Automated Peptide Synthesizer (Biotage, Uppsala, Sweden). The 
peptides were cleaved from the Wang-resin (Wang, Calbiochem-Novabiochem, Läufelfingen, Switzerland) 
using a TFA:TIS:H2O:DTT (94:1:2.5:2.5) solution and purified using a C18 cartridge Sep-pak (Waters) and 
semipreparative RP-HPLC-UV (λ=214 nm).  Characterization MH+ (ESI–MS): 464.2 NSIM, 484.3 GVVPL, 
302.2 LGL; 554.3 SFVTT, 334.2 ALM. 
4.2.10.1.1 Purification of peptides: semipreprative HPLC-UV 
The purification of compounds has been made with semipreparative HPLC-UV (1525 Binary HPLC Pump, 
Waters) using a RP column (JUPITER 5 μm C18 300 Å 250 x 10 mm, Phenomenex).  Injection volume 
500µl, flow 5ml/min. Gradient elution was as follows: eluent A, water with 0.1% formic acid; eluent B, 
acetonitrile with 0.1% formic acid; gradient: 0-5 min 100% A, 5-10 min  from 100% A to 85% A (this % 
change in function of compound to purified), 10-20 min linear in 85% A, 20-25min 0%A, 25-30min 
100A%, 35-50 min 100%A. 
4.2.11 Synthesis of NPADS 
4.2.11.1 Synthesis of L-Phenylalanine methyl ester hydrochloride (deuterated) 
1g of deuterated L-phenylalanine (d5-L-Phe) were dissolved in 50 ml of dry-methanol and kept under 
continuous stirring in an ice bath; SOCl2 was added to a final concentration of 1 M (3,62 ml of SOCl2  plus 
46,38 ml dry-methanol). The reaction closed with a valve of calcium chloride, was left to react overnight 
and was monitored by TLC (n-butanol: acetic acid:water 4:1:1 as eluent, UV and ninidrine detection). The 
reaction mixture was dried at rotavapor. Residual HCl was eliminated by adding methanol (50 ml) and 
redrying by rotavapor (4 times). Characterization MH
+
 (ESI–MS): 185.2 L-Phenylalanine methyl ester 
hydrochloride (deuterated). 
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4.2.11.2 Synthesis of L-Lactoyl-L-Phenylalanine (d5) 
 (S)-(-)-2-Acetoxypropionic acid (1.56 mmol) was diluted in CH2Cl2 (3 ml) together with 1.48 mmol of 
HBTU and the mixture was kept under continuous stirring at room temperature for 30 min, in order to 
activate the carboxylic function. L-Phenylalanine-methyl ester d5 (1.56 mmol) was dissolved in 2 ml of 
CH2Cl2, together with DIPEA (4.68 mmol) and then added to the activated acetoxypropionic acid. The 
reaction was left to react under magnetic stirring overnight at room temperature. The reaction was 
monitored by TLC (ethyl acetate as eluent, UV absorbance detector). The organic solution was washed with 
the 10 ml of saturated solutions of KHSO4 (3 times) and NaHCO3 (3 times) in order to remove the unreacted 
reagents, dried with Na2SO4 and filtered. The product was dried under nitrogen flux and vacuum. The 
methyl and acetyl protecting groups were removed by reaction in 5 ml of THF (without inhibitor) and 5 ml 
of water with 0.78 mmol of Ba(OH)2 (which corresponded to 2 equivalents of the protected molecules, ratio 
between THF and H2O is 1:1) for 20 min, on ice bath. THF was then eliminated under vacuum by rotavapor 
and the aqueous solution was acidified to pH 3 with HCl. Characterization MH
+
 (ESI–MS): 243.2 L-
Lactoyl-L-Phenylalanine (d5). 
4.2.11.3 Synthesis of L-Pyroglutamyl-L-Phenylalanine (d5) 
1.5 mmol of L-pyroglutamic acid were diluted in CH2Cl2 (5 ml) together with 1.42 mmol of HBTU and the 
mixture was kept under continuous stirring at room temperature for 30 min, in order to activate the 
carboxylic function. L-Phenylalanine-methyl ester d5 (1.5 mmol) was dissolved in 2 ml of CH2Cl2, together 
with DIPEA (4.5 mmol) and then added to the activated pyroglutamic acid. The reaction was left to react 
under magnetic stirring overnight at room temperature. The reaction was monitored by TLC (ethyl acetate 
as eluent, UV absorbance detector). In order to make the reaction complete, 0.75 mmol of L-pyroglutamic 
acid and 0.71 mmol of HBTU in 2 ml of CH2Cl2:dry DMF (1:1) plus 2.25 mmol of DIPEA were added. The 
organic solution was evaporated under vacuum, at 40°C, in order to eliminate the DMF and redissolved in 5 
ml of CH2Cl2.  The organic solution was washed with 10 ml of saturated solutions of KHSO4 (3 times) and 
NaHCO3 (3 times) in order to remove the unreacted reagents, dried with Na2SO4 and filtered. The product 
was dried under nitrogen flux and vacuum. The methyl protecting group was removed by dissolving the 
ester in 12 ml of THF (without inhibitor) and 12 ml of water with 0.9 mmol of Ba(OH)2 (which 
corresponded to 2 equivalents of the protected molecules, ratio between THF and H2O is 1:1) for 1h and 30 
min, on ice bath.  The reaction was monitored by TLC (ethyl acetate as eluent, UV detector).   THF was 
then eliminated under vacuum by rotavapor and the aqueous solution was acidified to pH 3 with HCl. 
Characterization MH
+
 (ESI–MS): 282.2 L-Pyroglutamyl-L-Phenylalanine (d5). 
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4.2.11.4 Synthesis of γ-glutamil-L-Phenylalanine (d5) 
N
α
-Boc-L-Glutamic acid α-tbutyl ester (2.055 mmol) was dissolved in DMF (2.5ml) together with 1.955 
mmol of HBTU and the mixture was stirred at room temperature for 30 minutes. L-Phenylalanine-methyl 
ester d5 (2.055 mmol) was dissolved in DMF (1 ml) together with 6.125 mmol of DIPEA and added to the 
reaction. The mixture was left to react under magnetic stirring overnight and the reaction was monitored by 
TLC (ethyl acetate as eluent, UV detector). In order to react the residual phenylalanine, 1.027 mmol of N
α
-
Boc-L-Glutamic acid α-tbutyl ester and 0.511 mmol of HBTU in 1.5 ml of DMF and 3.06 mmol of DIPEA 
were added. The organic solution was evaporated under vacuum, at 40°C, in order to eliminate the DMF and 
redissolved in 5 ml of CH2Cl2.  The organic solution was washed with 10 ml of saturated solutions of 
KHSO4 (3 times) and NaHCO3 (3 times) in order to remove the unreacted reagents, dried with Na2SO4 and 
filtered. The product was dried under nitrogen flux and vacuum. The residue was dissolved in 15 ml of a 
trifluoroacetic/methylene chloride 1:1 solution, containing also 4% of m-cresol and 4% of thioanisol as 
scavengers. The mixture was stirred at room temperature for 1 h and then the solvent was evaporated under 
vacuum by nitrogen flux. Cold ethyl ether was added to the residue in order to precipitate the free dipeptide. 
The precipitate was washed several times with cold ethyl ether and the product dried by nitrogen flux and 
under vacuum. The methyl protecting groups was removed by dissolving the ester in 5 ml of THF (without 
inhibitor) and 5 ml of water with 0.5 mmol of Ba(OH)2 (which corresponded to 2 equivalents of the 
protected molecules, ratio between THF and H2O is 1:1) for 20 min, on ice bath.  The reaction was 
monitored by TLC (ethyl acetate as eluent, UV detector).   THF was thne eliminated under vacuum by 
rotavapor and the aqueous solution was acidified to pH 3 with HCl. Characterization MH
+
 (ESI–MS): 300.2 
γ-glutamil-L-Phenylalanine (d5). 
 
For product characterization, 5 µl of all obtained NPADs were dissolved in 1 ml of H2O+0.1% HCOOH and 
the solution (1 µl) was injected in UPLC-ESI-MS (the analysis conditions are the same described in 
paragraph number  3.2.5.1). 
 
4.2.11.4.1 Purification of Npads: semipreprative HPLC-UV 
The purification of compounds has been made with semipreparative HPLC-UV (1525 Binary HPLC Pump, 
Waters) using a RP column (JUPITER 5 μm C18 300 Å 250 x 10 mm, Phenomenex). Injection volume 500 
µl, flow 5 ml/min. Gradient elution was as follows: eluent A, water with 0.1% formic acid; eluent B, 
acetonitrile with 0.1% formic acid; gradient: 0-5 min 100% A, 5-10 min linear from 100% A to 81% A (this 
% change in function of compound to purified), 10-20 min 81% A, 20-25 min linear to 0%A, 25-30 min 
linear to 100 A%, 35-50 min 100%A. 
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4.2.11.4.2 Quantification of Npads 
The concentration of purified compounds has been made with spectrophotometer UV (Jasco V-530, UV-
Vis, Easton, USA) monitoring the absorbance of the amino acid phenylalanine (ε=200M-1cm-1) at 257 nm in 
water.  The calibration curve was set up plotting the ratio between areas NPADs:FF (internal standard) vs 
different concentration of NPADs (γ-glutamil-L-Phenylalanine (d5) and L-Lactoyl-L-Phenylalanine (d5) 
from 1 μM to 20 μM; L-Pyroglutamyl-L-Phenylalanine (d5) from 10 μM to 150 μM). 
4.2.12 Ace-inhibitory activity 
4.2.12.1 Ace-inhibitory activities: fractions, purified peptides, Npads  
Ace-inhibitory activity was determined by the methods of Cushman et al (Chushman, 1971) and Nakamura 
et al (Nakamura, 1995), with some modification. The following solutions were prepared: sodium borate 
buffer (0,1 M, NaBB) with NaCl (300 mM), pH = 8.3; potassium phosphate buffer (0,01 M, KPB) with 
NaCl (500 mM), pH = 7; 5 mM HHL (Hippuryl-Histidyl-Leucine) in NaBB buffer. The experiment is 
carried out at 37°C determining the following parameters: maximum activity of ACE (MAX) = 200 µl HHL  
+ 80 µl NaBB + 20 µl ACE; control blank of ACE (Bmax) = 200 µl HHL + 80 µl NaBB + 20 µl KPB; 
minimum activity of ACE (MIN) = 200 µl HHL + 80 µl sample/digestion blank at different concentration + 
20 µl ACE; control blank of sample/digestion blank (Bmin) = 200 µl HHL+ 80 µl sample/digestion blank at 
different concentration + 20 µl KPB. After 60 minutes of incubation the reaction was quenched with 250 µL 
HCl (1N). The analysis was performed by HPLC-UV (Alliance 2695 separation, Waters with  Dual λ  
Absorbance 2487, Waters) with the following conditions: column, RP JUPITER C18, 5 μm, 300 Å 250 x 2 
mm I.D.; gradient elution: eluent A, water with 0.1% formic acid and 0.2% acetonitrile, eluent B, 
acetonitrile with 0.1% formic acid; gradient, 0-10 min 100% A, 10-22.50 min linear from 100% A to 50%  
A, 22.50-23.50 min 50% A, 23.50-30 min linear from 50% A to 100% A; column temperature, 35°C; 
sample temperature, r.t.; injection volume, 10 μl; acquisition time, 30 min. UV detector: λ = 228, aufs 2. 
Data analysis was performed with Empower software. 
4.2.12.2 ACE-inhibitory activity: samples from co-culture Caco-2/ H29-MTX and  from Ussing 
chamber 
Ace-inhibitory activity was determined by the methods of Cushman et al (Chushman, 1971) with some 
modifications. Prepare the following solution: CHES 50mM buffer containing 300mM of NaCl, pH 8.3; 
HHL 5,2mM in CHES 50mM buffer (as prepare before); ACE 0,025U/ml is solubilized in CHES buffer 
50Mm (as prepared before) with 5% glycerol; stop solution composed by  captopril 15µM, EDTA 3mM and 
0.2% TFA. The ace-inhibitory activity was performed as follow: 65µl HHL 5.2mM + 25 µl samples from 
co-culture/HBSS or 12 µl samples from Ussing chamber/Krebs-ringer+ 10µl ACE (0,025U/ml) at 37°C. 
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After 1 hour of incubation time, the reaction is inactivated by 37 µl stop solution.  The analysis was 
performed in UHPLC-UV (Shimadzu, Kyoto, Japan), injection volume 30 µl, samples temperature 4°C, 
Column temperature 29°C, flow 0,25ml/min, eluent A: water and 0,1%TFA, eluent B: ACN and 0,1%TFA, 
Column Kinetex C18 2.6µ XB 100Å 150*2.10mm (Phenomenex), Gradient: 0-7min from 87% A to 50%A, 
7-8 min from 50% A to 1%A, 8-17 min 1inear 1%A, 17-18 min 1% to 87%A, 18-35 min linear 87% A. 
Detector UV, PDA (Shimadzu, Kyoto, Japan), λ=228nm. Data were elaborated by software LabSolutions 
(Shimadzu). 
4.2.12.3 ACE: in silico model 
Molecular modeling. The models for both C- and N-domains of ACE were derived from the Protein Data 
Bank (http://www.rcsb.org) structures having PDB codes 4APH and 4BZS, respectively (Masuyer et al., 
2012; Kramer et al., 2014). Protein structures and ligands were processed by using the software Sybyl, 
version 8.1 (www.tripos.com). 
Docking simulations and rescoring procedure. The coupling of GOLD (version 5.1), to perform docking 
simulations, and HINT software, as re-scoring function, has been already proved to be effectively able to 
evaluate the bioactivity of small molecules including peptides (Dellafiora, 2012-2014). 
4.2.13 Antioxidant activity. 
4.2.13.1 ABTS assay 
Antioxidant activity was measured using the method of  Re R. et al (Re, 1999)  with same modifications. 
For the analysis, digested samples were diluted 1:100 in PBS, whereas no dilution was applied to the 
fractionated samples. The test parameters were determined as follows: MAX = 0.2 ml PBS + 1.8 ml ABTS 
work solution; MIN = 0.2 ml sample + 1.8 ml ABTS work solution; B_MIN = 0.2 ml sample + 1.8 ml 
ABTS work solution. Each prepared solution was analysed after 60 minutes with a UV-VIS 
spectrophotometer (LAMBDA BIO 20, Perkin Elmer) at 734 nm. Data analysis was performed with the 
LambdaBio software. 
4.2.13.2 Acid linoleic assay 
The method of Beker et al. (Beker, 2011) was used with some modification. 
All solutions were prepared daily. Aqueous solutions of ethanol (75%), ammonium thiocyanate (NH4SCN) 
30%, and ferrous chloride (0.02M in 3.5% of HCl),  sodium phosphate monobasic buffer 0.2M (up to pH 7 
with NaOH), cupric nitrate trihydrate 0.05 M  were used in the determination of lipid hydroperoxides with 
the Fe(III)–SCN reagent. A stock linoleic acid emulsion was prepared as followed linoleic acid: tween 20 
1:1 in 0.2M of phosphate buffer and homogenized for 1 minute with UltraTurrax T18 Basic (Ika). 
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Solutions to test are composed as report below: 
-blank: 3.125 mL of emulsion (already described before) + 2.5 mL phosphate buffer (0.2M) + 0.125 mL 
cupric nitrate (0.05M) + 0.500 mL ethanol absolute; 
-blank of digestion: 3.125 mL of emulsion (already described before) + 2.5 mL phosphate buffer (0.2M) + 
0.125 mL cupric nitrate (0.05M) + 0.125 mL sample blank of digestion + 0.375 ml ethanol absolute; 
- digested samples: 3.125 mL of emulsion (already described before) + 2.5 mL phosphate buffer (0.2M) + 
0.125 mL cupric nitrate (0.05M) + 0.125 mL digested samples + 0.375 ml ethanol absolute; 
 
The solutions, in contact with air, are placed in a water bath thermostated at 37 ◦C, in continuous magnetic 
stirring. After 20 minutes of beginning to the test and after every hour for 24 hours, take aliquots of 
solutions and test them for lipidic oxidation with the ferric thiocyanate method (Lea, 1952; Mihaljevic et al., 
1996): the degree of oxidation was measured by sequentially adding ethanol (2,350 mL, 75%), ammonium 
thiocyanate (0.05 mL, 30%), sample solution (0.05 mL), and ferrous chloride (0.05mL of 0.02Min 3.5% 
HCl). After 3 minutes of incubation time of the mixture, the peroxide concentration was 
spectrophotometrically determined by reading the absorbance at 500nm against a reagent blank containing 
identical components without the sample solution (substituted by phosphate buffer)  (Yen and Hsieh, 1998). 
Data analysis has been made with software Lambda 20 Bio. 
 
 
4.3  RESULTS AND DISCUSSION 
 
4.3.1 Simulated in vitro gastro-intestinal digestion 
The gastrointestinal digestion process has a major influence on the release of peptide sequences encrypted in 
food proteins. In this contest, although simplified approaches based on the use of gastrointestinal enzymes 
may be used to evaluate protein digestibility, digestion model better simulating the real environment of the 
human gastrointestinal tract are more effective to assess the nutritional value and the biological activity of 
the released peptides. 
Thus, in order to understand the effect of the digestion process, dry-cured ham samples have been subjected 
to a simulated gastro-intestinal digestion. Samples are taken from the Biceps femoris muscle, regarded as 
the reference muscle for evaluating most technological and nutritional parameters of dry-cured ham, such as 
salt content, texture, colour, etc. The digestion procedure was adapted from (Versantvoort, 2005): the 
method mimics the subsequent steps of the digestion process in terms of composition of the juices in the 
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different compartments (simulation of salivary juice, gastric juices, duodenal juice and bile) as well as the 
relative residence times. 
4.3.1.1 Sample clean-up 
The chyme at the end of the digestion process is characterized by an high amount of and an high salt 
concentration, which may impair the chromatographic analysis by UPLC-ESI-MS. Thus, we have 
developed a properly clean-up procedure of the samples.. 
In Figure 23 the UPLC-ESI-MS chromatograms obtained for the same sample subjected both to no clean-up 
(a) or to clean-up with Sep-Pak C18 cartridge (b) are reported. 
 
Figure 23. Chromatograms of a sample of digested ham sample not subjected to clean-up (a) or subjected to 
clean-up by Sep-Pak C18 cartridges (b). 
Clean-up on Sep-Pak C18 cartridges allows to eliminate very efficiently bile salts, thus we have developed 
the clean-up method testing different solvent mixtures to elute the peptides from the cartridge. The tested 
eluents are: 
- H2O: CH3OH 30:70 v / v; 
- H2O: CH3CN 70:30 v / v; 
- H2O: CH3CN 50:50 v / v; 
- H2O: CH3OH 50:50 v / v; 
 
The UPLC-ESI-MS chromatograms obtained using the different mixtures are reported in Figure 24. 
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Figure 24. Chromatograms of a sample of raw ham after clean-up on Sep-Pak cartridge using as eluents: H2O: 
CH3OH 30:70 v / v (a), H2O: CH3CN 70:30 v / v (b), H2O: CH3CN 50:50 v / v (c), H2O: CH3OH 50:50 v / v (d). 
 
From the analysis it can be concluded that no significant differences were observed for the peptide profile, 
whereas the best solvent mixture to efficiently eliminate the maximum amount of bile salts is the mixture 
H2O: CH3OH 50:50 (v / v) (chromatogram d). Thus, the clean-up method using Sep-Pak C18 cartridge with 
the eluent H2O: CH3OH 50:50 was applied to the analysis of all the digested ham samples. 
4.3.2 Efficiency of digestion process 
The efficiency of the digestion process was evaluated comparing the protein and peptide profile of dry-cured 
ham samples before and after the digestion process. 
In particular, comparing an aqueous acidic extract of the ham with the profile of the digesta by 
monodimensional gel electrophoresis large differences were observed: several bands of muscle proteins and 
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protein fragments were found in the extracts, whereas these bands completely disappear upon digestion with 
the concurrent accumulation of low molecular weight compounds (Figure 25). 
 
Figure 25. Sds-page of extracted and digested samples: 1, extract at 18 months; 2, extract at 24 months; 3, 18 
months  digesta; 4, 24 months digesta, M marker. 
 
The only protein bands present in digested samples are those of serum albumin (with molecular weight 
around 66200 Da), troponin C (the band slightly below 21500 Da) and fragment probably derived by 
superoxide dismutase (around band 6500Da). It appears evident that the digestion process was very 
effective and we focused our attention to the characterization of the peptide pattern by liquid 
chromatography-mass spectrometry analysis. 
 
4.3.3 Chromatographic profile of ham samples before and after the digestion process 
First, we performed an UPLC-ESI-MS analysis of the peptide fraction before and after the digestion 
process, focussing on peptides with a MW up to 10 kDa.  
A typical UPLC-MS peptide chromatographic profile of a digested sample compared with that of the 
corresponding extract as well as of the digestion blank is reported in Figure 26. 
 
 
M 
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Figure 26. Total Ion Chromatogram in UPLC-ESI-MS of: a) digesta sample; b) blank digesta (matrix without 
ham); c) extract sample. 
 
The peptide profile of digesta from dry-cured ham (a) is completely different from that of the extract before 
digestion (c) and absolutely richer than that obtained for the digestion blank (matrix-without ham) (b), 
which contains only some endogenous peptides in far lower amounts than those observed in the case of 
ham. 
Some common peaks are related to the free amino acids (phenylanine and tryptophan) and to the bile salts of 
the digestive juices (the last eluting peaks between 35 and 45 min). In particular, as already underlined, the 
peptide profile of the extract before digestion (c) is characterized by a higher amounts of high MW peptides 
and a lower amounts of low MW peptides in comparison with the profile of the digested sample. 
Indeed, LC-MS analysis reveals large differences in terms of molecular weights: in the extract before 
digestion we observed a very complex mixture of peptides with a range of MWs between 188 and 9166 Da: 
54% of these peptides have MWs > 1000 Da and 15% have MWs > 5000 Da. In the digesta, MWs span 
between 200 and 1600 Da, with 80% of the peptides having a MW < 1000 Da. 
 Peptide sequences were identified and characterized by HPLC-ESI-MS/MS, confirming the identification 
by exact mass determination with LTQ-Orbitrap. The main peptides occurring in ham extract before 
digestion are not found in the digesta: degradation by the digestion process leads to a completely different 
pattern, which has been characterized as reported below.  
4.3.4 Characterization of the peptide profile of the digested samples 
The cleavage of peptide bonds by digestive proteases results into the release of peptides of various length 
and free amino acids. The peptide profile of digested ham samples was analyzed in order to identify the 
peptides regarded as the most significant (obtained by UPLC-ESI-MS): on account of the large number of 
peptides and the great complexity of the chromatogram, the identified peptides are those corresponding to 
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the most intense signals. The identification was carried out matching the results obtained by HPLC-ESI-
MS/MS and LTQ-Orbitrap analyses. As stated before, most peptides found in the profile of digested 
samples have MWs between 200 and 1700 Da: these dimensions are typical of most known bioactive 
peptides and also of peptides able to easily cross the gut lumen, thus potentially able to exert a nutritional or 
systemic bioactive function. The length of the peptide fragments are between 2 and 14 amino acids, in 
agreement with other studies of peptide profile obtained upon a digestion process (Escudero, 2010; 
Bauchart, 2007). 
The most important proteins of origin with reference to the amount of the peptides found in the mixture 
were identified by LTQ-Orbitrap analysis (Table 4). 
 
Table 4. Main proteins of origin of the peptides present in the digested samples. 
Protein Code 
(UniProtKB-Swiss 
Prot-ExPASy) 
Score Protein Description  
Q9TV61 411.40 Myosin-1 OS=Sus scrofa GN=MYH1 PE=2 SV=1 - [MYH1_PIG] 
Q9TV62 361.68 Myosin-4 OS=Sus scrofa GN=MYH4 PE=2 SV=1 - [MYH4_PIG] 
Q9TV63 246.12 Myosin-2 OS=Sus scrofa GN=MYH2 PE=2 SV=1 - [MYH2_PIG] 
P79293 218.49 Myosin-7 OS=Sus scrofa GN=MYH7 PE=2 SV=2 - [MYH7_PIG] 
F1RZC8 176.06 Uncharacterized protein OS=Sus scrofa GN=TTN PE=4 SV=1 - [F1RZC8_PIG] 
K7GMH0 174.08 Uncharacterized protein (Fragment) OS=Sus scrofa GN=MYH6 PE=4 SV=1 - 
[K7GMH0_PIG] 
P68137 128.36 Actin, alpha skeletal muscle OS=Sus scrofa GN=ACTA1 PE=3 SV=1 - [ACTS_PIG] 
F1SHL9 101.93 Pyruvate kinase (Fragment) OS=Sus scrofa GN=PKM PE=2 SV=2 - [F1SHL9_PIG] 
F1SS61 93.60 Uncharacterized protein OS=Sus scrofa GN=MYHC PE=4 SV=1 - [F1SS61_PIG] 
F2Z5B6 76.92 Tropomyosin alpha-1 chain OS=Sus scrofa GN=TPM1 PE=3 SV=1 - [F2Z5B6_PIG] 
F1SG00 72.09 Uncharacterized protein OS=Sus scrofa GN=TPM2 PE=3 SV=1 - [F1SG00_PIG] 
A1XQT6 58.04 MLC1f OS=Sus scrofa GN=MYL1 PE=2 SV=1 - [A1XQT6_PIG] 
Q5XLD3 42.86 Creatine kinase M-type OS=Sus scrofa GN=CKM PE=2 SV=1 - [KCRM_PIG] 
F1RFY2 42.73 Beta-enolase OS=Sus scrofa GN=ENO3 PE=3 SV=1 - [F1RFY2_PIG] 
F1RJ25 42.66 Fructose-bisphosphate aldolase OS=Sus scrofa GN=ALDOC PE=2 SV=2 - 
[F1RJ25_PIG] 
 
 
 
The identification has been performed by online bioinformatics resource portal such as “Expasy” with  the 
tool “FindPept” and by the “Proteomics Toolkit”(MS/MS Fragment Ion calculator): the identification 
91 
 
process is based on the comparison of the theoretical fragmentation (Proteomics Toolkit) of the possible 
peptide sequences obtained by in silico experiments from unspecific cleavage of proteins (FindPept) with 
the sequence fragmentation obtained by MS/MS experiments. An example is reported in Figure 27.  
 
 
Figure 27. Peptide identification example: comparison of the theoretical fragmentation with the sequence 
fragmentation obtained by MS/MS experiments. 
The sequences of the peptides identified in the digesta are reported in Table 5, along with their main 
putative proteins of origin.  
 
 
Table 5. Identified peptide sequences in digesta of dry-cured hams analysed at 18 and at 24 months of ageing. 
MW Sequences  Parent Protein Average amount ± std. dev. * 
   18 months 24 months 
202 AI(L)  5.80±0.95 2.16±0.53 
248a VM  0.98±0.18 0.32±0.08 
932 n.i.  0.22±0.09 0.09±0.06 
232 TI(L)  1.50±0.17 0.65±0.15 
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188 GI(L)  1.39±0.14 0.60±0.15 
242a SH  2.31±0.30 0.90±0.20 
248b MV  0.81±0.07 0.26±0.05 
230a I(L)V  3.39±0.41 0.82±0.15 
230b VI(L)  2.10±0.32 0.72±0.13 
331a n.i.  0.82±0.18 0.22±0.05 
230c L(I)V  2.56±0.32 0.81±0.15 
1035 RVAPEEHPT actin B 2.62±0.56 1.32±0.30 
879 VAPEEHPT actin 1.05±0.21 0.30±0.09 
487 LAPST actin 0.46±0.08 0.11±0.04 
477 FQPS  actin 1.19±0.17 0.44±0.09  
639 APLNPK actin 0.10±0.03 0.12±0.10 
256 n.i.  0.01±0.02 0.01±0.01 
501 n.i.  0.38±0.05 0.11±0.04 
262a IM  1.60±0.24 0.53±0.11 
230d VI(L)  3.06±0.34 1.17±0.22 
331b SIL/SLI myosin 1 0.84±0.12 0.54±0.12 
471 PGIAD actin 0.95±0.16 0.09±0.02 
802 KLEGDLK myosin 1 0.58±0.11 0.29±0.11 
262b LM  0.27±0.04 0.09±0.02 
659 n.i.  0.79±0.13 0.25±0.07 
688 n.i.  0.21±0.07 0.21±0.06 
264 FV  1.19±0.15 0.44±0.09 
244a II/LL/IL/LI  0.97±0.16 0.25±0.04 
672 YPIEH methylated actin 0.84±0.13 0.25±0.07 
869 TEAPLNPK actin 2.26±0.43 0.72±0.29 
455 IVAPG Fructose aldolase biphosphate 0.88±0.17 0.14±0.04 
662 MDLER myosin 1 0.19±0.08 0.23±0.09 
262c MI(L)  0.07±0.1 0.04±0.01 
359 ELV myosin 1 0.25±0.04 0.16±0.03 
333 ALM myosin 1 0.33±0.06 0.28±0.06 
244b II/LL/IL/LI  1.31±0.15 0.53±0.08 
463 NSIM actin 1.10±0.15 0.29±0.07 
244c II/LL/IL/LI  6.18±0.73 1.91±0.33 
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795 IIAPPER actin 0.61±0.12 0.44±0.09 
402 DIR actin 0.93±0.22 0.55±0.14 
445 IGGSI β -actin 0.73±0.17 0.09±0.02 
1002  n.i.  1.05±0.15  0.36±0.06 
506 MDLE myosin 1 0.80±0.13 0.23±0.06 
988 n.i.  0.08±0.03 0.22±0.06 
244d II/LL/IL/LI   2.02±0.42 0.99±0.18 
830 LQDLVDK myosin 1 1.38±0.28 1.02±0.22 
982 LTEAPLNPK actin 3.25±0.80 1.37±0.33 
415 PSIV actin 1.64±0.40 0.26±0.07 
553 SFVTT actin 0.40±0.08 0.35±0.10 
329 DPV pyruvate kinase 1.15±0.16 0.42±0.09 
625 DLTDY actin 0.45±0.14 0.54±0.14 
937 NWDDMEK actin 1.18±0.22 0.38±0.07 
441 NVPI actin 5.67±0.75 1.69±0.34 
1066 KMEGDLNEM myosin 1 0.41±0.08 0.11±0.02 
278a FI(L)  0.93±0.13 0.32±0.06 
345 LTL myosin 1 0.24±0.05 0.04±0.01 
430 LEGI myosin 1 0.65±0.12 0.24±0.05 
908 SYELPDGQ actin 0.30±0.06 0.10±0.02 
331c SIL/SLI myosin 1 0.40±0.06 0.08±0.02 
444 PTVE β-enolase 0.93±0.22 0.21±0.06 
301 LGL  2.66±0.35 0.93±0.2 
278b I(L)F  1.11±0.22 0.57±0.10 
801 IKAKSALA myosin 1 0.84±0.14 0.40±0.12 
278c FI(L)  0.24±0.07 0.14±0.03 
372 L(I)KL(I)/L(I)QL(I)  0.81±0.13 0.20±0.04 
1349 PEILPDGDHDLK aldolase A fructose biphosphate 1.50±0.32 0.28±0.15 
635 n.i.  0.42±0.08 0.22±0.05 
474 IDDL/LDDL myosin 1 1.01±0.22 0.09±0.02 
649 SLSTEL myosin 1 0.71±0.14 0.45±0.12 
343 LVL myosin 1 0.91±0.15 0.29±0.06 
     
1577 VEPEILPDGDHDLK aldolase A fructose biphosphate 0.98±0.35 0.28±0.07 
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335 AVF / GLF / LGF actin / myosin1/ myosin1 0.12±0.03 0.04±0.01 
776 TSLINTK myosin 1 0.23±0.05 0.18±0.06 
317 VTV myosin 1 0.25±0.08 0.14±0.03 
1285 LKGADPEDVITGA myosin light chain 2 0.65±0.24 0.21±0.06 
1084 DIDSPPITAR pyruvate kinase 0.03±0.02 0.27±0.09 
483 GVVPL aldolase A fructose biphosphate 0.76±0.14 0.16±0.04 
558 n.i n.i 1.14±0.18 0.40±0.10 
1220 PEILPDGDHDL aldolase A fructose biphosphate 0.32±0.09 0.02±0.02 
970 DQIISANPL myosin 1 0.22±0.14 0.07±0.04 
1097 LLASIDIDHT myosin 2 0.37±0.11 0.07±0.02 
1109 TVKDLQHRL pyruvate kinase 0.15±0.08 0.29±0.14 
1314  IQLVEEELDRA tropomyosin a-1 0.25±0.09 0.40±0.10 
933 DIDDLELT myosin 1 0.22±0.05 0.09±0.02 
1015 LFDKPVSPL creatin chinase 0.27±0.06 0.11±0.03 
1393 RMKKNMEQTVK myosin 1 0.25±0.11 0.41±0.09 
571 RVAPE actin 0.30±0.07 0.18±0.04 
1048 INTTLETKQ myosin 7 0.21±0.04 0.10±0.03 
1653 NAYEESLDQLETLK myosin 1 0.09±0.05 0.22±0.07 
1160 n.i.  0.21±0.05 0.05±0.02 
n.i.: not identified 
* semiquantification values (expressed as ratio between “Area peptide” and “area Phe-Phe” as internal standard). When reported 
peptides are significantly different between 24 or 18 months of ageing time (p < 0.05,  Student’s t-test), the higher one is reported in 
bold character. 
 
As already underlined and also observed by other authors, the identified sequences in digested samples 
show that most peptides originated from myofibrillar proteins (actin and myosin) and from sarcoplasmic 
proteins (such as creatine kinase, pyruvate kinase, fructose bisphosphate aldolase, etc.). In comparison to 
what observed in the literature (Ferranti, 2014), in our case a higher amount of short sequences were found 
in the digesta: indeed, up to 21 dipeptides and 11 tripeptides were found among the 81 identified sequences.  
As far as the identified sequences, peptides originated by the sequential activity of pepsin and pancreatin are 
present and many N- or C-terminal amino acid residue correspond to the known cleavage site of these 
enzymes. Nevertheless, it’s not possible to certainly assign one particular sequence to a specific enzyme 
activity due to the combined and complex action of the enzyme pool. 
Some of the identified peptides are already known in the literature. In particular, the peptide sequences 
IIAPPER, PEILPDGDHDL, LTEAPLNPK have been identified in in vitro digestion of pork meat 
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(Escudero, 2010), whereas DIDSPPITAR and SYELPDGQ share partial homology with DIDSPPIT, 
YELPDGQ, as well as VTV, AVF, LGF with VTVNPY, AGDDAPRAVF, LGFNPPDL. The sequences 
RVAPEEHPT, VAPEEHPT, IGGSI, LFDKPVSPL were also found in pork meat digesta (Escudero, 2010). 
A partial homology occurs between DLTDY and DLAGRDLTDYL, identified in the in vivo proteolytic 
digestion of beef meat and trout flesh in pigs (Bauchart, 2007). 
Many identified sequences are encrypted in those found in a recent work on Bresaola  (Ferranti, 2014) like 
LAPST, PGIAD, IVAPG, PSIV, SFVTT, DLTDY, NWDDMEK, NVPI, SYELPDGQ, IDDL, 
LKGADPEDVITGA, TVKDLQHRL, but also in a study on Spanish dry-cured ham (Mora, 2014).Peptide 
sequences like LTEAPLNPK, PTVEVDLH, LFDPVSPL, NAYEELSDQLETLK also occur.  
As a general remark, most sequences found in our work are shorter than those reported in other studies, 
and/or are parts of the longer ones identified in the above mentioned works: it is indeed worth noting that in 
these papers the minimum length of identified peptides is around 8 amino acid residues, whereas in our 
samples lots of dipeptides and tripeptides have been found. These findings could be ascribed to a number of 
factors such as a more efficient digestion model, but also to the advanced proteolytic process in long aged 
hams, which are characterized by a high percentage of low MW oligopeptides more easily prone to further 
degradation during digestion. In order to evaluate the latter effect we have compared the results obtained 
with hams of 18 and 24 months of maturation. 
4.3.5 NPADS  
Npads are peptides of non-proteolytic origin. They are present in dry-cured hams as already described in 
chapter 3.3.2.2.1. In the literature it is already known that these compounds are resistant to gastro-intestinal 
digestion (Bottesini, 2014). We have checked the digested samples for the occurrence of these compounds 
and their eventual quantification. The results are reported in Figure 28. 
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Figure 28 NPADs in digesta of dry-cured hams of 18-24 months of ripening (statistical analysis:T-student test, 
p<0.05). 
 
The NPADs detected in dry-cured ham extracts such as γ-Glu-Tyr, pyro-Pro, lacto-Met, lacto-Tyr and lacto-
Phe are not found in the digested samples. NPADs in extracted samples are present in maximum amount of 
50µg/g, instead in digested samples the maximum amount is about 150 µg/g. As these compounds may not 
be originated by digestive enzyme (Bottesini, 2014), their higher amount in digesta may be due to a more 
efficient extraction on account of the degradation of the food matrix. Anyway, both in the extracted as well 
as in the digested samples, Lactoyl-Leu is the amino acyl derivative present in highest amount. 
 
4.3.6  Peptide profile of the digesta as a function of the ageing time 
Ham samples of 18 and 24 months were subjected to the simulated gastrointestinal digestion process, the 
peptide profile was characterized and the identified peptides were semiquantified using a suitable internal 
standard (Phe-Phe, 1mM), by measuring the ratio between the peptide area and the area of the internal 
standard. Data were statistically evaluated by principal component analysis in order to highlight the possible 
differences occurring between samples: indeed, dry-cured hams can be grouped as a function of ageing time 
(18-24 months) after the gastro-intestinal digestion step (Figure 29). 
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Figure 29. PCA digesta samples at different ageing time. 
 
 
The cumulative variance explained is 86%, of which 76% determined by component 1. 
In order to verify which peptides are responsible for the observed difference, the semiquantification values 
of all the peptides were compared by T-student test: results are reported in Table 2.  
Most peptides are found in higher amounts in 18 aged hams than in 24 aged ones: this result could be 
determined by an higher digestibility and bioaccessibility of the nitrogen fraction in more aged samples on 
account of the proteolytic process during maturation. 
Although somehow expected, these findings underline that the proteolysis process taking place during the 
ageing period strongly influences the peptide profile of the digested sample, and, as a consequence, the 
nutritional value and possible biological activity of the peptides encrypted in meat proteins. 
4.3.7 Study of peptides transport across the intestinal barrier 
In order to exert their functional bioactivity peptides have to be able to cross the intestinal barrier and enter 
the blood circulation in an intact form. In order to study this ability, the digested samples at 18 and 24 
months (with also the digestion blank as control) have been tested on model of intestinal barrier systems like 
Caco-2 and Ussing chamber. The first method is a simplified model that mimics the intestinal barrier (as a 
good and valuable model for assessing the physiological response of enterocytes) re-creating the two 
compartments: the apical one represents the intestinal lumen, the basolateral compartment represents the 
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blood circulation. Caco-2 cells are able to mimic the intestinal barrier: they express a number of carrier-
mediated transport systems and enzymes (as the enterocytes) (Behrens, 2003) and numerous brush border 
membrane peptidases similar to those of human intestinal epithelium (Xie, 2014). To obtain a better 
physiological model, it’s possible to create a co-culture of Caco-2 with HT29-MTX that are mucus cells 
(Picariello, 2013). The second method (Ussing chamber) is an ex-vivo method because the two 
compartments (mucosa = apical, serum = basolateral) are created using a real intestinal epithelium of a pig, 
excited immediately after the slaughter of the animal. This second model is more complex but more similar 
to the real physiological environment. 
In the literature these methods have been applied to test the ability of few purified peptides with bioactive-
function to cross the barrier of the intestinal epithelium (Cakir-Kiefer,  2011; Bejjani, 2013) or to evaluate 
fractions of protein of different source subjected to similar gastrointestinal digestion and Caco-2 cells 
permeation (Samaranayaka, 2010) and by (Cristina Megías, 2009). 
The aim of our work is to apply these systems to study the behavior of a complex matrix such as the digesta 
of dry-cured ham in order to verify the resistance of the peptides to brush border peptidases and their ability 
to cross intestinal barrier. 
4.3.7.1 Caco2/HT29-MTX 
Briefly, the two different types of cells (Caco2 and HT29-MTX) are first cultivated separately and then 
combined together in ratio 90:10 for 21 days in specific inserts and medium. Then, the medium is 
substituted by the digested sample/ HBSS (as a control of the system) in the apical compartment and only 
HBSS in the basolateral compartment, like in Figure 30. 
 
Figure 30. Scheme of co-culture experiment. 
 
Sampling was performed at 30, 60 and 120 minutes. Some preliminary experiments were made in order to 
verify the proper sample dilution in order to obtain a non-toxic bile salt concentration for the cells (Cakir-
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Kiefer, 2011,): the Measurement of Transepithelial Electrical Resistance (TEER) allows to assess integrity 
of the Caco-2 cell monolayer, as reported in Figure 31. 
 
Figure 31.  Toxic test of samples on co-culture Caco-2/HT29-MTX: digested samples without clean-up (blue); 
digested sample diluted 1:23 without clean-up (red); digested sample with clean-up on Sep-Pak C18 cartridges; 
digested sample with clean-up on Sep-Pak C18 cartridges diluted 1:10. 
 An increase to 350 Ω cm2 of the TEER indicated a confluent cell monolayer with tight junctions. As the 
graph show, the TEER of samples with and without clean-up collapses immediately after the test and at 20 
hours of the end of experiments its value is very low: these results indicated that the monolayer has been 
damaged. Instead, the same digested sample but with an opportune dilution in HBSS allows to maintain a 
confluent monolayer.  For these reason has been choice the samples diluted 1:23 were chosen because the 
samples cleaned-up on Sep-Pak cartridges does not provide additional benefits.  
The concentration of digested samples (only the supernatant) has been determined with the Kjeldhal 
method. 
The samples obtained at 30, 60 and 120 minutes of test on co-culture have been analyzed by UPLC-ESI-MS 
in order to evaluate their resistance to peptidases and their ability to cross the intestinal barrier in their native 
form or after modification by intestinal enzymes. An example of the total-ion-chromatogram (TIC, full scan 
mode) obtained from tested samples of HBSS, blank digestion, 18 and 24 months ham digesta (60 minutes, 
apical compartment) is reported in Figure 32.  
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Figure 32. Superimposed chromatograms obtained by the analysis of the apical compartment of Caco2 system:  
24 months ham digesta at the top (time zero and 120 min), digestion blank and HBSS at the bottom. 
Between 35 and 45 minutes the bile salts are eluted. The chromatograms are very similar to the 
chromatograms obtained from digested samples before the test on co-culture Caco-2/HT29-MTX: the 
profile of peptides is very rich and so it’s difficult to identify new peptides or peptides with some 
modifications due to enzymatic actions. In order to evaluate the hydrolysis of peptides by brush border 
peptidases, the peptides already identified in chapter 4.3.4 (in Table 4) have been searched.   
Evaluating the variation of these peptides, it’s possible to note that generally most of the peptides seem to 
decrease during time, from zero to 120 minutes.  An example of this decrease is show in Figure 33: the main 
four highest peaks corresponds to peptides II/LL/IL/LI and their decrease during time in the apical 
compartment is evident. 
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Figure 33. Peptides decrease from time zero to 120 minutes of test on Caco-2/HT29-MTX: apical compartment. 
The decrease of peptides may be due to the actions of hydrolytic enzyme present in the apical compartment 
released from Caco-2 cells. There are some peptides that seem to be resistant: for example peptides like 
VTV, ELV, PTVE seem to be constant during all time of experiment. This decrease may be also due to the 
crossing of the Caco2 layer. 
In order to evaluate the ability of peptides to cross into the basolateral compartment, the total ion 
chromatogram (TIC, obtained in full scan mode) have been analyzed. An example of chromatogram 
obtained from the sample taken at 60 minutes of experiment is reported below, in Figure 34. 
 
Figure 34. Chromatograms of digested samples in systems like co-culture Caco-2/HT29-MTX: basal 
compartment. TIC are of HBSS, blank of digestion, 18 and 24 months. Bile salts are present from 35 to 45 
minutes. 
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The peaks between 35 and 45 min correspond to the bile salts. Chromatograms are very complex and rich of 
several signals that are also present in the TIC of HBSS, thus, it is very difficult to identify eventual peaks 
related to the peptides of the digesta. Thus, we decided to test for the presence of peptides already identified 
in the digesta in order to verify if they are able to cross the intestinal barrier, although in low amounts. 
By applying this approach, surprisingly we found most of the peptides identified in the profile of the 
digested ham: indeed, we were able to identify 55 sequences out of the 80 previously identified in the 
digesta, although most of them are present in very low amount. Considering the type of peptides found and 
their MW, probably different transport mechanisms are involved: carrier-mediated transport system as 
PepT1 for di-tripeptides, transcytosis (an intracellular vesicle mediated transport) for small oligopeptides 
and paracellular diffusion for larger oligopeptides as well as di- and tripeptide. The amount of most peptides 
in the basolateral compartment seems to increase during time, as shown in Figure 35. 
 
Figure 35. Peptides increase during time in basolateral compartment in systems like Caco-2/HT29-MTX. 
More reliable indications may be obtained a simpler mixture of peptides, nevertheless these results are very 
interesting as they clearly demonstrate the ability of several peptides of the digesta to cross the intestinal 
barrier without being modified or degraded, thus being potentially able to exert a functional bioactivity in 
vivo. 
4.3.7.1.1 NPADS in basolateral compartment of co-culture  
Also NPADs have been searched in the basolateral compartment: some of them seem to be able to cross the 
intestinal barrier, probably on account of their low molecular weight and their resistance to the proteolytic 
activities of blood serum (Bottesini, 2014). More studies will be needed to outline their ability to be 
absorbed in the gastrointestinal tract and their eventual biological and nutritional significance. 
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4.3.7.2 Ussing chamber 
The Ussing chamber provides a physiological system to measure the transport of ions, nutrients, and drugs 
across various epithelial tissues. One of the most studied epithelia is the intestine. Ussing chamber is a 
particular chamber where the two compartments are created by the insertion of a real piece of pig intestine. 
The Ussing chamber is shown in Figure 36. 
 
Figure 36. Ussing chamber.  
 
The samples analyzed are 18 and 24 months hams, digestion blank and Krebs solution as control of the 
system. The analyzed samples have been diluted (11 times) in Krebs ringer: in this case bile salts at the 
concentration present in the digesta are not toxic for the intestine, thus it’s possible to use a more 
concentrated sample in comparison with the experiment on Caco-2. The sampling time is always 0, 30, 60, 
120 minutes for the mucosa compartment whereas for serum compartment only one sampling at 120 
minutes was performed: it must be taken into account that the subsequent sampling steps of the mucosa 
compartment causes a dilution of the components, as it is necessary to replace the sample volume with the 
same volume of Krebs-Ringer. 
All samples have been analyzed in UPLC-ESI-MS. The chromatograms for the mucosa compartment are 
shown in Figure 37. 
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Figure 37. Chromatograms obtained by the analysis of the mucosa compartment in the Ussing chamber in the 
presence and in the absence of the digested samples: 24 months digested hams (time zero in green and time 120 
min. in black) at the top, Krebs buffer and digestion blank at the bottom. 
 
As already observed in the experiments with Caco-2, the chromatographic profile is very complex. 
Nevertheless, also in this case it was possible to identify all the peptides of the digesta and to verify their 
strong decrease during time as shown in Figure 38 in the case of VAPEERHPT.  
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Figure 38. Peptides in Ussing chambers: variation of the peptide VAPEERHPT with time. 
 
The decrease is stronger than that observed in the case of Caco-2. The chromatograms obtained from the 
analysis of the serum compartment are much more complex as outlined in Figure 39: 
 
120 min 
0 min 
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Figure 39. Chromatograms obtained by the analysis of the serum compartment of the Ussing chamber in the 
presence and in the absence of digested ham samples (18, 24 months ham, digestion blank and Krebs ringer). 
We tried to verify, as already done in the case of Caco2, if some peptides of the digesta were able to cross 
the intestinal barrier: unfortunately, in this case we didn’t succeed in identifying any of the peptides 
occurring in the digesta. As a plausible explanation of this negative result, it is worth noting that there are 
several interfering substances coming from the complex composition of the Krebs-ringer and, as already 
evidenced in the case of the Caco2, the amount of peptides that crosses the epithelial barrier is very low. 
    
4.3.8 ACE-inhibitor activity 
Angiotensin I converting enzyme (ACE) inhibitor peptides are in the last years the most studied owing to 
their potential beneficial effects on hypertension: there is a growing interest in using these bioactive peptides 
as efficient agents in treating and preventing hypertension. Many peptides from enzymatic hydrolysis of 
proteins of meat product have been identified showing the ability to inhibit ACE and/or to lower blood 
pressure in vivo (in spontaneously hypertensive rats, SHR). Among meat products, attention has been 
devoted also to dry-cured hams as important and appreciated high value products: researches on this topic 
are continuously growing. To exert a systemic function, bioactive peptides must be able to cross the 
intestinal barrier and enter the blood stream in an intact form. The first phase in which structure 
modification takes place is during the gastrointestinal digestion of food and for these reasons ham have been 
subjected to simulated gastrointestinal digestion and the analysis and bioactivity tests have been performed 
on digesta. Among the identified sequences, some short sequences have been found that are already known 
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and tested in the literature for their ACE inhibitor activity, such as AI(L), GI(L), I(L)F, LVL (BIOPEP 
online database). Some sequences were identified that are known not to have an inhibitor activity, such as 
IGGSI. Most of the other identified sequences have never been tested, such as RVAPEEHPT, VAPEEHPT, 
and LFDKPVSPL.  
Thus, the first step was to evaluate the ACE inhibitor activity of digesta and the eventual possibility for 
peptides to cross the intestinal barrier as well as the bioactivity could be transferred from the gut lumen to 
the blood stream, also using the previously described system like co-culture Caco-2/HT29-MTX and Ussing 
chambers. 
The antihypertensive activity of the samples was measured by monitoring the release of hippuric acid 
originated from the substrate hippuryl-histidyl-leucine (HHL) by the action of ACE (Figure 41): most 
inhibitory peptides are able to inhibit the enzyme activity thus leading to a lower release of hippuric acid.  
 
Figure 40. Release of hippuric acid from Hippuryl-Histidyl-Leucine by enzyme action of Angiotensin-
Converting-Enzyme (ACE). 
 
Generally the result are expressed as IC50, that is the amount of peptide mixture required to inhibit of 50% 
the activity of the enzyme ACE or as the percentage of inhibition generated taking in account the maximum 
of activity of ACE without inhibitor (ACEmax) and the minimum value generated by the presence of 
inhibitor (Ace min), calculed as follow:  
𝐼% =
(𝐴𝐶𝐸𝑚𝑎𝑥 − 𝐵𝑚𝑎𝑥) − (𝐴𝐶𝐸𝑚𝑖𝑛 − 𝐵𝑚𝑖𝑛)
(𝐴𝐶𝐸𝑚𝑎𝑥 − 𝐵𝑚𝑎𝑥)
∗ 100 
where Bmax is the maximum value of absorbance of the solution of the substrate (HHL), to take into 
account the eventual release of hyppuric acid by the auto-hydrolysis of HHL; Bmin is the solution of the 
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inhibitor with HHL in the absence of the enzyme again to verify the eventual release of hyppuric acid from 
the auto-hydrolysis of HHL or the contribution of some interfering substances; ACEmax is the maximum 
absorbance value in the presence of the enzyme (maximum release of hyppuric acid) and ACEmin is the 
minimum absorbance value obtained in the presence of the inhibitor. 
4.3.8.1 Caco-27/HT29-MTX 
We have tested for ACE inhibitor activity the solution coming from the apical and basolateral compartments 
in Caco2 experiments at the different sampling time already tested for the presence of peptides. Thus, the 
samples collected at 30, 60 and 120 minutes in apical and basolateral compartment were tested for ACE-
inhibitory activity.  The results are expressed as % of inhibition and are shown in Figure 41. 
 
Figure 41. Ace-inhibitor activity of digested samples collected at different time (minutes) in the two 
compartments of a co-culture of Caco-2/HT29-MTX (statistical analysis Anova test, LSD post-hoc test, p<0.05). 
Digesta samples at 18 and 24 months showed high ACE-inhibitory activity, with an inhibition % around 
60%. Monitoring the apical compartment at 30, 60 and 120 minutes no significant changes have been 
measured. The most important results are about the activity in the basolateral compartment that represent the 
potential transfer of the activity into the blood serum. ACE inhibitor activity appears at time 60 minutes for 
samples aged 24 months and at 120 min for samples aged 18 months. These results indicate that peptides 
with ace-inhibitory activities are able to cross the Caco2 cell layer. 
4.3.8.2 USSING CHAMBER 
In the case of Ussing Chamber’s experiments, results are much more difficult to explain, as already seen 
also for the evaluation of occurrence of peptides. The samples collected at 30, 60 and 120 minutes in 
mucosal compartment and only at 120 minutes in the serum were tested for ace-inhibitory activity.  The 
results are expressed as % of inhibition and they are shown in Figure 42. 
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Figure 42- Ace-inhibitory activity in Ussing Chamber of digesta samples (18 and 24 months) during 0, 30, 60 and 
120 minutes of test: mucosa and serum compartment (statistical analysis Anova test, LSD post-hoc test, p<0.05).  
An ACE inhibitor activity has been measured in the mucosa compartment, but with high variability. It’s 
possible to note that for 18 months aged sample % inhibition seems to decrease with time, whereas it seems 
to increase for sample at 24 months. These variations are probably complex results of uptake from the 
intestinal epithelia and by the enzymatic activity released by the cells. 
Results in serum compartment are too much affected by a very high variability and it’s not possible to draw 
a conclusion.  
In this case, probably the use of a very complex peptide mixture didn’t allow to obtain clearly 
understandable results. 
4.3.8.3 Ace-inhibitor activity: integration in vitro and in silico approach 
In order to identify new peptide sequences with ACE inhibitory activity in the dry-cured ham digesta, the in 
vitro experimental approach has been coupled to an in silico evaluation of the ability of peptides to interact 
with the active site of ACE. 
4.3.8.3.1 Experimental assay 
First of all, in order to identify the peptide sequences responsible for the ACE inhibitor activity found in the 
digested ham samples, a fractionation of the digesta by semipreparative HPLC-UV has been performed, 
collecting 1 fraction for each minute (starting from the minute 1) for a total of 51 fractions. All fractions 
have been then tested for antihypertensive activity.  
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The results of ACE-inhibitory test, expressed as % inhibition, are reported below in Figure 43 for 24 and 18 
months, respectively. 
  
Figure 43. Ace-inhibitory activity of fractions of digested dry-cured hams at 24 and 18 months. 
Several fractions have shown significant ACE inhibitor activity, the most significant being fractions number 
6, 14, 46 and 47 for samples at 24 months to which also the fraction number 42 may be added for samples at 
18 months.  In order to identify the peptides present in these fractions, LC-MS analysis have been 
performed. Mostly amino acids like tyrosine, phenylalanine and some dipeptides occurred in fractions 
number 6 and 14. In the fractions 47, 46 and 42 peptides like RVAPE, IQLVEEELDRA, DIDDLELT, 
DIDSPPITAR, LKGADPEDVITGA, and GVVPL were found, as reported in Figure 44. 
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Figure 44. Mass spectrum of fractions number 42, 46 and 47 of samples at 18 months of ageing time. 
 
4.3.8.3.2 In silico docking simulations 
The computational model involves the sequential docking simulation of peptides within both the two 
domains of human enzyme ACE (C-domain an N-domain). It has been hypothesized that if a given 
molecules is predicted to be able to interact with at least one domain, it might be able to exert inhibitory 
effects. Therefore, the coupling of docking simulations and rescoring procedures by using the HINT scoring 
function– whose correlation with the free energy of binding was previously reported (Cozzini, 2002)– can 
be effectively used to predict the inhibitory activity. In silico analysis involved docking simulations and 
rescoring procedures by using the empirical scoring function HINT. HINT score provides the evaluation of 
thermodynamic benefits of protein-ligand interaction (Cozzini, 2002). In general, low and negative scores 
indicate the instability of protein-ligand complex. Therefore molecules with low and negative scores should 
be considered unable to interact with the target under investigation. At this stage of model development, a 
quantitative evaluation cannot be obtained; rather, a qualitative cut-off is provided to identify compounds 
virtually able to interact with the catalytic binding sites. 
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The simulation of the interactions between peptides and ACE has been performed using the entire peptide 
profile previously identified after the in vitro gastrointestinal digestion of 18-24 months aged dry-cured 
ham: solely the unambiguous sequences were considered for the analysis. Moreover, since most dipeptides 
were already known as active like I(L)F, GI(L), AI(L) (BIOPEP database  
http://www.uwm.edu.pl/biochemia/index.php/pl/biopep), they were excluded throughout. Overall, a total of 
54 sequences were analyzed.  The results are reported in Table 6. 
Table 6. HINT scores and expected activity of peptides. 
Peptide sequence C-domain N-domain Expected Interaction 
RVAPEEHPT -5202 -3442 Negative 
VAPEEHPT -3113 -5273 Negative 
LAPST 1046 416 Positive 
FQPS -494 308 Positive 
APLNPK -396 -4126 Negative 
PGIAD 195 728 Positive 
KLEGDLK -211 -3021 Negative 
YPIEH methylated -1238 -616 Negative 
TEAPLNPK < -10000 -1859 Negative 
IVAPG 267 -228 Positive 
MDLER 1434 -2354 Positive 
ELV 503 581 Positive 
ALM * 1885 1200 Positive 
NSIM * 1001 848 Positive 
IIAPPER -2734 -787 Negative 
DIR -677 -1314 Negative 
IGGSI 846 283 Positive 
MDLE 729 365 Positive 
LQDLVDK -1342 -2949 Negative 
LTEAPLNPK -5231 < - 10000 Negative 
PSIV 688 1558 Positive 
SFVTT * 1481 542 Positive 
DPV 1398 1463 Positive 
DLTDY -5 -2265 Negative 
NWDDMEK -2130 -410 Negative 
NVPI 400 -227 Positive 
KMEGDLNEM -3471 -2962 Negative 
LTL 1030 1432 Positive 
LEGI 169 847 Positive 
SYELPDGQ -2173 -2000 Negative 
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Peptide sequence C-domain N-domain Expected Interaction 
PTVE 428 1242 Positive 
LGL * 2503 2285 Positive 
IKAKSALA 251 -852 Positive 
PEILPDGDHDLK < -10000 < -10000 Negative 
SLSTEL -1359 492 Positive 
LVL 1473 1641 Positive 
VEPEILPDGDHDLK < -10000 < -10000 Negative 
TSLINTK 1094 -284 Positive 
VTV 1930 1180 Positive 
LKGADPEDVITGA < -10000 -7295 Negative 
DIDSPPITAR -3137 -3436 Negative 
GVVPL * 1075 -1129 Positive 
INAEL -92 101 Positive 
PEILPDGDHDL < -10000 -6684 Negative 
DQIISANPL -3516 -2260 Negative 
LLASIDIDHT < - 10000 -3236 Negative 
TVKDLQHRL -5802 < -10000 Negative 
IQLVEEELDRA < -10000 < -10000 Negative 
DIDDLELT -3807 -1487 Negative 
LFDKPVSPL -7900 -1585 Negative 
RMKKNMEQTVK < -10000 < -10000 Negative 
RVAPE -735 -1897 Negative 
INTTLETKQ -3525 -789 Negative 
NAYEESLDQLETLK < -10000 < -10000 Negative 
Note → * indicates peptides selected for experimental trials 
 
A total of 25 peptides were predicted as active and, with the exception of 3 peptides (i.e. IKAKSALA, 
SLSTEL and TSLINTK), most of them ranged from 3 to 5 amino acids.  
4.3.8.3.3 Experimental and in silico assay: potential bioactive peptides 
Among the putatively active peptides, 5 were selected for the in vitro evaluation of ACE inhibition, namely 
ALM, NSIM, SFVTT, LGL and GVVPL. The inclusion criteria were based (i) on the finding that short 
peptides may be easily adsorbed trough the intestinal epithelium, thus giving a greater physiological 
significance; (ii) on the relative abundance within the most active fraction of digested mixture; and (iii) on 
the computational results, with the aim to cover a reasonable high range of scores. Specifically, LGL 
showed highest scores for both ACE domains, GVVPL – whose relevant abundance was detected in the 
most active fraction – showed a putative interaction only with the C-domain, and ALM, NSIM and SFVTT 
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were arbitrarily selected among the remaining peptides with high scores. With respect to this, albeit a 
correlation between HINT scores and inhibitory activity cannot be sustained yet, since HINT scores have 
proved to be correlated with the free energy of binding (as aforementioned) it is reasonable to think that the 
selection of high scoring peptides may increase the chances to discover truly active peptides. 
ALM, NSIM, SFVTT, LGL are peptides that have been find in fractions number 32, 31, 33 and 37 
respectively. NSIM and SFVTT are present in fractions without any activity. ALM and LGL are present in 
fractions with low ACE-inhibitor activity. Only GVVPL is present in one of the most ACE-inhibitory 
fraction (number 42).  All five peptides, after synthesis and purification, have been tested for Ace-inhibitory 
activity in order to verify if they actives and second to determine the IC50, the concentration of peptide 
required to inhibit 50% the ACE activity.  
All peptides results actives: the in vitro experiment about ACE-inhibitory activity show the silico model 
adopted is useful to discover potential bioactive peptides. The results are reported in Table 7 and an example 
of IC50 curve is show in Figure 45. 
Table 7. IC50 (μM) of peptides. 
 IC50 (μM) 
LGL 145 
ALM >1100 
SFVTT 395 
GVVPL 956 
NSIM >1100 
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Figure 45. Curve inhibition LGL: determination of IC50. 
 
The peptide with the highest activity is LGL with an IC50 of 145 μM. The structure activity relationships of 
ACE inhibitory peptides in the literature is not clear but as reported by different papers it seem that the 
presence at the penultimate positions at the C-terminal end of aliphatic residues as I present in peptide our 
NSIM or of L and M residues at the ultimate position like peptides LGL, NSIM, ALM and GVVPL are 
preferred.  
In the literature GL is known as an ACE-inhibitor peptide (BIOPEP database): thus, in order to verify if 
LGL is a true-inhibitor, the mixture LGL-ACE-HHL has been analyzed in UPLC-ESI-MS. The Extracted-
ion chromatogram (XIC) are reported below, Figure 46. 
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Figure 46. a) TIC of LGL in presence of ACE and HHL; b) XIC of LGL; XIC of LG/GL. 
The peptide LGL is a true inhibitor as peptides like ALM, SFVTT, GVVPL but with high ace-inhibitory 
activity.  Instead, NSIM instead seem to be a substrate due to release of dipeptide IM as shown in Figure 47.  
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Figure 47. a) TIC of mixture NSIM, ACE, HHL; b) XIC of NSIM; c) XIC of IM; d) fragmentation in source of 
IM and theoretical fragmentation. 
Further analysis are necessary to confirm these results and to confirm the eventually activity of IM.  
It is worth noting that all these peptides have been found to be able to cross the intestinal barrier in the 
model Caco-2/HT29-MTX co-culture. 
LGL is the peptide with the highest ace-inhibitory activity between the five peptides tested in vitro. The  
IC50  of this peptide allows to consider it a good potential bioactive peptide. In order to verify its amount in 
the digesta of dry-cured ham, a calibration curve of ratio LGL:PhePhe (internal standard) vs concentration 
from 1 to 125 µM of LGL has been done.  
In digested samples at 24 and 18 months of ageing time, the LGL peptide’s amount is 61,65 µg/g and 
112,04 µg/g, respectively. Being the IC50 = 145 µM for LGL obtained by 829,255 µg of peptide, a slice of 
ham (about 15 g) is enough to reach this value: 13,56 g of ham at 24 months and only 7,4 g of ham at 18 
months contain this amount.   
118 
 
4.3.8.4 NPADs ace-inhibitory activity 
Also NPADs were tested for ace-inhibitory activity. No bioactivity studies have been performed until now 
on these compounds, apart from their well-recognized contribution to the umami taste. These compounds 
are interesting because they have been shown to be resistant to gastro-intestinal digestion and to proteases in 
blood samples and they are dipeptides that can easily cross the intestinal barrier.  First of all they have 
evaluated by the described docking simulation. 
The results are reported below, in Table 8. 
Table 8. HINT scores and expected activity of peptides. 
SEQUENCE AVERAGE C-domain AVERAGE N-domain 
γGlu-Ile -2035 382 
γGlu-Leu -2126 304 
γGlu-Met -2127 450 
γGlu-Phe -1927 484 
γGlu-Trp -1875 618 
γGlu-Tyr -1186 961 
γGlu-Val -2069 270 
Lactoyl-Met 964 704 
Lactoyl-Tyr 2054 1291 
Lactoyl-Val 819 853 
Pyroglutamil-Ile 221 353 
Pyroglutamil-Pro 217 36 
Pyroglutamil-Leu 326 70 
Lactoyl-Ile 929 948 
Lactoyl-Leu 689 852 
Lactoyl-Phe 1360 566 
Pyroglutamil-Phe 603 -593 
 
All Npads have a positive response on one domain, so they could be considered potentially active, 
althouhgh their scores are not very high. The predict activity is tested on the three standards already 
synthetized and purified: γ-Glu-Phe (d5), Lactoyl-Phe (d5) and Pyro-Phe (d5).  
Results in terms of IC50 are reported in Table 9. 
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Table 9. Npads IC50 
Npads IC 50 (µM) 
Lacto-Phe >1100 
Pyro-Phe  Inactive  
γ-Glu-Phe >1100 
 
The results show that Lactoyl-Phe and γ-Glu-Phe are active compounds but that their IC50 is >1100µM, 
whereas Pyro-Phe seems to be totally inactive (up to 1100 M). These findings indicate that NPADs aren’t 
good candidate for ace-inhibitory activity. 
 
4.3.9 Antioxidant activity 
Among the several bioactivities potentially exerted by peptides, the antioxidant is one of the most studied 
and a lot of paper deals with this topic in the literature. Several methods exist to study the antioxidant 
activity of a molecule: most methods have been developed to study the antioxidant activity of polyphenols. 
Owing to the fact that these compounds mainly behave as radical scavenging compounds, thus 
counteracting the autooxidation process of food lipids, many assays have been developed based on the 
evaluation of the ability of a particular molecule to quench active radicals. Thus, the famous ABTS assay or 
DPPH assays have been developed, which are spectrophotometric methods based on the measurement of the 
ability of a particular molecule to quench a chromophoric radical. Antioxidant capacity is then ranked 
against a proper standard antioxidant. Also, some methods have been developed which are closer to the 
physiological conditions in which an antioxidant molecule could encounter in vivo, such as for the 
protection of the peroxidation of phospholipids of cell membrane, i.e. the study of peroxidation of linoleic 
acid in an emulsion system that mimic the cellular membranes. 
4.3.9.1 ABTS assay 
The digested samples after gastro-intestinal digestion have been evaluated for their capacity to act as radical 
scavengers by ABTS assay. The samples tested are in particular the same obtained from co-culture and 
Ussing chambers. In this way, we evaluate the potential antioxidant exerted by a digested sample and its 
ability to be transferred into the bloodstream crossing the intestinal barrier where antioxidant activity against 
free radicals could be exerted.  
120 
 
The results expressed as % of inhibition, obtained in the apical compartment of co-culture Caco-2/HT29-
MTX are reported in Figure 48.  
 
 
Figure 48. Antioxidant activity: ABTS assay of samples in the apical and basolateral compartments of the co-
culture Caco-2/HT29-MTX (statistical analysis Anova test, LSD post-hoc test, p<0.05). 
From the graphs, it is possible to note that the potential antioxidant of dry-cured hams after gastro-intestinal 
digestion is very high in the apical compartment and those samples of 18 and 24 months of ripening are 
characterized by similar values which did not change during the experiment. Noteworthy is the fact that 
antioxidant peptides are able to cross the intestinal barrier: indeed, after only 30 minutes a sharp increase of 
the antioxidant power in the basolateral compartment is observed, which tends to increase with time from 60 
to 120 min. 
 
Also samples obtained from Ussing Chamber have been tested with ABTS assay. The results are reported 
below in Figure 49. 
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Figure 49. Antioxidant activity: ABTS assay of samples in the mucosa and in the serum compartments of Ussing 
(statistical analysis Anova test, LSD post-hoc test, p<0.05). 
Again, results of these experiments are not so clearly explainable as in mucosa compartment an increase of 
antioxidant activity is observed, and this could be due to the activity of the living intestine cells which can 
release antioxidant compounds in the medium or exert some enzymatic activity which can have an influence 
on the recorded antioxidant values. Moreover, in the serum compartment a low increase of antioxidant 
activity has been measured at 120 min incubation: it could be inferred that this activity could have been 
generated by antioxidant peptides able to cross the pig intestinal barrier, but evidently other experiments 
should be performed in order to better clarify these results. 
As already done in the case of the ACE experiments, the digested samples have been fractioned by 
semipreparative HPLC-UV, collecting 51 fractions, one for minutes in order to find out the most interesting 
fractions and eventually to identify the peptides able to exert this antioxidant activity. 
The results expressed as % of inhibition (I%) for samples at 24 and 18 months are reported below 
respectively in Figure 50. 
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Figure 50. Antioxidant activity of LC-fractions of digested dry-cured hams at 24 months. 
 
Figure 51. Antioxidant activity of LC-fractions of digested dry-cured hams at 18 months. 
Most of the fractions are characterized by an antioxidant activity: in particular the most antioxidant fractions 
are the 6, 24, 25 both at 24 and 18 months of ripening. The antioxidant activity of these fractions seems to 
be mainly related to the presence of the antioxidant amino acids Histidine, Tryptophan, Tyrosine, which 
have been identified by LC-ESI-MS analysis of the specific fraction and which are well known antioxidant 
molecules (Bottesini, 2013). 
4.3.10 Linoleic acid assay 
The linoleic acid assay was set up according to Beker et al. (Beker, 2011). The test is aimed at evaluating 
the ability of antioxidant molecules to inhibit linoleic acid peroxidation within an emulsion system, which 
mimicks the conditions encountered in lipid cellular membranes, rich in unsaturated fatty acids such as 
linoleic and arachidonic acids, highly prone to peroxidation reactions.  
Therefore, to simulate the lipid membrane an emulsion of linoleic acid and tween20 is prepared; then, the 
oxidation of linoleic acid is induced maintaining the emulsion in contact with oxygen, under constant 
agitation, in the presence of copper (II) (the LA/Cu(II) molar ratio = 10 with [LA]: 0.01M and [Cu(II)]: 
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0.001 M have themost strongest prooxidant effect)  and incubated at 37° C (physiological temperature). The 
digested samples obtained from ham of different ageing times are then added to the emulsion in order to test 
the ability of the peptide mixture to counteract lipid peroxidation. Taking aliquots at regular intervals of 
time and  testing it by the iron thiocyanate method, it’s possible to quantify the increase in peroxides with 
time.   
The determination of peroxides is performed by the iron thiocyanate colorimetric assay, which is based on 
the formation of red-rust complex of iron (III) thiocyanate in acidic environment, which originate from the 
reaction with oxygen: absorbance measurement is done at 500 nm.
  
The presence of peptides with antioxidant activity causes a prolongation of the lag phase and / or a decrease 
of the maximum speed and / or a lower accumulation of oxidized compounds.  
The change in absorbance has been recorded for 27 hours: results for digested samples obtained from hames 
aged 18 and 24 months are shown in the graphs below, Figure 52.  
 
Figure 52. Antioxidant activity of digested samples at different ageing time by the linoelic acid assay: B is the 
blank sample (maximum of peroxidation); BD is the blank of digestion; 4D and 2V are digested dry-cured ham, 
aged 18 months and 24 months, respectively.  
 
In the first eight hours there are no significant differences between samples and the blank control (blue, 
maximum of oxidation) and the blank of digestion (pink). Only in the second part of the test, at 24 hours, 
the samples seem to exert an inhibitory action against peroxide formation, thus underlying a possible 
antioxidant effect of the peptide mixture also in lipophilic systems. Nevertheless, the measured activity is 
probably low on account of the relative water solubility of most of the considered peptides. 
 
4.4 CONCLUSIONS 
The simulated gastrointestinal digestion of ham using a physiological digestion model was performed for 
the first time and gave rise to a complex mixtures of peptides derived mainly from myofibrillar and 
sarcoplasmic proteins. MWs spans from 200 to 1700 Da, with high numbers of di- and tripeptides. The 
peptide pattern is influenced by the proteolysis process occurring in ham during ageing, thus leading to a 
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different profile in 18 and 24 months aged products. Among the identified sequences, many are known to be 
bioactive or precursors of potential bioactive sequences, which may be qualitatively and quantitatively 
different in raw meat or in meat products matured for more or less time.  
The bioactive substances have to be absorbed in an active form in order to exhibit physiological activity in 
human body. The use of models like co-culture Caco-2/HT29-MTX or Ussing chambers are useful to 
evaluate the ability of peptides to cross the intestinal barrier an t to evaluate their resistance to brush border 
peptidases. Between the peptides able to join the “bloodstream”, with the help of in silico model, some 
peptides have been evaluated for their potential as ace-inhibitor peptides. The peptide LGL, in particular, 
has been characterized by a high ace-inhibitor activity: its amount in digesta is compatible to a 
physiologically relevant concentration to exert a bioactive function. In vivo tests are of course necessary to  
evaluate its real potential as antihypertensive compound.  
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5 GENERAL CONCLUSIONS and PERSPECTIVES 
Dry-cured ham is one of the most important traditional products in the Mediterranean area, with a 
strong popularity among consumers, on account of its peculiar organoleptic properties. Ham 
production plays a key role in the meat industry, with high market value. Ham is characterized by 
high content of protein with high biological value, it has a moderate caloric value and an interesting 
lipid profile, being also a good source of vitamins and minerals. Nevertheless, some aspects its 
composition could impair its nutritional value such as the high sodium content and the saturated 
fatty acid and cholesterol content. Consumers are increasingly aware of the aspects of health and 
well-being. Therefore, a new strong trend in the food industry is to take various measures at the 
level both of livestock husbandry as well as during production and processing to face the problems 
aroused by compounds with health implications, yet without compromising the quality of the 
finished product. On the other side, new scientific investigations are increasing about functional and 
bioactive components naturally occurring in foods or generated during processing with positive 
effects on human health. One of the most negative aspects of processed meat product is the salt 
content which, on the other side, is a fundamental ingredient to obtain the specific texture, color, and 
taste, to control the enzymatic activities (proteolysis) and to assure the microbiological safety. 
Generally, the reduction of salt is obtained by partial or total substitution of sodium chloride with 
other salts like KCl or with flavor enhancers that maintain the taste and the texture of the final 
product. AT present, this substitution is not allowed in high quality POD products as dry-cured 
hams. An alternative approach is to lower the amount of salt used by applying different salting 
techniques and varying the duration of the different processing steps opportunely. The reduction of 
25% of sodium chloride in high quality dry-cured hams have been studied in chapter 3 , in particular 
taking into account the proteolysis process and the changes occurring in the peptide fraction. The 
results confirm that salt-reduced hams are different from the traditional ones: the long resting step 
necessary to obtain the microbiological safety and the low amount of salt added gave rise to several 
differences in terms of proteolysis and, thus, peptide fraction as well as in texture, color, 
organoleptic properties. Changes in the process parameters and a strict control of raw materials are 
probably necessary in order to obtain products more similar to the traditional ones. 
In order to check for the release of bioactive peptides during ham ageing and/or human digestion, an 
in vitro physiological digestion model has been applied in order to characterize the released 
peptides, to test their ability to cross the intestinal barrier and to evaluate their bioactivity (chapter 
0). The characterization with mass spectrometry of digested samples has allowed to determinate the 
sequences of several new peptides, generated from the digestion model. Then, following these 
peptides in systems like co-culture Caco-2/HT29-MTX or Ussing chamber, it has been possible to 
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discover the most peptides are strongly affected by brush border enzymes (peptidases) but at the 
same time most of them are able to cross the Caco-2 monolayer as a model of the intestinal barrier. 
In more complex system, such as the living excited pig intestine in Ussing chamber, the experiments 
must be improved in order to determine the peptides able to cross the intestinal barrier. Several bio-
peptides with antioxidant and antihypertensive activity were found in the digesta: biopeptides are 
able to transfer these bioactivities into the bloodstream. Among the several bioactive sequences 
identified, the peptide LGL has been found to be characterized by a significant ace-inhibitory 
activity (IC50=145 μM): its quantification in samples have shown its occurrence at a physiologically 
relevant concentration already in a slice of ham. In vivo tests are nevertheless needed in order to 
definitely prove the bioactivity of these compounds.  
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6 SUMMARY 
Among the different types of dry-cured meat products, dry-cured hams are the most appreciated by 
consumers. Dry-cured ham is produced by pork legs properly worked and salted during a relatively complex 
process and a long maturation and ageing period. The most important changes during ageing are 
consequences of biochemical (enzymatic) and chemical reactions: in particular, proteolysis and lipolysis, as 
the effects of the action of endogenous enzymes characteristic of the muscle such as proteases and lipases on 
proteins and lipids are the most relevant (Toldrá, 1998a). The speed of these reactions depend largely on the 
process conditions (temperature, relative humidity and time) (and, especially, on the salting process (amount 
and type of added salt (Toldrà, 2006). Proteolysis generates a considerable amount of small peptides and 
free amino acids, accumulating during ageing, through the breaking of myofibrillar proteins (such as 
myosin, actin, troponin, tropomyosin) by endoproteases (calpains and cathepsins) and, subsequently, by 
exoprotease (peptidase and aminopeptidase). Recent innovations in the meat industry are addressed towards 
the production of healthier meats and processed meats. Recent innovations in the meat industry are 
addressed towards the production of healthier meats and processed meats. The strategies are based on either 
reducing the content or substitute unhealthy substances like salt. Indeed, sodium chloride has been linked to 
hypertension and to an increased risk of cardiovascular disease (Morgan, 2011):  the  salt intake has serious 
public health implications nowadays. The reduction of salt in hams is not easy task. Salt content affects the 
microbiological growth, the proteolysis, the texture of the product, the development of the aroma and flavor, 
the color. To establish strategies for optimizing the enzyme reactions towards optimal quality of the 
products, and so to benefit the production and economy related to this important sector, the optimization of 
the proteomic strategy is crucial in the identification of key peptides acting as biomarkers to control and 
direct the industrial processes for dry-cured ham. The peptide fraction of traditional ham has been 
investigated in order to understand the differences between traditional hams and salt-reduced dry-cured 
hams obtained reducing sodium chloride by 25% (but without use of substitutes), with the final aim of 
identifying the changes in the production processing necessary to obtain healthier products but similar to the 
traditional ones in terms of other qualitative characteristics.  The main peptides characterizing all phases of 
production (from salting to ripening step) of hams have been identified by mass spectrometry coupled to 
chromatographic and electrophoretic separations. Among the identified peptides there are 13 compounds 
that are aminoacyl derivatives of non proteolityc origins (Npads): 3 NPADs have been synthesized, purified 
and quantified.  
The results obtained from principal component analysis, from the elaboration of the chromatograms, show 
that reduced-salt and traditional hams are different: the lower value of salt could increase the activity of 
proteolytic enzymes, could decrease the extraction of myofibrillar proteins. The longer period of rest, 
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necessary to obtain the microbiological safety, generated hams with an increased proteolysis index, more 
“gummy” texture, with a peptide profile richer in peptide with low molecular weight. To obtain a ham with 
the characteristics more similar to the traditional ones, it will be necessary to change the process parameters 
(as temperature, activity waters, humidity, etc) and to strictly control the raw materials.  
If the excessive consumption of meat products is indicated as a risk factor for certain diseases, it is equally 
true that proteolysis is able not only to positively influence the digestibility of the products, but also to 
generate a pool of peptides that might be characterized by interesting biological activities, which may 
potentially counteract these negative effects. The bioactive peptides can be naturally present in the product 
or may be released during the gastro-intestinal digestion step but they can exert their biological functions if 
they are able to join the bloodstream (chapter 0).  For this reason, first an in vitro physiological digestion 
model has been applied in order to characterize the peptides released upon digestion of traditional hams of 
different ageing time, thus elucidating the effect of proteolysis during maturation on the peptide profile 
generated by digestion. The sequences characterized with mass spectrometry are numerous and most of 
them are not present in the literature: the in vitro physiological digestion method is never been applied to 
dry-cured hams. Secondly, the peptide transport across the intestinal barrier and their resistance to intestinal 
peptidases have been studied: to this purpose models such as co-culture of Caco-2/HT29-MTX and an ex-
vivo technique such as Ussing Chambers have been applied. These models are very popular for studies of 
absorption of nutrients, bioactive diet components, and drugs. The results obtained show that the majority of 
peptides are strongly hydrolyzed by brush border peptidases, in particular in the more physiological system 
as Ussing chamber, but also that they are able to cross the Caco-2 cell monolayer. These good results 
allowed to investigate the digested samples for their potential to exert antioxidant and ace-inhibitory 
activities, the bio-functions more studied in the last years. The results show that traditional hams possess 
bioactive peptides able to join intact the blood circulation. With the help of fractioning experiments and in 
silico model, it has been found that aminoacids like tryptophan, tyrosine and fenilalaniline are the main 
responsible of antioxidant activity. Instead, for ace-inhibitory activity several peptide sequences were 
identified. 5 peptides (LGL, NSIM, ALM, SFVTT, GVVPL) have been synthesized, purified and tested in 
order to determine their IC50 value: the peptide LGL have been found to possess a significant ace-inhibitory 
activity (IC50=145μM), to be a true-inhibitor of Angiotensin-Converting-enzyme (Ace) and its 
quantification allowed to determine that its amount in a slice of ham may be sufficient to reach a 
physiologically relevant concentration. Also three Npads have been tested for the first time for this activity 
but, unfortunately, one is completely inactive (pyro-Phe (D5)) and the others two (Glu-Phe (D5), Lacto-Phe) 
have an IC50, although they were good candidate as bioactive peptides due to their resistance to the digestion 
process and someone also maybe to brush border peptidases. Among the identified sequences present there 
are RVAPEEHPT, VAPEEHPT, and LFDKPVSPL have not been tested in the literature for Ace-inhibitor 
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activity. Instead, IGGSI have not shown any ace-inhibitory activity. Peptides like AI(L), GI(L), I(L)F, LVL, 
instead, are ace-inhibitor sequences known in the literature (BIOPEP online database). Finally, the digested 
samples have shown also their potential to exert an antioxidant activity as radical scavengers and against 
peroxides. 
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07/2000 Forest sector: internship 
Valle D'Aosta 
11100 Aosta (Italy)  
Protection forest land. 
01/01/2012–31/12/2014 PhD student in Food Science and Technology  
Department of Food Science- Parma University, Parma (Italy)  
▪ Study of peptides, proteins in dry-cured hams 
▪ Nitrogen fraction characterization using Kjeldahl, chromatographic techniques 
(LC ), UV, fluorescence, mass spectrometry, MS/MS 
▪ Bottom-up proteomic: mono- and bidimensional electrophoresis, in-gel digestion, 
MS/MS 
▪ Simulated gastrointestinal digestion of dry-cured and characterization of the 
peptides generated 
▪ Solid phase and liquid peptide synthesis of peptides of interest in food  
▪ Study of transport of peptides in systems like co-culture Caco-2/H29-MTX and 
Ussing Chamber 
▪ Bioactive peptides: antioxidant and ace-inhibitory peptides 
2008–2010 Master Degree in Food Science and Technology (106/110)  
Faculty of Agriculture, Parma (Italy)  
Master thesis degree of six months: "Characterization of the Parmigiano-Reggiano 
soluble fraction and study of bioaccessibility using simulated gastrointestinal 
digestion" in the Department of Organic and Industrial Chemistry - University of 
Parma. 
▪ Chemistry, biochemistry and nutrition applied to the food sector 
▪ Food microbiology 
▪ Food businesses management 
▪ Food products and processes design 
2005–2008 Bachelor Degree in Food Science and Technology 
(102/110) 
 
Faculty of Agriculture, Parma (Italy)  
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PERSONAL SKILLS   
 
 
 
 
 
Bachelor thesis of three months: "Determination of free amino acids in complex food 
matrices: comparison of extraction, chromatographic and detection methods" at the 
Department of Organic and Industrial Chemistry, University of Parma. . 
▪ Food chemistry, 
▪ Food microbiology 
▪ Food technologies 
▪ Food nutrition 
 
2000–2005 High School diploma: scientific Lyceum (80/100)  
E. Berard (Liceo scientifico) 
Av. du Conseil des Commis 36, 11100 Aosta (Italy)  
▪ Chemical-biological science 
▪ Physics, mathematics 
▪ History, philosophy, latin 
▪ Italian, French, English 
Mother tongue(s) Italian 
  
Other language(s) UNDERSTANDING SPEAKING WRITING 
Listening Reading Spoken interaction Spoken production  
French B1 B2 B1 B1 B1 
English B1 B1 A2 A2 A2 
 
Levels: A1/A2: Basic user - B1/B2: Independent user - C1/C2: Proficient user 
Common European Framework of Reference for Languages  
Communication skills  
Team spirit gained from scouting and football activities. 
Good ability to adapt to multicultural environments gained university experience. 
Laboratory of food chemistry for the bachelor degree in Food Science and 
Technology 
Organisational / managerial 
skills 
Laboratory activity correlator of master degree and bachelor thesis in food science 
and technology. 
Job-related skills ▪ Liquid chromatography techniques 
▪ Mass spectrometry and MS/MS, UV, FLD 
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ADDITIONAL 
INFORMATION   
 
 
▪ Protein electrophoresis 
▪ Antioxidant activity 
▪ Ace-inhibitory activity 
▪ Peptides and peptide-derivatives synthesis 
▪ UV-Vis spectrophotometry 
Computer skills ▪ Good command of Microsoft Office™ (Word™, Excel™ e PowerPoint™); 
▪ Software for chromatographic data acquisition (MassLynx, Empower) and 
spectrophotometric data acquisition (LambdaBio) 
Driving licence B 
Publications ▪ Sara Paolella, Falavigna Claudia, Faccini Andrea, Virgili Roberta, Sforza Stefano, 
Dall'Asta Chiara, Arnaldo Dossena, Galaverna Gianni (2014). Effect of dry-cured 
ham maturation time on simulated gastrointestinal digestion: Characterization of 
the released peptide fraction, Food Research International, 2014 
▪ Claudia Vineis, Cinzia Tonetti, Sara Paolella, PierDavide Pozzo and Stefano 
Sforza,A UPLC/ESI–MS method for identifying wool, cashmere and yak fibres, 
Textile Research Journal, 2013 
▪ Chiara Bottesini, Sara Paolella, Francesca Lambertini, Gianni Galaverna, Tullia 
Tedeschi, Arnaldo Dossena,Rosangela Marchelli, and Stefano Sforza,Antioxidant 
capacity of water soluble extracts from Parmigiano-Reggiano cheese, Int J Food 
Sci Nutr, 2013 
▪ Sara Paolella, Mariangela Bencivenni, Francesca Lambertini, Barbara Prandi, 
Andrea Faccini, Cinzia Tonetti, Claudia Vineis and Stefano Sforza,Identification 
and quantification of different species in animal fibres by LC/ESI-MS analysis of 
keratin-derived proteolytic peptides, J. Mass Spectrom. 2013, 48, 919–926 
▪ Claudia Alessandri, Stefano Sforza, Paola Palazzo, Francesca Lambertini, Sara 
Paolella, Danila Zennaro, Chiara Rafaiani, Rosetta Ferrara, Maria Livia Bernardi, 
Mario Santoro, Sara Zuzzi,Ivana Giangrieco, Arnaldo Dossena, Adriano 
Mari,Tolerability of a Fully Maturated Cheese in Cow’s Milk Allergic Children: 
Biochemical, Immunochemical, and Clinical Aspects, PLoS ONE,July 2012, 
Volume 7, Issue 7, e40945. 
Conferences ▪ Sara Paolella, Characterization of bioactive peptides in dry-cured ham , PhD 
worshop 2014, 19
th 
Workshop on the Developments in the Italian PhD research on 
Food Science and Technology and Biotechnology, 24-26 Settembre 2014, Bari. 
▪ Gianni Galaverna, Sara Paolella, Claudia Falavigna, Roberta Virgili, Chiara 
Dall'Asta, Arnaldo Dossena,BIOACTIVE PEPTIDES GENERATED BY IN VITRO 
GASTROINTESTINAL DIGESTION OF DRY-CURED HAM, 6th International 
Symposium on Recent Advances in Food Analysis, 45, November 5–8, 2013, 
Prague, Czech Republic. 
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▪ Sara Paolella, Characterization and bioactivity of the peptide fraction of dry-cured 
ham as a function of production technologies, PhD workshop 2013, XVIII 
Workshop on the Developments in the Italian PhD research on Food Science and 
Technology and Biotechnology, 25-27 Settembre 2013, Conegliano. 
▪ Sara Paolella,Claudia Falavigna, Iulia Pantea, Arnaldo Dossena, Roberta Virgili, 
Gianni Galaverna,BIOACTIVE PEPTIDES GENERATED BY IN VITRO 
DIGESTION OF DRY-CURED HAM: EFFECT OF MATURATION TIME AND 
SALT CONTENT, EuroFoodChem XVII, Book of Abstracts,May 07-10,2013, 
Istanbul (Turkey). 
▪ S. Sforza, C. Bottesini, S. Paolella, F. Lambertini, G. Galaverna, M. Nocetti, A. 
Dossena, R. Marchelli, ANTIOXIDANT ACTIVITY OF PARMIGIANO-REGGIANO 
CHEESES AT DIFFERENTAGEING TIMES, Summilk, IDF World Dairy Summit, 
Parma, 15-19 ottobre 2011, Final Programme, Nutrition and Health: Dairy 
products, a healthy choice, p58. 
▪ S. Sforza, F. Lambertini, M. Bencivenni, S. Paolella, A. Dossena, SHEEP 
CHEESES AND CASHMERE PULLOVERS: MS-CERTIFIED AUTHENTICITY 
THROUGH PEPTIDE ANALYSIS,XXIV Congresso Nazionale della Società 
Chimica Italiana, Lecce, 11-16 settembre 2011, DSM-OR-03, p1170. 
▪ C. Bottesini, S. Paolella, F. Lambertini, G. Galaverna, A. Dossena, R. Marchelli, S. 
Sforza ANTIOXIDANT ACTIVITY OF THE PEPTIDE FRACTION FROM 
PARMIGIANO-REGGIANO AT DIFFERENT AGEING TIMES, EuroFoodChem 
XVI Polish Journal of Food and Nutrition Sciences,Conference Proceeding, 
Gdansk 6-8 luglio 2011. 
▪ P. Palazzo, S. Sforza, C. Alessandri, F. Lambertini, S. Paolella, M. Liso, D. 
Zennaro, A. Dossena, A.Mari, MILK ALLERGEN DETECTION IN ORIGINAL 
PARMIGIANO-REGGIANO CHEESE USING ISAC INHIBITION ASSAY 
(SPHIAa), 30th Congress of the European Academy og allergy and Clinical 
Immunology, Instanbul, Turkey, 11-15 giugno 2011. 
Honours and awards Winner of the third award of Trophelia 2008: award for food innovation in Italy and 
Europe with the project "Edible container of surprises for chocolate eggs." Award 
obtained with the team FIAMS STA, Faculty of Agriculture, University of Parma 
Competition organized by Trophelia-Federalimentare, May 8, 2008 
